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For Jesus, my family, Winston and Barbara, my parents, Winston, my brother  
and Christy Ringrose. 
Exodus 18:5-27: Jethro, Moses’ father-in-law, together with Moses’ sons and wife, came to him in 
the wilderness, where he was camped near the mountain of God. Jethro had sent word to him, “I, 
your father-in-law Jethro, am coming to you with your wife and her two sons.” So Moses went out to 
meet his father-in-law and bowed down and kissed him. They greeted each other and then went into 
the tent. Moses told his father-in-law about everything the LORD had done to Pharaoh and the 
Egyptians for Israel’s sake and about all the hardships they had met along the way and how 
the LORD had saved them. Jethro was delighted to hear about all the good things the LORD had done 
for Israel in rescuing them from the hand of the Egyptians. He said, “Praise be to the LORD, who 
rescued you from the hand of the Egyptians and of Pharaoh, and who rescued the people from the 
hand of the Egyptians. Now I know that the LORD is greater than all other gods, for he did this to 
those who had treated Israel arrogantly.” Then Jethro, Moses’ father-in-law, brought a burnt 
offering and other sacrifices to God, and Aaron came with all the elders of Israel to eat a meal with 
Moses’ father-in-law in the presence of God. The next day Moses took his seat to serve as judge for 
the people, and they stood around him from morning till evening. When his father-in-law saw all 
that Moses was doing for the people, he said, “What is this you are doing for the people? Why do 
you alone sit as judge, while all these people stand around you from morning till evening?” Moses 
answered him, “Because the people come to me to seek God’s will. Whenever they have a dispute, it 
is brought to me, and I decide between the parties and inform them of God’s decrees and 
instructions.” Moses’ father-in-law replied, “What you are doing is not good. You and these people 
who come to you will only wear yourselves out. The work is too heavy for you; you cannot handle it 
alone. Listen now to me and I will give you some advice, and may God be with you. You must be the 
people’s representative before God and bring their disputes to him. Teach them his decrees and 
instructions, and show them the way they are to live and how they are to behave. But select capable 
men from all the people—men who fear God, trustworthy men who hate dishonest gain—and 
appoint them as officials over thousands, hundreds, fifties and tens. Have them serve as judges for 
the people at all times, but have them bring every difficult case to you; the simple cases they can 
decide themselves. That will make your load lighter, because they will share it with you. If you do 
this and God so commands, you will be able to stand the strain, and all these people will go home 
satisfied.” Moses listened to his father-in-law and did everything he said. He chose capable men 
from all Israel and made them leaders of the people, officials over thousands, hundreds, fifties and 
tens. They served as judges for the people at all times. The difficult cases they brought to Moses,  
but the simple ones they decided themselves.  





This thesis describes approaches taken to classify the functionally diverse neutrophil 
by its different functions in a live-cell imaging tool. Human neutrophil elastase 
(HNE) cleaves over 30 substrates, its release is controlled with varying extents of 
degranulation and its activity is subject to complex modulation. HNE regulation is 
necessary for the maintenance of health via HNE’s multiplicity of functions.  
Although neutrophils are routinely quantified in assessments of chronic 
inflammation, we do not have a clinically translatable, integrated tool for measuring 
HNE in human tissues. Two novel probes have been characterised and multiplexed 
to form the basis of an imaging technique for understanding the functional 
implications of neutrophil activity in human tissues, in real-time. Neutrophil 
Activation Probe (NAP) and VE200 are novel probes for HNE activity and presence. 
These probes are characterised in vitro as sensitive and HNE-specific imaging agents 
for live-cell imaging and image cytometry. 
Multiplexed NAP and HNE are detect neutrophil activation, apoptosis and necrosis. 
These imaging agents can inform deep profiling techniques to separate neutrophils 
into untreated, primed, activated and primed-activated states and endogenous vs. 
exogenous stimulus sub-states. Finally, sections of adenocarcinomatous human lung 
and whole human lungs, ventilated ex vivo, demonstrate the applicability of HNE-
based, multiparametric profiling and neutrophil activation detection to clinically 





Chronic inflammatory diseases can vary so much that it’s not always clear which 
treatment is most appropriate. Sorting patients into the right treatment groups is 
called patient stratification. The body’s white blood cells, work together to respond 
to disease appropriately, restore health and keep us immune to diseases, they may 
be a reliable source of patient stratification and disease monitoring information. 
Extracting this information means accessing diseased tissues, finding white blood 
cells and understanding their activity. We can use optic fibres as microscopes to do 
this.  
My research describes two new reagents that make neutrophils light-up so that we 
can count and describe them. These reagents provide clear and sensitive 
measurements, telling us when neutrophils are activated to fight disease. Just 
counting neutrophils is already useful in patient stratification. But the enzyme that 
these reagents interact with is so carefully controlled that it can show us different 
patterns of light. I found that there was enough information in these images to 
organise neutrophils into different groups. This means that we can understand what 
different groups of neutrophils are responding to. These findings may be useful in a 
range of contexts: Biologists may use them to describe how neutrophils respond to 
a change, pharmacologists, to describe how neutrophils respond to a drug and 
clinicians for patient stratification. Further work will be needed to understand how 
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α-1-PI: alpha-1-protease inhibitor 
AAPV-pNA: colourimetric HNE substrate  
 
ARDS: acute respiratory distress syndrome  
CG: Cathepsin G 
 
EVLV: ex vivo lung ventilation 
 
FCE: fibred confocal endomicroscopy  
FLIM: fluorescence lifetime imaging  
FLIM: Fluorescence lifetime microscopy  
fMLF: N-formylmethionine leucyl-phenylalanine  
FMT: Fluorescence molecular tomography 
FSC: Forward Scatter 
HBSS: Hanks buffer salt solution 
HEPES: N-2-Hydroxyethylpiperazine-N-2-Ethanesulfonic 
Acid 
HNE: Human Neutrophil Elastase  
IL8: Interleukin 8 
LDA: Linear discriminants analysis  
LPS: Lipopolysaccharide  
LTB4: leukotriene B4 
mHNE: membranous Human Neutrophil Elastase 
vii 
 
AAPV-AMC – coumarin-labelled HNE substrate 
NAP: Neutrophil activation probe  
NET: Neutrophil extracellular trap 
OEM: Optical endomicroscopy 
OI: Optical imaging  
PAF: Platelet activating factor, β-Acetyl-γ-O-hexadecyl-L-α-
phosphatidylcholine hydrate  
PBMC – Peripheral blood mononuclear cell 
PBS: phosphate buffer saline  
PCA: Principle components analysis 
PFA: Paraformaldehyde  
PMN: polymorphonuclear cell 
PR3: Proteinase 3 
RFU: Relative fluorescence units  
ROS: reactive oxygen species  
SD: standard deviation  
SEM: Standard error of the mean  
SSC: Side scatter 
TAN: Tumour associated neutrophils 
TLR: Toll-like Receptor  
TPR: True Positive Rate 
VE200: HNE-targeted probe (the 200th synthetic attempt 
of Dr. Vikki Evans)  
viii 
 
PUBLICATIONS AND LICENSES 
 
I have contributed, as a joint-first author, to the following article:  
Birch, G., Campbell, T., Bradley, M. and Dhaliwal, K., 2019. Optical molecular 
imaging of inflammatory cells in interventional medicine-an emerging 
strategy. Frontiers in Oncology, 9, p.882. 
Licenses to reuse figures and tables in this thesis from other published works were 
granted under Creative Commons 3.0 or 4.0 licences or obtained through the 
Copyright Clearance Centre’s RightsLink Service or directly from the publisher. All 
reused figures and tables have appropriate permissions and are acknowledged in 















TABLE OF CONTENTS 
 
Declaration ................................................................................................ i 
Dedication ................................................................................................ ii 
Abstract ................................................................................................... iii 
Lay Summary .......................................................................................... iv 
Acknoweldegments .................................................................................. v 
Abbreviations ........................................................................................... vi 
Publications and Licenses ..................................................................... viii 
Table of Contents .................................................................................... ix 
List of Figrues ........................................................................................ xxi 
List of Tables ....................................................................................... xxiv 
 
Chapter 1: Introduction to Neutrophil Biology and Imaging .............. 0 
            1.1.0 Brief History of Neutrophil Discoveries ................................ 1 
            1.1.1 Neutrophils ......................................................................... 3 
                   1.1.2 Neutrophil Recruitment ................................................. 3 
                   1.1.3 Extravasation ................................................................ 5 
                   1.1.4 Neutrophil Lifespan ....................................................... 6 
                   1.1.5 Neutrophil Activation ..................................................... 8 
                   1.1.6 HNE Release in Sterile Inflammation ........................... 8 
x 
 
                   1.1.7 HNE Release in Non-Sterile Inflammation .................. 10 
         1.2.0 Fluorescence ...................................................................... 12 
                   1.2.1 Optical Imaging ........................................................... 14 
                   1.2.2 Depth and Resolution ................................................. 15 
                   1.2.3 Throughput ................................................................. 16 
                   1.2.4 Reproducing In Vivo Conditions ................................. 17 
                   1.2.5 Optical Imaging Probes .............................................. 18 
                     1.3.0 Clinical Optical Molecular …………………………….…19 
                   1.3.1 Neutrophils as Biomarkers .......................................... 22 
                   1.3.2 Neutrophil Imaging Probes ......................................... 26 
                   1.3.3 Probing Serine Proteases ........................................... 28 
                   1.3.4 Probing Formyl Peptide Receptor 1 ............................ 28 
                   1.3.5 Label free Neutrophil Imaging ..................................... 30 
                   1.3.6 Raman Spectroscopy ................................................. 31 
                   1.3.7 Two-Photon Endogenous FLIM .................................. 32 
                   1.4.0 Image Cytometry and data Science ............................ 34 
 
Chapter 2:  Materials and Methods ..................................................... 36 
            2.1.0 Ethical Statement .............................................................. 37 
            2.1.1 Materials ............................................................................ 37 
            2.1.2 SmartProbe Synthesis ....................................................... 38 
xi 
 
            2.1.3 Spectrophotometer Assays................................................ 40 
            2.1.4 Determining kinetic rate constants ..................................... 40 
            2.1.5 Data-reduction ................................................................... 40 
            2.1.6 Derivation of the Michaelis Menten Equation .................... 41 
            2.1.7 NAP Selectivity for Serine Proteases ................................ 42 
            2.1.8 Primary Human Neutrophil Supernatants and Lysates ...... 44 
            2.1.9 Determining Fixed Purified HNE Activity ........................... 45 
            2.2.0 Preparation of human polymorphonuclear cells and                 
.                    peripheral blood multi and mononuclear cells  from whole .                         
.                    blood .................................................................................. 45 
            2.2.1 Preparation of isolated leukocyte cytospins ....................... 46 
            2.2.2 Flow Cytometric Analyses of PMN .................................... 46 
            2.2.3 Determining HNE activity following PMN fixation ............... 47 
            2.2.4 Laser scanning confocal microscopy of PMN .............. 49 
                2.2.5 Intracellular NAP signal generation ............................... 50 
                2.2.6 Primary Human Neutrophil HNE Immunofluorescence .. 50 
                2.2.7 Laser scanning confocal microscopy image analysis .... 51 
            2.3.0 Spinning disk confocal microscopy of leukocytes ...... 51 
                 2.3.1 HNE-targeted probe dosing .......................................... 52 
                 2.3.2 Intracellular NAP signal generation under bacterial .                    
.                          product stimulation ...................................................... 52 
xii 
 
                 2.3.3 Intracellular NAP signal generation under inhibition ..... 53 
                 2.3.4 HNE labelling of viable, apoptotic and necrotic .                    
.                         neutrophils .................................................................... 53 
                 2.3.5 NAP and HNE-targeted probe multiplexed labelling ..... 54 
                 2.3.6 HNE presence and activity under varying chemokinetic .                    
.                         stimulation .................................................................... 54 
                 2.3.7 HNE presence and activity in COPD neutrophils under .                         
.                         varying chemokinetic stimulation .................................. 55 
                 2.3.8 Immunohistochemistry of  Paraffin-Embedded Human .                         
.                         Tissues ......................................................................... 55 
          2.4.0 Fibred confocal endomicroscopy of leukocytes ............ 56 
                 2.4.1 Fibred confocal HNE imaging in vitro ........................... 56 
                 2.4.2 Fibred confocal HNE imaging in  an ex vivo ventilated .                         
.                         lung model .................................................................... 57 
          2.5.0 Image Analysis of Spinning disk confocal microscopy of 
.                   leukocytes ......................................................................... 57 
                 2.5.1 Intracellular NAP signal generation under bacterial .                         
.                         product stimulation ....................................................... 57 
                 2.5.2 HNE targeted probe dosing .......................................... 58 
                 2.5.3 Neutrophil Apoptosis and Necrosis ............................... 58 
                 2.5.4 Image Cytometric Analysis ........................................... 59 
                 2.5.5 Immunohistochemistry of human tissues ...................... 60 
xiii 
 
         2.5.6 Neural Network modelling .................................................... 60 
         2.5.7 Fibred confocal endomicroscopy .......................................... 61 
         2.6.0. Statistical analysis ............................................................... 61 
 
Chapter 3: Characterising Neutrophil Activation with Neutrophil 
Activation Probe in vitro ...................................................................... 62 
         3.0.0 Introduction……………………………………………..……..63 
          3.1.0 Pharmacological Neutrophil Activation ................................ 64 
                 3.1.1 Serine Proteases in Apoptosis ...................................... 65 
                 3.1.2 Serine Protease Kinetics .............................................. 67 
.                       3.1.3 NAP Toxicity……………….……...………………………68 
                        3.1.4 Hypothesis and Aims……………………………………..69 
         3.2.0 Results…………………………………………...………………71 
                  3.2.1 Characterising the dose-fluorescence relationship for             
.                           NAP.. .......................................................................... 69 
                 3.2.2 Characterising NAP: temperature-fluorescence                     
.                         relationship………………………………………………...72 
                 3.2.3 Characterising NAP: the ph-fluorescence relationship . 74 
                 3.2.4 Characterising the serprocidin specificity of NAP:              
.                         absolute fluorescence ................................................... 76 
                 3.2.5 Characterising the serprocidin specificity of NAP: .                         




                3.2.6 The effect of calcium ionophore on neutrophil adhesion .                         
.                         molecule expression ..................................................... 81 
                3.2.7 The sensitivity of NAP to pharmacological HNE inhibition.                                       
.                          ………………………………………………………….83 
                 3.2.8 Intracellular nap signal kinetics during pharmacological .                                                   
.                         neutrophil activation ...................................................... 85 
                 3.2.9 Intracellular NAP signal kinetics during bacterial product-
.                         induced neutrophil activation ........................................ 87 
                 3.3.0 Detecting neutrophil activation across the neutrophil .                         
.                         lifespan: Whole-cell fluorescence ................................. 89 
                 3.3.1 Detecting neutrophil activation across the neutrophil.                         
.                         lifespan: Intracellular fluorescence ............................... 92 
                 3.3.2 Summary ...................................................................... 98 
         3.4.0 Discussion 
                 3.4.1 NAP Characterisation Studies with Purified Human.                         
.                         Neutrophil Elastase ...................................................... 98 
                 3.4.2 NAP Characterisation Studies with Primary Human .               
.                         Neutrophils ................................................................. 101 
 
Chapter 4: Characterising Neutrophil Activation using VE200 
in vitro ................................................................................................. 105 
.                4.0.0 Introduction …………………………………………………...106 
xv 
 
                 4.1.0 Irreversible Inhibitors of HNE ...................................... 107 
                 4.1.1 Serine Proteases ........................................................ 107 
                 4.1.2 Monocyte Elastase and Probe Specificity ................... 113 
.                                 4.1.3 HNE-targeted Probe Toxicity…………….……………114 
                         4.1.4 Hypothesis and Aims…………………………………..115 
     4.2.0 Results…………………………………………………………….117 
               4.2.1 Kinetics of the HNE – AAPV substrate interaction ….…116 
               4.2.2 GW447631 potency in primary human neutrophil lysates. .                                                                     
.                        ……………………………………………………………..118 
                 4.2.3 GW447631 kinetic analysis in live neutrophils ............ 120 
                 4.2.4 Fibronectin coated wells affect neutrophil activation ... 123 
                 4.2.5 HNE activity affects neutrophil shape-change ............ 125 
                 4.2.6 Spectral characteristics of the HNE-targeted probe                                                
.                         panel…………………………………………...…………127 
                 4.2.7 Neutrophil specificity of HNE-targeted probes ............ 129 
                 4.2.8 VE136 sensitively detects neutrophil activation .......... 131 
                 4.2.9 Neutrophil-specific targeted probes are HNE-specific 133 
                 4.3.0 VE200 demonstartes irreversible inhibitor kinetics ..... 135 
                 4.3.1 Establishing an optimal imaging dose for VE200 ........ 137 
                 4.3.2 VE200 labels neutrophils via its HNE-inhibitor moiety 139 
                 4.3.3 VE200 titration allows multiplexing with NAP .............. 141 
xvi 
 
                 4.3.4 Detecting neutrophil activation across the neutrophil .                         
.                         lifespan: intracellular fluorescence .............................. 144 
                 4.3.5 HNE-probe multiplexing across the neutrophil lifespan.          
.                         …………………………………………………………….150 
                 4.3.6 HNE-Probe signals are not correlated in neutrophil.                         
.                         apoptosis .................................................................... 152 
                 4.3.7 Initial kinetic characterisation of GW447631 inhibitory .                         
.                        constant ....................................................................... 155 
                 4.3.8 Summary .................................................................... 157 
           4.4.0 Discussion                                                                                  
.                4.4.1 Characterisation of GW447631 50% Inhibitory Constant.                                 
.                         …………………………………………………………….157 
                 4.4.2 Intracellular Kinetic Imaging of GW447631 Inhibition.158 
                 4.4.3 Flow Cytometric Analysis of  HNE-Targeted Probe .                
.__                      Labelling .................................................................... 160 
                 4.4.4 Sensing Graded Neutrophil Responses with                                                                               
.                          HNE-Targeted Probe Signals .................................... 161 
                 4.4.5 Live Cell VE200 Dosing and Image Analysis .............. 162 
                 4.4.6 Characterising VE200 and nap Multiplexing ............... 162 
                 4.4.7 NAP and VE200 Signal Decorrelation from Ageing PMN 




Chapter 5: HNE Imaging as a Neutrophil Stratification Tool in the 
Human Lung ....................................................................................... 167 
.                5.0.0 Introduction,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,……168 
                5.1.0 The Study of HNE under Fixation ................................ 169 
                 5.1.1 Differential HNE Release ............................................ 171 
                 5.1.2 Fibred Confocal Endomicroscopy ............................... 173 
                 5.1.3 Image Analysis ........................................................... 174 
                 5.1.4 Neural Networks ......................................................... 175 
                        5.1.5 Hypothesis and Aims………………………..………….178 
         5.2.0 Results………………………………………………………….180  
.                5.2.1 The effect of formaldehyde fixation  on purified human 
HNE.        ……………………………………………… ………………….. 180 
                 5.2.2 The effect of formaldehyde fixation on neutrophilic HNE 
.__                      activity and immunofluorescence ............................... 182 
                 5.2.3 Immunofluorescent staining of membranous HNE ..... 184 
                 5.2.4 Comparing HNE release and activity  by chemokinetic     
.__                      stimulus ..................................................................... 186 
                 5.2.5 Neutrophil activation detection  by HNE textural features.                                                   
.                         …………………………………………………………….190 
                 5.2.6 Neutrophil activation detection  by HNE intensity .__                      
.__                      features...................................................................... 193 
xviii 
 
                 5.2.7 Stimulus-dependent neutrophil classification by HNE .__                      
.__                      textural features ......................................................... 195 
                 5.2.8 Stimulus-dependent neutrophil classification                                            
.__                      by HNE intensity features .......................................... 198 
                 5.2.9 Stimulus-dependent neutrophil classification  by .__                      
.__                      multidimensional HNE imaging features .................... 201 
                 5.3.0 Stimulus-dependent classification of entire neutrophil .__                      
.__                      populations by neural network modelling ................... 203 
                 5.3.1 Comparing HNE release and activity  by chemokinetic ._                     
.__                     stimulus over time ....................................................... 205 
                 5.3.1 Quantifying NAP and VE200 fluorescence over time  209 
                 5.3.3 Comparing NAP and VE200 rate of labelling                                                 
.__                      by chemokinetic stimulus ........................................... 212 
                 5.3.4 Stimulus-dependent neutrophil classification  by .__                      
.__                      multidimensional hne features over time ................... 214 
                 5.3.5 Stimulus-dependent classification of entire neutrophil .__                      
.__                     populations over time by neural network modelling .... 217 
                 5.3.6 Stimulus-dependent classification of entire neutrophil .__                      
.__                     populations by time-grouped neural network modelling.                                                   
.                          ……………………………………………………………220 
                 5.3.7 Neutrophil activation detection in human lung .__                      
.__                     adenocarcinoma histological samples ........................ 222 
xix 
 
.                       5.3.8 Significance of Neutrophil infiltration in Human lung            
.                                  adenocarcinoma histological samples………………224 
                 5.3.9 Dual-probe neutrophil activation detection by fibred .__                      
.__                     confocal endomicroscopy in vitro ................................ 226 
                 5.4.0 Low spatial resolution dual-probe neutrophil activation 
.__                     detection in an ex vivo ventilated human lung ............ 229 
                 5.4.1 Comparing targeted and activable probe detection .__                      
.__                     sensitivity in an ex vivo ventilated human lung ........... 231 
                 5.4.2 High spatial resolution dual-probe neutrophil activation 
.__                     detection in an ex vivo ventilated human lung ............ 233 
                 5.4.3 Separating activated neutrophils populations  in an ex 
.__                      vivo ventilated human lung ........................................ 235 
                 5.4.4 Summary .................................................................... 237 
         5.5.0 Discussion 
                 5.5.1 HNE Activity Following Formaldehyde Fixation .......... 238 
                 5.5.2 Membranous HNE immunofluorescence .................... 239 
                 5.5.3 Characterising and Classifying Fixed Neutrophil .                         
.                          Populations by Chemokinetic Response ................... 240 
                 5.5.4 Characterising Live Neutrophil Populations.                         
.                          by Percentage Activation ........................................... 243 
                 5.5.5 Characterising Rate of Signal Accumulation in Neutrophil 
.                          Populations ................................................................ 244 
xx 
 
                 5.5.6 Classifying Live Neutrophil Populations by .                          
.                          Chemokinetic Response ............................................ 245 
                 5.5.7 Neutrophil activation detection in Human lung .                          
.                          adenocaricnoma samples .......................................... 248 
                 5.5.8 Fibre-Based Neutrophil Activation Detection  with .                          
.                          Multiplexed NAP and VE200 ...................................... 249 
Chapter 6 Summary and Future Directions ...................................... 252 
          6.1.0 Conclusions ..................................................................... 253 
                 6.1.1 Chapter Three summary ............................................. 254 
                 6.1.2. Chapter Four Summary ............................................. 256 
                 6.1.3 Chapter Five Summary ............................................... 258 
          6.2.1 Limitations and Future Directions ................................. 259 
                 6.2.3 Physical limitations to the Current Fibred confocal .                          
.                          microscopy technique ................................................ 261 
                 6.2.4 Contextualised Neutrophil quantitation ....................... 262 
                 6.2.5 Summary .................................................................... 263 
          6.3.0 Appendix ........................................................................... 264 
                 6.3.1 Substrates of HNE and the effects of their cleavage .. 264 
                 6.3.2 Statistical Ranking for objective feature selection ....... 268 




LIST OF FIGRUES  
Figure 1.1 Energy Transitions of Fluorescence 
Figure 1.2 Comparison of Optical Imaging techniques  
Figure 2.0 Synthetic Schemes for Neutrophil Activation Probe development  
Figure. 2.1 Synthetic precursors to Neutrophil Activation Probe 
Figure 2.2 Chemical Structure and Molecular Mass of Neutrophil Activation Probe 
Figure 2.3 Diagram of a data analysis workflow for image cytometric analyses 
Figure. 3.0. Structure and Function of Neutrophil Activation Probe 
Figure 3.1 NAP signal is dose dependent 
Figure 3.2 Baseline NAP signal varies with pH and temperature 
Figure 3.3 HNE activity increases in alkali pH. 
Figure 3.4  NAP selects for HNE activity at high physiological enzyme concentrations 
Figure 3.5  HNE selectivity of NAP signal increases with increasing serprocidin 
concentration and pH  
Figure 3.6 Percoll blood preparation derived neutrophils are sensitive to activation 
Figure 3.7 NAP detects HNE release and pharmacological inhibition. 
Figure 3.8 HNE is required for Neutrophil Activation Imaging using NAP  
Figure 3.9 In response to bacterial products neutrophil activation is rapidly detectable 
with NAP 
Figure 3.10 NAP continues to report activation as activated neutrophil populations age 
Figure 3.11 NAP detects neutrophil activation in stimulated, ageing neutrophil 
populations 
Figure 4.1 Activable FRET HNE Probe 
Figure 4.2 Schematic and in vivo function of NE680 FAST 
xxii 
 
Figure 4.3 Kinetics of the HNE-AAPV interaction 
Figure 4.4 GW447631 dose dependently inhibits HNE in neutrophil lysates  
Figure 4.5 GW447631 displays dose dependent intracellular HNE inhibition 
Figure. 4.6 GW447631 reverses the co-stimulatory effect of well-incubation on 
neutrophil activation    
Figure. 4.7 High GW447631 dose dependently reduces neutrophil activation dependent 
spreading  
Figure 4.8 Structures and spectral properties of candidate HNE-targeted probes 
Figure 4.9 Cell-type specificity of HNE-targeted probes 
Figure 4.10 PMN specific VE136 is sensitive to varying PMA stimulation 
Figure 4.11 Cellular and molecular specificity of HNE-targeted probes 
Figure 4.12 VE200 binds purified HNE irreversibly and with dose dependence 
Figure 4.13 200 nM VE200 optimally enables activated neutrophil detection  
Figure 4.14 VE200 labels neutrophils more efficiently than Free Cy5 
Figure 4.15 Low nanomolar VE200 doses enable multiplexed neutrophil labelling with 
NAP  
Figure 4.16 NAP and VE200 multiplex to report activation in ageing neutrophil 
populations 
Figure 4.17 VE200 reduction of NAP signal is most pronounced at 20 hours  
Figure 4.18 Correlation between NAP and VE200 signal decreases at 6 hours 
Figure 5.0 Signalling pathway for adhesion-enhanced chemokinetic degranulation 
Figure 5.1 Schematic of an Artificial Neural Network 
Figure 5.2 Formaldehyde can be titrated to preserve HNE activity 
xxiii 
 
Figure 5.3 NAP can detect neutrophil activation after fixation 
Figure. 5.4 Spatial Relationship between HNE and Plasma Membrane 
Figure. 5.5 HNE Immunofluorescence and NAP fluorescence are insufficient for binary 
classification 
Figure. 5.6 Textural features exhibit insensitive identification of neutrophil activity  
Figure. 5.7 Intensity features exhibit moderately sensitive identification of neutrophil 
activity 
Figure. 5.8 Textural features exhibit insensitive classification of neutrophils by stimulus 
Figure. 5.9 Intensity features exhibit sensitive classification of neutrophils by stimulus 
Figure. 5.10 Optimal textural and intensity features are sufficient for NAP and HNE.ab 
bright activated neutrophil subclassification 
Figure. 5.11 Neural network classification of six distinct classes neutrophils following 
fixation 
Figure. 5.12 Chemokinetic stimuli elicit varying HNE patterns in COPD patient 
neutrophils 
Figure. 5.13 VE200 and NAP label neutrophils with different temporal patterns 
Figure. 5.14 Rate of HNE labelling may vary with chemokinetic specificity 
Figure. 5.15 VE200 classifies activated COPD neutrophils more specifically than NAP 
over time 
Figure. 5.16 A neural network classifies six neutrophil populations by chemokinetic 
stimulus using live-cell imaging data 
Figure. 5.17 Neural network classification improves with time-resolved image sets 
xxiv 
 
Figure 5.18 Immunohistological HNE imaging enables multiparametric neutrophil 
activation detection 
Figure 5.19 Significance of neutrophil infiltration in human lung adenocarcinoma 
histological samples 
Figure 5.20 Activated neutrophils are visible via Versicolour fibred confocal 
endomicroscopy with multiplexed NAP and VE200 
Figure 5.21 At 200 nM VE200, optical molecular imaging shows activated neutrophils 
are rapidly detected with low spatial resolution 
Figure 5.22 200 nM VE200 detects activated neutrophils despite low spatial resolution 
Figure 5.23 NAP and VE200 signals colocalize at sites of neutrophil activation in an ex 
vivo human lung 





LIST OF TABLES  
Table 1.1 Evidence for the role of neutrophils as biomarkers in various diseases 
Table 1.2 Overview of optical probes developed for neutrophil imaging.  


















CHAPTER 1:  
INTRODUCTION TO NEUTROPHIL 















1.1.0 BRIEF HISTORY OF NEUTROPHIL DISCOVERIES  
Since its discovery in 1882, by the Russian biologist Ilyia Metchnikoff, the neutrophil 
has been under constant scrutiny. Inserting rose thorns into starfish, Metchnikoff 
discovered cells engulfing the distal end of his instrument, which he divided into 
macrophages and microphages based on their size and phagocytic function. 
Microphages would later come to be known as neutrophils, and in addition to 
phagocytosis, many more functions would be revealed as the cellular components 
of the immune system were classified. With this initial taxonomic step neutrophil 
biology began, setting the stage for subsequent discoveries. For his pioneering 
work, Metchnikoff is regarded as the father of natural immunity. 137 years later we 
have learned much about neutrophil phagocytosis, degranulation, extravasation, 
apoptosis, necrosis, NETosis and more. The neutrophil has a diverse array of 
functions, elicited in various activation states, making paradoxical contributions 
both to health and disease. Neutrophil priming was discovered in 1984 when 
Guthrie et al. added this pre-activated and activation-augmenting state to those 
known prior: quiescence, activation, apoptosis and necrosis.1 Neutrophil NETosis, 
an evolutionarily ancient means of weaponising DNA, was only discovered in 2004 
by Brinkman et al., and has gained mechanistic importance in several disease 
processes since then.2 Today we know far more about the neutrophil than 
Metchnikoff did and this leaves greater challenges of knowledge organisation and 
integration incumbent on the immunologist. Basic and translational research are co-
dependent, synergistic disciplines and the recent ten-year commitment to 
“Transforming UK Translation” of The Wellcome Trust, The Royal Academy of 
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Engineering, The Royal Society and The Academy of Medical Sciences emphasizes 
the need for the latter. Many “new” therapies exploit the same mechanisms as 
existing drugs.3 And yet immunological research is one of many scientific disciplines 
which are advancing simultaneously and thereby creating opportunities to harness 
neutrophil biology for truly innovative therapeutic interventions. Image cytometry 
has realised previously unimaginable rates of learning from large biological 
datasets. Machine-learning techniques may provide tools of sufficient sophistication 
to characterise the pleiotropic set of neutrophil behaviours. With such a taxonomy, 
neutrophil states could be classified in real-time, using molecular imaging, in the 
changing inflammatory milieu of the patient. Numerous studies have demonstrated 
the prognostic power of simple neutrophil enumeration.4–9 A qualitative 
understanding of each neutrophil in a population is the logical consequence of 
neutrophil enumeration, refining quantitation with precision that may enhance its 
application in academic research, drug development and clinical trials. I sought to 
create this precise tool by leveraging the informative pleiotropism of human 







1.1.1 NEUTROPHILS  
Their capacities to respond en masse and rapidly, underscore their potential as 
biomarkers, capable of producing large readouts in short time-frames – properties 
that are particularly desirable for surgical guidance and drug development assays. 
The relatively short neutrophil half-life acts to limit any off-target consequences of 
labelling to timeframes of days or hours whilst the persistence of the neutrophilic 
influx in inflamed tissues, makes neutrophil readouts useful over the entire disease 
monitoring period, irrespective of its duration. Overall, neutrophil imaging creates 
an ideal paradigm for patient-specific disease monitoring and intervention. 
1.1.2 NEUTROPHIL RECRUITMENT  
Circulating neutrophils can be divided into circulating and marginated pools as the 
Wintrobe group first demonstrated. The finding that nearly 50% of 32P-labelled, 
autologous neutrophils disappear from circulation following infusion lead the group 
to postulate technical errors or redistribution of infused neutrophils between the 
circulation and an additional pool.10 Subsequent work demonstrated that the 
missing neutrophils could be restored to the circulation with the addition of 
adrenaline, providing good support for the margination of infused neutrophils.11 
The release of neutrophils from marginated pools into the systemic circulation helps 
to explain their accumulation at an inflammatory site and sustained numbers in 
circulation following recruitment, a processes that classically follows five phases. 
With respect to the endothelium, recruited neutrophils are first captured, that is 
they form initial attachment, before executing rolling adhesion, firm adhesion -
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accompanied by cell spreading, crawling motility and finally transmigration. 
Following transmigration into the tissue, the neutrophil may be exposed to a range 
of pro-inflammatory stimuli which lead to neutrophil activation and the sequelae 
thereof. The range of chemoattractants, their combination with different humoral 
factors and the specialisations of different marginated pools may each contribute to 
detectable differences in recruited neutrophils. Quantifying these differences could 
enable data-driven classification of phenotypes and reveal the recruiting conditions. 
During rolling adhesion, the majority of leukocytes can withstand sheer stresses of 1 
dyn/cm-2. Neutrophils have a unique capacity to withstand up to 10 dyn/cm-2 during 
rolling adhesion, and 30 dyn/cm-2 in the presence of P-selectin. To achieve such 
sheer stress resistance neutrophils have a range of strategies. Flattening out 
increases adhesion molecule engagement, and neutrophils employ more selectins. 
Selectin “catch-bonds” are strengthened by increased sheer stress.12 Finally 
neutrophils employ specialised membranous protrusions: slings and tethers, 







1.1.3 EXTRAVASATION  
A critical role for HNE in neutrophil biology is extracellular matrix (ECM) digestion, 
allowing neutrophils to leave the blood space, enter the tissue space and effect 
their characteristic pro-inflammatory roles. This is extravasation and it makes use of 
HNE’s unusual multiplicity of targets and plasma membrane affinity, 
simultaneously. Neutrophil extravasation, or transendothelial migration, can take 
paracellular15 or transcellular16 forms moving between or through endothelial cells 
respectively. HNE is localized to the leading edge of transmigrating neutrophils17 
where it cleaves intercellular adhesion molecules18 and ECM components including 
elastin, laminins, decorin, collagens and fibronectin.19–25 These proteolytic events 
allow neutrophils to traverse the ECM but also produce a range of neutrophil, 
monocyte and macrophage chemoattractants24,26–28 and release vascular 
endothelial growth factor.29  
Under the influence of a chemotactic gradient neutrophils use high affinity 
chemokine receptors to move towards a chemoattractant source and low affinity 
receptors to halt chemotaxis.30 However, neutrophils execute different migration 
patterns with chemoattractant specificity. Leukotriene B4 (LTB4) and fMLF elicit 
highly directional neutrophil migration, so called convergent migration, as it 
facilitates rapid convergence on the source of chemoattractant. LTB4 is released in 
a paracrine fashion, increasing the number of migrating neutrophils and their 
overall migratory distance.31 LTB4 stimulation also promotes paracrine LTB4 release 
and the resultant positive feedback loops are important in facilitating neutrophil 
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swarming motility.32 C5a and IL8 however, stimulate a more meandering, divergent, 
chemotaxis. Convergent and divergent migration are chemokine concentration-
independent processes. Neither convergence or divergence are precipitated by one 
signalling cascade but by more complex mechanisms that allow signal integrations 
and modulated receptor expression in the presence of competing chemokines.33 
Competing chemokinetic signals are integrated hierarchically as signalling from 
certain chemokines supervenes that of others. Unlike platelet-activating factor 
(PAF) receptors, fMLF receptors are stored in mobilisable intracellular pools and 
their increased expressions enable fMLF signalling to become dominant in a PAF-
laden milieu.34 Whereas convergent migration may be expected of neutrophils 
seeking a bacterial target, divergent migration may serve a more 
exploratory/surveillance function.31 Convergent and divergent migration and 
dynamic chemokinetic signal processing demonstrate the neutrophil’s ability to 
employ detectable behaviours with stimulus specificity. 
 
1.1.4 NEUTROPHIL LIFESPAN  
The view that neutrophils circulate with a half-life of 6-8 hours under normal 
physiological conditions, is widely-held and yet in a seminal report (Mauer et al. 
1960) neutrophils were labelled with a reagent which was both radioactive and a 
structural analogue of the nerve gas, sarin.10 More early support for the 6-8 hour 
half-life came from studies of neutrophils following allogeneic blood transfusion.35 
In 1971, Dresch, Najean and Beauchet reported that the sarin analogue, DF32P has 
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the cytotoxic effect of reducing neutrophil half-life.36 Pillay et al. reported a 90 hour 
half-life claiming that such extensive lifespans can only be observed using in vivo 
methods.37 However off-target labelling can confound in vivo measurements and 
Pillay et al.’s work has been criticised as an over-estimate of neutrophil half-life by 
labelling bone-marrow neutrophils.38 Neutrophils can become primed by a variety 
of methods for their isolation from whole-blood and so differences in measured 
half-lives may be methodological in origin.39 Indeed, in their 2013 review of 
neutrophil lifespan studies from 1960 to 2010 Tak et al. decry a variety of 
methodological limitations confounding reported half-life measurements, from 
toxic neutrophil labels, to manipulative ex vivo conditions, to uncertainty between 
measurements arising from the systemic circulation and the bone marrow.40 More 
conclusive work on the in vivo lifespan of neutrophils is required to establish this 
fundamental question of neutrophil kinetics and thanks to a wealth of fluorescent 
neutrophil labelling techniques (discussed in 1.3.2 Neutrophil Imaging Probes) this 
data may not take another fifty years to acquire. In the field of neutrophil kinetics, it 
is well accepted that neutrophil lifespan extends several-fold following neutrophil 






1.1.5 NEUTROPHIL ACTIVATION 
Circulating in a quiescent state, neutrophils become partially activated on 
transmigration through the vascular endothelium. Upon activation neutrophils gain, 
pinocytic, phagocytic, degranulating and NET-releasing functions. If neutrophils are 
exposed to priming and subsequent activating stimuli their activation-dependent 
functions are augmented. Neutrophils detect activating stimuli through numerous 
cell-surface receptors which are comprehensively reviewed by Futosi et al.42 Briefly 
these include receptors for pathogen-associated molecular patterns, opsonization, 
chemokines, cell signalling and complement. Neutrophils also express a range of 
intracellular receptors sensitive to nucleotides and viral RNA.43,44 Receptor 
occupancy activates intracellular signalling leading neutrophils to execute their 
effector functions. Neutrophil activation has been described in sterile and non-
sterile inflammatory paradigms. 
 
1.1.6 HNE RELEASE IN STERILE INFLAMMATION 
Although commonly considered in its pathogen-response paradigm, the immune 
system also responds to sterile host-tissue damage. In fact, recent research 
indicates that host-tissue damage may be necessary for the neutrophil response to 
bacterial infection.45 In under an hour, neutrophils, responding to a diffusion of lytic 
cell contents or a fragmenting extracellular matrix, begin infiltrating damaged 
tissue.25,46 These chemoattractant factors are known as damage associated 
molecular patterns (DAMPs), a diverse and growing number of molecules capable of 
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stimulating leukocyte recruitment including adenosine, mitochondrial formylated 
peptides and collagen fragments. Instead of traversing the parenchyma or 
interstitium, their intravascular migration allows neutrophils to approach the 
damaged lesion.46 Extravasation can incur collateral host-tissue damage and 
sustained intravascular migration mitigates this effect.46 Similarly, DAMPs and 
paracrine signalling help neutrophils to accumulate, even swarm, at sites of injury, 
away from healthy tissue.32 
However neutrophil swarming does not prevent reverse transmigration, as these 
cells re-enter the systemic circulation and become widely dispersed throughout the 
body. Endogenous LTB4, which facilitates swarming, can also lead to reverse-
transmigration by promoting HNE-mediated proteolysis of intercellular adhesion 
molecules (JAM-C).18 The dissemination of activated neutrophils to multiple organs 
via reverse transmigration can have wide-spread, deleterious effects on healthy 
tissue. The Nourshargh group found that injecting LTB4 into mouse cremaster 
muscles lead to neutrophil accumulation and organ damage in the lungs, heart and 
liver.18 Increased plasma HNE, LTB4 and soluble JAM-C may implicate this 
mechanism of deleterious neutrophil dissemination in several sterile inflammatory 
diseases, including trauma-induced secondary acute respiratory distress syndrome, 
rheumatoid, psoriatic and osteoarthritis and systemic sclerosis.47–50 
The heterogeneous causes of sterile inflammation can result in varying neutrophil 
responses. Dry-eye disease, atherosclerosis and lung cancer represent three distinct 
patterns of sterile inflammation in which HNE serves pathological and reparative 
10 
 
functions. In dry-eye disease HNE’s reparative mucin stimulation is overwhelmed by 
HNE-rich neutrophil NETs, a key pathological factor as demonstrated by Mun et al.’s 
recent clinical trial.51–54 In atherosclerosis neutrophil infiltration occurs soon after 
fatty streak deposition and persists. Unfortunately increased neutrophil count in 
atheroma is a negative prognostic indicator with HNE promoting plaque 
destabilisation and pathological neovascularisation.55,56 In various solid tumours 
neutrophils may demonstrate anti- and pro-tumorigenic phenotypes, N1 and N2 
respectively.57 Although the existence of these two phenotypes in humans is 
contested as an oversimplification, the extremes of a spectrum of activated 
neutrophils.57  Supraphysiological HNE concentrations may kill cancer cells, however 
in lung cancer HNE alleviates growth-inhibiting signals and promotes metastasis.58,59 
 
1.1.7 HNE RELEASE IN NON-STERILE INFLAMMATION 
To detect pathogen associated molecular patterns neutrophils have pattern 
recognition receptors such as the toll-like receptors (TLRs). The well characterized 
LPS-TLR4 interaction precipitates increased TLR4 expression, ROS production, 
pinocytosis, phagocytosis and degranulation.60 Following TLR4 occupancy 
neutrophils engulf bacteria, forming the intracellular phagosome. Lysosomes and 
azurophil granules fuse with the phagosome forming the phagolysosome which 
undergoes proton-pump-mediated alkalinisation reaching an optimal pH range (pH 
8.5-9.0) for HNE activity.61 Phagolysosomal alkalinisation depends on potassium ion 
influx and this also results in phagolysosomal hypertonicity which displaces HNE 
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from anionic sulphonated proteoglycans.62 Dispersed through the alkaline 
phagolysosome HNE accesses and degrades microbes with maximal efficiency. 
Interestingly LPS exposure also facilitates hierarchical chemotaxis by preventing 
chemotaxis in response to C5a, IL8 and LTB4 and not fMLF.63  
 
Phagocytosis is not the only antimicrobial process which employs HNE activity. HNE 
is degranulated into the extracellular space and weaponizes ejected DNA in 
antimicrobial NETosis. Early in NETosis HNE translocates to the nucleus to cleave 
histones, decondensing chromatin.64 Following chromatin decondensation, the 
nuclear envelope disintegrates forming a chain of vesicles which deteriorate to 
allow positively charged proteases like HNE to associate with negatively charged 
chromatin.65 Neutrophils then round up and contract until the cell membrane 
ruptures allowing the intracellular homogenate to erupt and spread from this focal 
point. With associated endothelial cell toxicity in vitro, NETs may represent a high-
risk strategy for antimicrobial defence which requires careful regulation.66 The 
Papayanopulous group have demonstrated that when pathogens are too large for 
phagocytic clearance, the absence of phagosomes is detected in a dectin-1 
mediated fashion. HNE not sequestered to the phagolysosome translocates to the 
nucleus leading to NETosis.64 However Papayanopulous et al. do not explain how 
NETs are produced in the presence of smaller targets such as Staphylococcus 
aureus.67 Since its discovery in 2004 there are at least two forms of NETosis, suicidal 





Aleksander Jablonski first proposed the schematic illustration known as the 
“Jablonski Diagram” in 1933 to describe the electronic states of a molecule and its 
transitions between them. Molecules have a ground state (S0) and excited states (S1 
– Sn). Each state subdivides into vibrational levels. Energy entering the system as 
light is absorbed (a), driving electrons into higher energy excited states, but excited 
electrons will return to the ground state. Between vibrational levels of an excited 
state electrons may lose energy as heat or movement via internal conversion (d). 
Internal conversion can explain the descent of electrons from higher to lower 
energy excited states and electrons can return to the ground state via non-radiative 
transitions (b).  When an electron is in the lowest vibrational level of the lowest 
excited state it may lose energy as fluorescence (c) returning to (any of the 
vibrational levels of) the ground state. The range of ground state vibrational levels 
an electron may fall to explains the flourescence specturm of a given molecule, as 





Figure 1.1 Energy Transitions of Fluorescence 
An adapted Jablonski diagram shows light absorption (a), non-radiative transition 
(b) and light emission (c) internal conversion (d) and thte electronic states (S0 -Sn). 
Hence absorption (a), non-radiative transitions (such as internal conversion) and 
fluorescence emission help to explain the effects of incident light on a fluorescent 
molecule. Importantly, in single photon imaging techniques, emission photons 
always have less energy than excitation photons and hence emitted light is longer in 
wavelength than absorbed light. This helps to design multispectral imaging 




1.2.1 OPTICAL IMAGING  
Biological research uses fluorescent proteins and fluorophore-conjugated 
antibodies, it combines imaging and fluorescence sensing techniques, and so it 
relies heavily on optical imaging (OI) techniques. Utilising the 400-700 nm 
wavelengths of visible light allows OI to achieve sub-cellular microscopic resolution. 
Meso and macroscopic images are also accessible to the investigator via OI. 
Fluorophore synthesis is relatively cheap, antibody conjugation is readily achieved 
at the bench, and a variety of fluorescent reagents are commercially available so 
that OI can be implemented at low cost. OI is minimally invasive and highly versatile 
with a range of signal accumulating strategies and spectrally distinct fluorophores 
for multiplexed OI. Capitalising on the advantages of OI, a range of imaging 
techniques have emerged, adapting the utility of light microscopy to a variety of 











1.2.2 DEPTH AND RESOLUTION 
Fluorescence microscopy became three-dimensional with the introduction of 
confocal scanning microscopy in 1955. Marvin Minsky’s invention could sample in-
focus light across a range of lateral positions and at a series of depths, stacking two-
dimensional cross-sections in the axial plane.69 Thirty-five years later the shallow 
penetration depths of OI would be overcome as Denk and Strickler combined two-
photon absorption with laser scanning technology to create multi-photon 
microscopy. High resolution imaging could now be acquired at 0.5 – 1.0 mm 
penetration depths instead of the 0.25 mm depth, previously attainable.70,71  
Through optical windows, multiphoton microscopy advanced in vivo imaging making 
cellular and molecular dynamics visible in diseased tissues with multispectral, sub-
cellular resolution imaging.72 Since 1999, with stimulated emission-depletion (STED) 
microscopy, super-resolution microscopy has emerged in a range of formats 
extending the lateral resolution of OI beyond the 100 nm diffraction limit of light 
and visualising intracellular organelles such as the endoplasmic reticulum with ≈50 




Figure 1.2 Comparison of Optical Imaging techniques  
Imaging depth vs. spatial resolution for super-resolution techniques (STED, PALM, 




Although OI became increasingly sophisticated to achieve greater lateral resolution 
and penetration depths, the new platforms were inherently, extremely low-
throughput. High-throughput imaging platforms emerged to capture population-
level metrics which could generalize more reliably across biological phenomena.  
Numerous plate-reader spectrometers have integrated CMOS camera technology to 
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offer high-throughput imaging for more comprehensive investigations. And digital 
flow cytometry has employed a similar strategy to simultaneously capture 
fluorescent images and per cell fluorescence intensity measurements across large 
populations of cells. These integrated systems failed to deliver high-resolution, 
multidimensional imaging that makes traditional confocal microscopy such a useful 
technique. Finally, by using cell-segmentation image analysis, the microscopic field 
of view could be dissected into its component cells, now individual regions of 
interest. Image cytometry developed to describe populations of cells, at the level of 
the individual cell, without compromising microscopic resolution or dimensionality. 
 
1.2.4 REPRODUCING IN VIVO CONDITIONS 
With OI observations becoming more representative of in vivo molecular events, 
more recent OI efforts have focused on reducing the perturbations required in 
image acquisition. Fluorescence molecular tomography uses sequential scanning 
and a series of detector pairs to describe fluorescence emission from stained, 
excised tissues and whole animal models in vivo.74 Using three-dimensional, 
sequential scanning and image reconstruction, image acquisition times are 
relatively long for fluorescence molecular tomography and resolution is limited by 
≈4 mm3 voxels.75 Label-free phase microscopy achieves a 90 nm lateral resolution, 
reconstructing live samples as three-dimensional refraction tomograms using image 
analysis and complex deconvolution techniques.76  
Fibred confocal endomicroscopy (FCE) is used in humans to access cells in situ and is 
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capable of multiplexing intrinsic autofluorescence, targeted and functional 
labelling.77 
1.2.5 OPTICAL IMAGING PROBES 
Four classes of fluorescent contrast agents are free dyes, targeted probes, activable 
probes and sensor probes. Free dyes are designed to avoid molecular interactions in 
vivo, instead they label entire fluid volumes illuminating the structure of fluid-filled 
compartments in a variety of organs. Indocyanine green (ICG) is a near-infra red 
fluorophore with FDA approval. Cheap, and non-toxic, ICG enables repeat-
measurements and is used in a variety of clinical settings including angiography, 
tumour resection and ophthalmic examination.78,79 For targeted, activable and 
sensor probes, target specificity becomes an important consideration if 
measurements are to be reliable. Targeted probes are designed to remain in 
solution until the molecular target is bound. Unbound targeted probe remains 
diffuse so that signal accumulation at target sites creates signal to noise contrast 
appropriate for imaging. Unbound probe may also be washed from off-target sites 
to enhance image contrast. Activable probes have a more sophisticated signal 
generation mechanism. Fluorescently quenched prior to encountering their 
molecular target, large signal to noise ratios can be generated by these probes.80 
Activable probes are often designed with in-built substrates for specific enzyme 
cleavage and generate higher resolution, more specific images when a mechanism 
to accumulate activated fluorescent fragments is employed.81 These properties 
make activable probes useful for cell tracking and describing varying extents of 
19 
 
probe activation within a cellular population. Finally, sensor probes rely on 
environmental changes, for example, in pH or redox state, to activate 
fluorescence.82 Like activable probes, sensor probes enable functional imaging in 
addition to the structural information they relay. The transient signals of sensor 
probes are lost as environmental conditions revert or exceed their detection ranges 
making these probes useful for kinetic studies but also increasing the likelihood that 
signalling events will go unnoticed. Different classes of contrast agent can be 
multiplexed towards different aims, for example, combined cell tracking and 
functional imaging. The mechanisms of signal generation in these four classes of 
contrast agent can be recombined to create variants such as the recent BODIPY 
probe for detecting fungal infection in vivo. Medive-Tapia et al. used an 
environmentally sensitive fluorophore to render a targeted probe fluorescently 
silent until interaction with its fungal target.83  
 
1.3.0 CLINICAL OPTICAL MOLECULAR IMAGING 
Recent developments in optical molecular imaging are enabling the identification 
and evaluation of inflammatory cells such as neutrophils in a variety of imaging 
scenarios. This is important as these leukocytes are an important part of host 
defence and immune homeostasis. The pivotal role of neutrophils as professional 
phagocytes in acute and chronic inflammatory disease may allow their use as 
versatile interventional biomarkers and as such fluorescent imaging of these cells 
has the potential to advance disease treatment and management, producing sub-
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cellular information in real-time.  Intrinsic tissue autofluorescence adds further 
value when the structures of the extracellular matrix or metabolic activities are of 
interest. The predominant modality of fluorescence intensity measurements, 
coupled with recent technological developments such as label-free nonlinear optical 
images and Raman analysis,84,85 have opened up the possibility of giving the 
surgeon functional images of the surgical site in real time. Furthermore, exciting 
developments are resulting from the integration of cell classification and machine 
learning techniques, allowing deeper analysis of the richness of the datasets of each 
image.  
Macroscopic widefield open fluorescence systems and high-resolution 
endomicroscopy are the predominant systems that have been used clinically to 
detect optical molecular tracers and recent advancements in imaging technology 
mean that fluorescence guided surgery is becoming a reality in cancer resection.86 
Complete tumour removal is crucial for patient outcomes, but difficult to ensure by 
conventional microscopy as visual characteristics and palpitation are inadequate to 
determine tumour-free margin. With fluorescence systems, surgeons will have the 
future ability to assess the extent of tumour excision and local metastases in real-
time using a fluorescent label that “lights-up” the tumour and hence delineates its 
margins. Optical endomicroscopy (OEM) enables optical imaging at high resolution 
typically via a bundle of optical fibres to enable imaging with microscopic 
resolution, with the added ability to explore within a variety of cavities. Recently 
fibre-bundle endomicroscopy has been used in the lung to assess alveolar structure 
in emphysema, neoplastic changes in epithelial cells and real-time in vivo detection 
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of bacteria.87–89 As well as in the GI tract where it has been used to detect changes 
associated with squamous cell carcinoma and colorectal polyps.90 There are a range 
of OEM platforms, spanning clinical use and developmental systems,89,91 although 
standardisation is necessary to generate meaningful diagnostic data.92  
To maximise the utility of real-time fluorescence imaging devices, optical molecular 
probes that provide contrast and are suitable for use in vivo are required. Although 
extensive libraries of optical tracers for many targets have been developed,93,94 
none have been licensed for routine clinical use. Here I will focus on fluorescent 
molecular probes for neutrophils. Recent agents allow the identification of 
neutrophils, as well as providing information on dynamic cellular processes such as 
enzymatic activity, redox processes and phagocytic ability; processes that impact 
pathophysiology. Overall, inflammatory cell imaging creates an ideal paradigm for 
patient-specific disease monitoring and intervention (Table 1.1). Recent advances in 
fluorescent and Raman imaging are enabling neutrophil burden and activity to be 
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Table 1.1 Evidence for the role of neutrophils as biomarkers in various diseases. Data 
referenced to meta-analyses or patient studies in the literature. Copyright Birch et al. 2019101 
 
1.3.1 NEUTROPHILS AS BIOMARKERS  
As cells that migrate to diseased tissues and accumulate, both over the course of a 
disease and due to chemotactic stimuli, neutrophils can provide meaningful 
prognostic data just by their enumeration. Neutrophil counts have long been used 
to stratify patients by scoring disease, for example in ulcerative colitis.102 Several 
large patient studies and systematic reviews, show the more recent neutrophil to 
lymphocyte ratio useful in staging inflammatory bowel disease (IBD) and numerous 
solid tumours6,103 as well as predicting cardiovascular disease, diabetic neuropathy, 
glaucoma, sepsis-induced acute kidney injury and bacteremia.95–97,99,104,105 Simple 
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neutrophil enumeration may even resolve the controversial question of when to 
intervene in carotid artery disease.106 Using explanted human tissues Ionita et al. 
evidenced correlations between neutrophil count and several critical factors in 
atherosclerotic plaque stability.107  
 
More sophisticated pathological insights can be drawn from qualified neutrophil 
enumeration, considering the viability status of neutrophils and quantifying 
neutrophil extracellular traps (NETs) independently of neutrophils in altered 
activation states. The accumulation of neutrophils on the ocular surface in dry-eye 
disease (DED) is thought to result in pathological NET formation.108,109 With the 
recent success of a phase I/II study evaluating DNAse treatment, NET burden is 
becoming an important clinical parameter in this disease.54 Impression cytology is a 
standard technique employed in the diagnosis of DED. However, there is now a 
convincing case for the replacement of the poorly standardized and potentially 
damaging impression cytology technique with in vivo laser scanning confocal 
microscopy, a technique which may itself be superseded by the rapidity and 
operational ease of OEM devices.110 Neutrophil nuclei undergo morphological 
changes in DED that can assist the detection of DED-related hyperosmolarity.109 
With the abundance of HNE in NETs and this enzyme’s stimulatory role in mucin 
production HNE may allow diagnostic disease monitoring in DED.51,111 Beyond the 
conjunctiva, the eye has vascular and neural similarities to the brain which are 
optically accessible. Through non-invasive eye examination, Alzheimer’s-related 
neurodegeneration has been linked to the development of retinal vasculature 
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abnormalities112 and Ramierez et al. have highlighted the retina’s biomarker 
potential in Alzheirmer’s, glaucoma and Parkinson’s disease.113 Neuroprotectin D1 
halves cerebral infarct size and counteracts neutrophil influx.114 Taken together 
these findings may indicate a role for retinal neutrophil monitoring in 
neurodegenerative disease. 
Another layer of insight may be accessible via measurement of neutrophil activity as 
studies of patients with inflammatory bowel disease have demonstrated. Patient 
studies found changes in faecal lactoferrin, calprotectin and HNE were significantly 
correlated with endoscopy and could be used to distinguish between mild disease, 
mucosal healing and clinical remission, and even predict flare onset.115 HNE is 
further implicated in IBD treatment by cleaving therapeutic monoclonal antibodies 
Infliximab, Adalumimab, Vedolizumab.116 The varied and clear benefits of such 
simple and direct analyses highlight the precision of the inflammatory response and 
the diagnostic potential of optical probes for neutrophil imaging. 
 
Where the inflammatory response yields more nuanced information, sophisticated 
neutrophil imaging techniques may be required for accurate disease monitoring. 
Tumour associated neutrophils (TANs) may produce particularly unintelligible 
neutrophil imaging readouts. TANs execute varied and oppositional roles in tumoral 
inflammatory milieu. In early stage lung cancer TANs help to limit disease progression 
however animal models have elucidated several pro-tumoral mechanisms for 
neutrophils.29,117,118 Some of the heterogeneity measured may come from relying on 
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the expression of TAN markers which can vary in different tumour 
microenvironments. Although yet unproven, N1 and N2 neutrophils may exert anti- 
and pro-tumoral effects respectively in humans, however there is no suitable marker 
exists for distinguishing between these phenotypes in the tumour.119  Label-free OEM 
could assist in the identification of neutrophils by accessing more stable features such 
as their polymorphic nuclei. Similarly, lymphocyte numbers have proven a useful 
means of gauging neutrophilia. The versatile NLR has become an attractive 
stratification tool for understanding patient risk in a variety of cancer settings. But 
the reported high and low risk thresholds are inconsistent and the prognostic value 
of NLR for individual patients is unclear.57 Imaging local inflammatory infiltrates may 
provide a necessary level of contextualisation for NLRs. Easily multiplexed and 
providing real-time, functional information at sub-cellular resolution neutrophil 
imaging probes may be uniquely capable of revealing an N1 to N2 ratio in the tumour 









1.3.2 NEUTROPHIL IMAGING PROBES 
Neutrophils make ideal biomarkers for several reasons. Constantly circulating and 
rapidly chemotaxing, neutrophils are the first leukocytes recruited to an 
inflammatory site. Neutrophil accumulate at the site of inflammation such that 
signal can be rapidly amplified. These properties are particularly desirable for 
fluorescence guided surgical operations. The neutrophilic half-life also benefits its 
biomarker potential as a relatively short neutrophil half-life limits any off-target 
effects which labelling might incur to days or hours. And neutrophils persist in 
inflamed tissues, providing information over the entire disease monitoring period, 
irrespective of its duration. Disease monitoring and intervention could benefit from 
such a biomarker. While fluorescence represents a cheap and versatile signal mode, 
recent advances in fluoresecence lifetime and Raman spectroscopic are also 
promising modes of optical imaging for non-invasive, real-time measures of 





























FPR1 Peptide Human 122 
Radioactive 
nanoparticle 
Dual PET/MRI Mouse 123 
Nucleus Label-free Raman Human Cells 
ex vivo  
124 
2-Photon FLIM Human 125 
 
Table 1.2 Overview of optical probes developed for neutrophil imaging. Copyright 




1.3.3 PROBING SERINE PROTEASES 
As the only class of optical imaging agents being developed for clinical optical 
molecular imaging of neutrophils to date, the serine protease-targeting probes are 
an exciting area of research. Of prime importance is the question of specificity 
between the serprocidins, the serine proteases with antimicrobial activity. There 
are three serprocidins, cathepsin G, protease 3 and HNE. Neutrophil serine protease 
4 is the recently discovered forth member of this class of enzyme and its 
antimicrobial status is yet to be established. Great advances have been made in 
structure-activity studies for the fine-tuning of substrates126,127 and inhibitors128–131 
specificity targeting only HNE in vitro. These advances have yielded excellent 
starting points for the development of targeted and activable imaging probes to be 
subjected to in vivo performance evaluation. The relative quantities and activities of 
each enzyme upon co-release must also be considered for clinical applications as 
HNE is the most abundant and often the fastest serine protease.132 These factors of 
serprocidin probe specificity will be discussed further in Chapter 4.1.2. 
 
1.3.4 PROBING FORMYL PEPTIDE RECEPTOR 1 
NIR imaging is often superior to other wavelengths as tissue autofluorescence is 
lowest in this region of the visible spectrum. Zhou et al. synthesized a NIR fMLF 
receptor 1 targeting nanoprobe for imaging inflammation.122 The issue of 
inflammatory site access was solved by building the labelling (cFLFLF) and 
fluorophore (Oyster-800) components onto a hydrophilic 8-arm PEG scaffold.  There 
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are many benefits to using the cFLFLF ligand: its high affinity FPR1 binding (Kd = 2 
nM) generates a sensitive readout of leukocyte distribution.133 The ability of cFLFLF 
probes to access inflammatory sites with either PET (Cu18, Tec) or NIR (Cy5,Cy7) 
labels has also been demonstrated. However FPR1 is not cell-type specific and these 
probes bound macrophages and neutrophils.134–136 cFLFLF probes may generate a 
useful readout when information on inflammatory cell accumulation is sought in 
broad terms but they may fail to clarify whether clinical intervention should focus 
on altering neutrophil or macrophage activity.   
Pellico et al. combined radiochemistry and nanotechnology to create neutrophil-
specific radiotracers by coating gallium-doped nanoparticles with cFLFLF for FPR1 
labelling, a radiotracer for murine neutrophils was generated with dual PET and MRI 
utility.123  Coating with peptide can produce significant probe hydrophobicity which 
has prevented other radiotracers from reaching the inflammatory site. By citrate-
coating nanoparticles, the relatively large nanoparticle surface confers the 
necessary solubility for targeting neutrophils in vivo. Although the authors showed 
neutrophil depletion was capable of removing signal, it also removes important 
crosstalk from the LPS inflammatory response such that nonspecific signalling may 
be harder to detect.   
 A truly neutrophil specific target for biomarker development has proved elusive. 
Instead neutrophil specificity has arisen from combinatorial strategies exploiting the 
unique properties of certain targets within neutrophils. For example, HNE reaches 
such high concentrations in neutrophils that most systems will fail to detect the 
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minority of HNE positive monocytes bearing far lower quantities of the enzyme.137 
Neutrophil specific functions can also be exploited by careful probe design. 
Phagolysosome alkalinisation, which enhances the fluorescence signal of some 
fluorophores does not occur in monocytes. A novel, super-silent FRET probe81 
combines these structural and functional cellular characteristics to achieve 
neutrophil specificity (discussed in 4.1.1 Serine Proteases). Label-free methods of 
cell identification have also sought neutrophils using targets found in other cell 
types but uniquely arranged in neutrophils.   
 
1.3.5 LABEL FREE NEUTROPHIL IMAGING 
Neutrophil imaging in the context of inflammatory research has aimed at 
understanding the relevance of cellular components to cell function. Questions of 
molecular colocalization and characterization are well served by fluorescent labels 
for elucidating the spatiotemporal relationships of cells and subcellular structures 
without altering the processes for investigation. As translational research influences 
surgical guidance questions of long-term cytotoxicity and ease-of-adoption are 
more important. Label-free imaging, which may seem imprecise for research 
purposes, is often cheaper, safer and does not require the considerable 
translational effort of alternative techniques. Molecules such as NADH, elastin and 
haemoglobin are established sources of intracellular and extracellular 
autofluorescence, but an amalgamation of signatures from yet more analytes may 
also contribute. Much characterisation is still required to generate clinically 
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meaningful autofluorescence imaging and techniques such as fluorescence lifetime 
imaging may become an important source of differentiation. Reflectance 
microscopy, which distinguishes between matter of different refractive indices, is 
now also capable of cellular resolution. For high-resolution imaging, individual 
molecules can be detected and quantified via Raman spectroscopy. Label-free 
imaging is en route to becoming as informative as fluorescence image-guided 
surgery can be, a limit it may exceed in a multi-modal platform.   
 
1.3.6 RAMAN SPECTROSCOPY  
By measuring the minute proportion of photons which interact with molecules 
inelastically, Raman spectroscopy can, non-destructively, describe the chemical 
composition of unlabelled matter. The first look at a leukocyte using Raman 
spectroscopy was when Puppels et al. compared eosinophils and Chinese hamster 
lung cells.138 The group found nuclei spectroscopically distinct from cytoplasm and 
that distinctions between granulocytes may be made on the basis of their 
cytoplasmic contents.139 In 1998, Otto et al. collected the first Raman spectrum of 
activated neutrophils.140 More recently Ramoji et al. demonstrated the ability to 
discern between lymphocytes and neutrophils with concomitant Raman mapping of 
nuclear morphology.124 With the application of principal components analysis (PCA) 
cells could be classified with 94% accuracy in the validation dataset and predicted 
with, 81% accuracy, in a new dataset from a completely different donor. Because 
Raman spectroscopy can describe intracellular contents it may be better suited to 
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quantifying cell function. Instead of identifying cells Harz et al. used spectrally 
distinct Raman and fluorescence excitation wavelengths to successfully multiplex 
these spectroscopic and microscopic techniques.85 Particularly in such a multiplexed 
system, intracellular localization and oxidation states of functionally significant 
molecules may be revealed through Raman mapping to intimate whether or not 
neutrophils are effecting clinically meaningful processes such phagocytosis and to 
what extent.141  
 
1.3.7 TWO-PHOTON ENDOGENOUS FLIM 
The question of whether or not technology as nascent and complex as two-photon 
microscopy can be translated into a clinical endomicroscopy technology is 
unanswered. Although confocal endomicroscopy is in clinical use, two-photon 
endomicroscopy (TPEM) carries additional fibre optics challenges such as fibre non-
linearity distorting the two-photon excitation light and the low quantum yields of 
intrinsic fluorophores.91 These and other hurdles were overcome in 2008 when 
TPEM of human and mouse sarcomeres was conducted using a GRIN lens.142 The 
technique involved a minimally-invasive needle clad fibre capable of imaging 
directly beneath the skin. In vivo TPEM was performed laparoscopically with a 
“stick” lens which avoids GRIN lens associated spherical aberrations revealing 
ovarian cancer through a laparoscopic procedure, centimetres into the body.143 
However murine tissues were investigated in vivo with a flexible Fluorescence 
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lifetime imaging microscopy (FLIM) endomicroscope, of working distance 135 µm in 
2011, and the field continues to rapidly improve this label-free technology.144  
Using two-photon excited fluorescence (TPEF) Zeng et al. characterised blood cells 
by their endogenous fluorescence lifetime signals. TPEF fluorescence lifetime 
imaging can detect differences in bound and unbound NADH such erythrocytes, 
agranulocytes and granulocytes are distinguishable.125 As proportions of bound and 
free NADH vary by the dominant metabolic pathway employed by the cell – TPEF 
FLIM is functional imaging. Metabolic functional imaging may be able to identify 
granulocytes undergoing phagocytosis but whether or not phagocytosis and other 
factors affecting the NAD/NADH ratio, such as oxygen availability, can be dis-
entangled remains unclear. By visualising cytoplasmic protein, TPEF FLIM can 
identify the size and shape of cells and (as absences in the cytoplasmic image) their 
nuclei - detailing the characteristic lobular structure of granulocyte nuclei. With 
neutrophils comprising 95% of the granulocytes population, these morphological 
distinctions give TPEF FLIM neutrophil specificity to rival the best ligand-based, 
fluorescent probes. Although the distinction between phagocytic and untreated 
neutrophils is subtle, this technique can separate untreated from activated 
neutrophils on morphological grounds. Quiescent neutrophils have a rounded 
morphology but membrane ruffling, characteristic of neutrophil activation was 





1.4.0 IMAGE CYTOMETRY AND DATA SCIENCE 
Cell segmentation was an important development in image analysis which enabled 
each individual cell to be analysed as a separate image. Because of cell 
segmentation cell-specific features such as ferret diameter and plasma membrane 
vs. cytoplasm comparisons could be quantified. Individual cell segmentation is 
commonly achieved when image analysis is applied to immunohistochemical images 
and images of cell monolayers such that hundreds or even thousands of cells, per 
image, can produce multiparametric quantitative data. Because so many individual 
parameters can be measured, data can be visualised in scatter plots, using 
parameter pairs as axes, and gating strategies can be applied using subsequent 
parameter pairs for multivariate analysis. Although this approach resembles flow 
cytometric data analysis, the challenges of multiplexing antibodies and fluorophores 
with similar properties do not constrain the generation of parameters in image 
cytometry to the same extent. For each imaging channel the distribution of pixels 
representing one cell and the application of mathematical functions may produce 
more meaningful visualizations than raw data. Positional data exists to describe the 
size and shape of cells and textural feature analysis combines pixel values and 
positions to understand the presence of patterns in the data. Such large datasets 
can be generated that statistical analysis becomes a necessary means of selecting 
optimal features for a data scientist’s understanding of cellular populations. When 
using clustering techniques, features are optimal when the variance between cells 
of different treatment groups or phenotypes is maximised and to this end PCA 
enables more powerful data visualisation than serial gating. Although both PCA and 
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gating strategies provide linear combinations of multiple variables, PCA need not 
exclude data. The contributions of raw variables to new combinatorial variables 
(principal components) can be weighted by the extent of sample variance explained 
by each raw variable. So organised, multiparametric data becomes a powerful tool 
































CHAPTER 2:  














2.1.0 ETHICAL STATEMENT 
All experiments using human samples were performed following approval of the 
appropriate accredited medical regional ethics committee (AMREC) and with informed 
consent of the patients. Whole blood for leukocyte isolation was taken from healthy 
volunteers following consent (AMREC ref no: 15-HV-013, CIRBRP004). COPD patient 
blood samples were collected following patient consent (REC reference 15/ES/0094, 
SR1063). Sectioned human lung samples were obtained from the lungs (cancerous and 
non-cancerous regions) of patients undergoing resection for lung cancer, approved by 
the NHS Lothian AMREC and facilitated by NHS Lothian SAHSC Bioresource (REC 
reference 15/ES/0094, SR1063). Whole human lungs for ex vivo lung ventilation studies 
were obtained from deceased organ donors whose lungs were not accepted for 
transplantation as part of the ENLIGHTEN programme (Universities of Edinburgh 
Glasgow and Newcastle) and with REC approval (REC No:16/LO/1883, SR1063). Next of 
kin gave consent for the lungs of the deceased to be used for research purposes. 
2.1.1 MATERIALS 
The following reagents were purchased from Sigma-Aldrich, St. Louis, MO, USA: 
Proteinase 3 from human leukocytes (P0615), Human leukocyte Cathepsin G (C4428), 
Fibronectin (F1141), Paraformaldehyde 4% (158127), 10% neutral buffered formalin 
(HT501128), HEPES (3375), Sodium Chloride (NacCl) (S5886), DAPI (D9542), AAPV-pNA  
(M4765), AAPV-AMC, (M9771), Phorbol 12-myristate 13-acetate (79346), calcium 
ionophore (A23187, C7522) Interleukin-8 (I1645-10UG), Leukotriene B4 (L0517-10UG) 




Antibodies against HNE (ab67682), Glut1 transporter (ab115730) and rabbit IgG 
(ab7171) were purchased from Abcam Cambridge, UK. 
The following reagents were purchased from ThermoFisher Scientific, Waltham, MA, 
USA unless otherwise stated: CellMaskTM orange plasma membrane stain (C10045), 
Hank’s Balanced Salt Solution without Phenol Red (14025092, Gibco),  Dulbecco’s 
Phosphate Buffered Saline (PBS) (14190144, Gibco), Dulbecco’s Phosphate Buffered 
Saline with Calcium and Magnesium (14040091, Gibco), [10x] PBS (14080048, Gibco), 
Cy3 tyramide (NEL 744Boo1kt, PerkinElmer, MA, USA), normal goat serum (GO-
605/500, Biosera, Heathfiled, UK), ER1 buffer (AR9961, Leica biosystems), H202 
(23622.260, VWR), Sputum purified Human Leukocyte Elastase (SE563, Elastin Products 
Company, MO, USA), Sivelestat (ONO-5046; Tocris Bioscience, Bristol, UK). 
2.1.2 SMARTPROBE SYNTHESIS 
The dendrimeric SmartProbe, Neutrophil Activation Probe (NAP), was synthesized 






Scheme 1        Scheme 2 
Figure 2.0 Synthetic Schemes for Neutrophil Activation Probe development 









Figure 2.1 Synthetic precursors to Neutrophil Activation Probe  
S1-S3 incorporate peptide sequences APEEIMDRQ and APEEIMRRQ optimised by Gauthier et al.  















Molecular mass = 4236.56 Daltons 
Figure 2.2 Chemical Structure and Molecular Mass of Neutrophil Activation Probe 
Diagram of NAP chemical structure with linker regions, amino acid sequence regions and 




Amino acid sequence  
Glutamic Acid (E) 
Glutamic Acid (E) 







2.1.3 SPECTROPHOTOMETER ASSAYS 
Samples were prepared in a 50 mM HEPES, 50 mM NaCl buffer (S7653, Sigma-
Aldrich) and data were acquired via the Synergy H1 hybrid reader, BioTek, Potton, 
UK.   
2.1.4 DETERMINING KINETIC RATE CONSTANTS  
HNE (100 nM) was added to colorimetric elastase substrate (1 µM, M4765, Sigma-
Aldrich) at room temperature and read, immediately after preparation, at 37 oC. 
Absorbance readings were performed at one-minute intervals. 
2.1.5 DATA-REDUCTION 
Enzyme velocities were calculated as  
 




Where Ev = Enzyme velocity 𝐴 = Absorbance  𝜀 = substrate extinction coefficient 𝑙 = 
path length 𝑡 = time and 𝑉 = reaction volume. 
Enzyme velocity was plotted against substrate concentration to fit a rectangular 
hyperbola, using GraphPad Software (version 5.01, La Jolla California, USA), 
whereby maximum velocity (Vmax) is the asymptote and the Michaelis-Menton 
constant (KM) is the gradient. The catalysis constant was calculated using equation 




2.1.6 DERIVATION OF THE MICHAELIS MENTEN EQUATION 








𝐸 + 𝑃          (1) 
 𝑣0 = 𝑘𝑐𝑎𝑡[𝐸𝑆]                        (2) 
 





 =  
[𝐸][𝑆]
[𝐸𝑆]
                                                          (4) 
𝑘−1+𝑘𝑐𝑎𝑡
𝑘1
 =  𝐾𝑀                 (5) 
[𝐸] =  [𝐸]𝑡𝑜𝑡𝑎𝑙 − [𝐸𝑆]     (6) 
 
Substituting 5 and 6 into 4: 
 𝐾𝑀 = 
([𝐸]𝑡𝑜𝑡𝑎𝑙−[𝐸𝑆])[𝑆]
[𝐸]
      (7) 
𝐾𝑀[𝐸𝑆] = [𝐸]𝑡𝑜𝑡𝑎𝑙[𝑆] − [𝐸𝑆][𝑆]     
𝐾𝑀[𝐸𝑆] + [𝐸𝑆][𝑆] = [𝐸]𝑡𝑜𝑡𝑎𝑙[𝑆]  
[𝐸𝑆](𝐾𝑀 + [𝑆]) = [𝐸]𝑡𝑜𝑡𝑎𝑙[𝑆]  
[𝐸𝑆] =  
[𝐸]𝑡𝑜𝑡𝑎𝑙[𝑆]
𝐾𝑀+[𝑆]
                            (8)                             
 




                             (9) 
𝑣𝑚𝑎𝑥 = 𝑘𝑐𝑎𝑡[𝐸]𝑡𝑜𝑡𝑎𝑙                 (10) 
 




                              (11) 
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Concentrations  Constants Velocities 
[E]total = total enzyme kcat = catalysis vmax = maximum enzyme 
[E] = enzyme k1 = association rate v0 = initial enzyme 
[S] = substrate  k-1 = disociation rate   
[ES] = enzyme-substrate 
complex  
KM = Michaelis-Menton    
[P] = Product   
 




Where T1/2 = half-life, 𝑘𝑖𝑛𝑎𝑐𝑡= inactivation constant 
To compare the effect of dose on fluorescence intensity, Neutrophil Activation 
Probe (NAP 0.5, 1, 2.5, 5 µM), flat-bottomed 96 well plates (Corning, NY, USA) were 
prepared with HNE 100 nM (SE563, Elastin Products Company, MO, USA) at room 
temperature and read, immediately after preparation, at 37 oC. Fluorescent 
intensity readings were performed at one-minute intervals. 
 
2.1.7 NAP SELECTIVITY FOR SERINE PROTEASES  
To compare serine protease activities with NAP (3 µM), flat-bottomed 96 well plates 
(Corning, NY, USA) were prepared on ice and read immediately after preparation at 
37 oC. Temperature fluctuation artefacts were removed by subtracting fluorescence 
changes of enzyme-free, NAP controls. Fluorescence intensity was read using 
λex/λem 488/525 nm light for fluorescein and fluorescein-based dyes in solutions of 
boron and potassium titrated to pH 5, 7 and 9. Detector gain was internally 
calibrated with each experimental replicate so that 488 nm light stimulation, of 5,6 
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carboxyfluorescein (15 µM) in freshly made up pH 12 buffer, was equal to 100,000 
relative fluorescence units. Fluorescence intensity reads were performed at one-
minute intervals. Proteinase 3 (E3539, Sigma-Aldrich), Cathepsin G (Sigma-Aldrich, 
C4428) and HNE (SE563, Elastin Products Company, MO, USA) concentrations were 
prepared by serial dilution. HNE was stored at 10 µM, at -20 oC in a 0.02M NaoAC, 
50% glycerol v/v buffer (G5516, Sigma-Aldrich) made up at pH 5. To investigate the 
effect of pH on HNE enzyme activity, fluorogenic elastase substrate (1 µM M4765, 
Sigma-Aldrich) fluorescence intensity was read at 37 oC, using λex/λem 370/460 nm. 
 
To determine kinetic constants measurements of enzyme velocity were performed 
when HNE 100 nM (SE563, Elastin Products Company, MO, USA) was added to 
fluorogenic elastase substrate (1 µM, 324740, Sigma-Aldrich) in the presence of 
irreversible elastase inhibitor (GW457427, GlaxoSmithKline) or HNE targeted probes 
(0.1, 0.2, 0.5, 1, 2, 5, 10 µM). Samples were prepared in flat-bottomed 384 well 
plates (Corning, NY, USA) with optically transparent seals (Sigma-Aldrich). 
Fluorescence intensity read at 37 oC, using λex/λem 370/460 nm and gain was set to 
90 arbitrary units with fluorescence intensity reads were performed at twenty-
second intervals. Experimental conditions for absorbance measurements differed 





Spectral Characterisation of HNE-targeted Probes  
Spectral scanning was performed using 500 nm light, with the monochromator fixed 
at 750 nm, to ensure spectra could be seen across the excitation and emission 
peaks. 10 µM solutions of Cy5-based dyes were prepared in distilled water or PBS 
with cations. Fluorescent emissions were detected at 10 nm intervals from 400 nm 
to 800 nm, at room temperature and with gain set to 100 arbitrary units. Samples 
were illuminated top down, with the light source aligned above detectors.  
 
2.1.8 PRIMARY HUMAN NEUTROPHIL SUPERNATANTS AND LYSATES  
To prepare supernatants and lysates, healthy human neutrophils, freshly isolated at 
2x107/mL, were incubated in PBS with cations at room temperature for 30 minutes 
before exposure to the relevant pharmacological stimulus for another 30 minutes. 
Cell suspensions were centrifuged at 350 rpm for 5 minutes and the supernatants 
removed were mixed with glycerol, 50% v/v. Supernatants were replaced with 
equivalent volumes of PBS without cations and cell lysates were obtained by using 
repeated dry ice/acetone baths. The resulting suspension was centrifuged at 13,000 
rpm for 20 minutes to remove debris. Aliquots of supernatant and lysates were 
placed in the chambers of a 96 well flat-bottomed plate. Samples were mixed with a 
stock solution of NAP (100 µM) to a final volume of 100 µL with final NAP 
concentrations of 3 µM. Where indicated, Sivelestat (ONO-5046; Tocris Bioscience, 




2.1.9 DETERMINING FIXED PURIFIED HNE ACTIVITY  
To determine the effect of fixation on HNE, samples of purified HNE (100 nM), 
formaldehyde (0, 1, 2, 4, 8, 16%, Sigma-Aldrich) and NAP 3 (µM) were measured 
using λex/λem 488/525 nm light. Fluorescent measurements were performed at one-
minute intervals in 96 well plates (Corning, NY, USA) well plates. 
 
2.2.0 PREPARATION OF HUMAN POLYMORPHONUCLEAR CELLS AND 
PERIPHERAL BLOOD MULTI AND MONONUCLEAR CELLS  
FROM WHOLE BLOOD 
Whole blood was separated into serum, polymorphonuclear cells (PMN) and 
peripheral blood mononuclear cells (PBMC) using a method previously described by 
our group39. In summary, whole blood was mixed with 3.8% sodium citrate before 
plasma was separated by centrifugation. Dextran sedimentation was used to 
remove erythrocytes and produce a leukocyte suspension which results in PMN and 
PBMC layers upon centrifugation in a discontinuous, isotonic Percoll gradient. PBMC 
and PMN accumulate at the 55/70% and 70/81% Percoll interfaces respectively. 
Autologous serum was prepared by missing 10 mL plasma with 220 µL calcium 
chloride 1 M. The PMN layer was used in neutrophil experiments without further 
purification for practical purposes. The PMN layer typically contains 95% 
neutrophils or more with a small minority of eosinophils and even less or no 
basophils.77 PMN and PBMC purity were determined after each isolation by mixing 
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198 µL, of 50 mL PMN or PBMC solutions in PBS without cations, with 2 µL 
autologous serum for cytospins.  
For COPD preparations, reagents volumes were quartered to correspond with 10 
mL whole blood, excluding wash steps. Whole blood was mixed with 0.75 mL 3.8% 
sodium citrate. 5 mL plasma was reduced to serum with 110 µL calcium chloride 1 
M prior to dextran sedimentation.  
 
2.2.1 PREPARATION OF ISOLATED LEUKOCYTE CYTOSPINS 
200 µL cell suspensions, containing 2% autologous serum, were spun at 300 rpm for 
3 minutes, allowed to dry, methanol fixed and stained in Diff-Quik. Autologous 
serum prevents cell from rupturing during the spin. Slides were allowed to air-dry 
for 10 minutes and a cell differential was calculated using an EL-Einsatz upright 
Axioskope microscope (Carl Zeiss, Jena, German) to count at least 200 cells.  
 
2.2.2 FLOW CYTOMETRIC ANALYSES OF PMN 
For the following flow cytometric analyses cell suspensions were preincubated for 
30 minutes at room temperature in PBS with cations. Flow cytometric 
measurements were performed on the BD FACSCalibur flow cytometer, with 1.5 mL 
Eppendorf tubes. Fluorescence cross-over compensation using single-stained 
samples and data-analysis was performed using FlowJo software (version 10.0.0 
Ashland, OR, USA). 
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HNE measurements across the PMN lifespan 
To investigate the effects of PMN apoptosis, primary and secondary necrosis on 
NAP signal PMN suspensions were resuspended at 1x107 cells/mL and incubated for 
30 minutes at room temperature in PBS with cations. PMN suspensions were 
incubated at 37 oC, 5% CO2 for 0, 2, 6 and 20 hours before transferring samples to 
1.5 mL Eppendorf tubes. Annexin-V-Alexa Fluor 647 antibody (1:200, 640912, 
Biolegend, San Diego, CA, USA) and propidium iodide (1:300, 556463, BD 
Biosciences Oxford, UK) were added to samples 20 minutes and immediately prior 
to flow cytometric analysis, respectively. Individual samples were briefly vortexed, 
immediately before measurement. 
 
2.2.3 DETERMINING HNE ACTIVITY FOLLOWING PMN FIXATION 
To  determine how paraformaldehyde fixation effects NAP labelling, PMN were 
seeded into round bottom 96 well plates (Corning, NY, USA) well plates and 
incubated at, 37 oC, 5% CO2, in 50 μL HBSS with cations and 10% auotologous 
serum, with or without stimuli (25 µg/mL LPS for 30 minutes, then 100 nM fMLF for 
15 minutes), NAP (3 µM) and anti-CD11b antibody (5 ug/mL 301414 Biolegend, San 
Diego, CA, USA). To fix PMN, suspensions were centrifuged at 300 g for 4 mins and 
resuspended in 4% paraformaldehyde, for 5 mins on ice before repeating 
centrifugation and washing twice in PBS without cations. Individual samples were 




For the following flow cytometric analyses cell suspensions were preincubated for 
30 minutes at room temperature in PBS with cations. Flow cytometric 
measurements were performed on Flow cytometric measurements were performed 
on the automated Attune NxT acoustic focusing cytometer, shaking round bottom 
96 well plates (Corning, NY, USA) well plates, between measuring each sample: 
Adhesion molecule expression following pharmacological stimulation 
To describe the activation assay window with calcium ionophore stimulation PMN 
suspensions were resuspended at 1x107 cells/mL. PMN were incubated with anti-
CD11b-Alexa Fluor 647 labelled antibody (5 µg/mL 301414 Biolegend, San Diego, 
CA, USA), anti-CD62L antibody (5 µg/mL 304806 Biolegend, San Diego, CA, USA) and 
calcium ionophore (final [1 µM], A23187) for 30 minutes at room temperature. 350 
µL PBS with cations were added to samples before spinning at 300 g for 4 minutes 
and resuspending in 200 µL PBS without cations for flow cytometric analysis using 
λex/λem 640/660 light and λex/λem 450/488 light. 
 
HNE targeted-probe cell-type specificity with varying PMA concentration 
To compare PMA dose responses in PMN and PBMC, 20 µL cell suspensions were 
resuspended at 1.25 x107 cells/mL and added to cyanine-based dyes with or 
without, phorbol myristate acetate (0, 10, 50, 100, 250, 500, 1000, 2000 nM, 79346, 
Sigma-Aldrich) or calcium ionophore (final [10 µM], A23187). PMN and reagents 
were briefly titurated in a final volume of 40 µL and incubated at room temperature 
for 10 minutes before adding 260 µL PBS with cations, spinning at 300g for 4 
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minutes and washing into 200 µL PBS without cations. PMN underwent flow 
cytometric analysis using λex/λem 640/660 light. 
 
Cell-type specificity comparison of HNE targeted-probes 
To investigate the cell-type and HNE specificity of cyanine-based dyes PMN 
suspensions were resuspended at 1.25 x107 cells/mL and 30-minute preincubations 
included Sivelestat (100 µM, ONO-5046; Tocris Bioscience, Bristol, UK) where 
indicated. 20 µL aliquots of PMN suspensions were added to the relevant 
combinations of cyanine-based dyes (final [1 µM]), calcium ionophore (final [1 µM], 
A23187) and Sivelestat (final [50 µM], ONO-5046; Tocris Bioscience, Bristol, UK). 
PMN and reagents were briefly titurated in a final volume of 40 µL and incubated at 
room temperature for 10 minutes before adding 260 µL PBS with cations, spinning 
at 300g for 4 minutes and washing into 200 µL PBS without cations. PMN 
underwent flow cytometric analysis using λex/λem 640/660 light.  
 
2.2.4 LASER SCANNING CONFOCAL MICROSCOPY OF PMN 
In the following experiments cell suspensions were preincubated for 30 minutes at 
room temperature in PBS with cations and imaged using a Zeiss LSM 510-META 
confocal laser scanning microscope (Carl Zeiss, Jena, German). 8 well LabTek II 
confocal chambers (VWR, PA, USA) were coated in 1 µg/mL fibronectin (Sigma 
Aldrich) for 10 minutes and air-dried prior to the addition of cell suspensions. 
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2.2.5 INTRACELLULAR NAP SIGNAL GENERATION 
PMN suspensions were incubated for 30 minutes at room temperature in PBS with 
cations and, where indicated, with Sivelestat (100 µM, ONO-
5046; Tocris Bioscience, Bristol, UK). Inhibitor concentrations were kept constant 
throughout the experiment and 192.5 µL PMN suspensions were added to each 
well. Wells seeded with PMN were washed once in PBS with cations and co-
incubated with 7.5 µL NAP (final [3 µM]). PMN were imaged, at their interface with 
the well bottom, over a 10 minutes time-course at 30 second intervals and 50 µL 
calcium ionophore (final [10 µM], A23187) was added at 90 seconds.  
 
2.2.6 PRIMARY HUMANY NEUTROPHIL HNE IMMUNOFLUORESCENCE  
PMN incubated in PBS with cations or calcium ionophore (final [1 µM], A23187) for 
10 minutes at 37 oC, 5% CO2. PMN were fixed in 4% paraformaldehyde for 5 mins on 
ice and twice washed in PBS without cations. Fixed PMN were coated in 0.3 
M glycine for 15 minutes at 37 oC, and blocked in 0.2 µM filtered, 10% goat serum 
for 30 minutes at 37 oC. After incubating in anti-HNE antibody (1:200, ab68672, 
Abcam Cambridge, UK) for 1 hour at room temperature and washed five times in 
PBS without cations. After primary antibody labelling PMN were then incubated in 
Cy5-labelled anti-rabbit antibody (1:1000 in PBS without cations, A-21206, 
ThermoFisher Scientific, Waltham, MA, USA) for 1 hr at room temperature and 
washed four times in PBS without cations before its replacement with 50 µL DAPI (1 
µM) for 5 mins at room temperature. After secondary antibody labelling DAPI 
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solutions were replaced by 50 µL CellMaskTM Orange (1:5000 in PBS without 
cations) 10 mins at 37 oC and PMN were imaged in z-stacked planes.  
 
2.2.7 LASER SCANNING CONFOCAL MICROSCOPY IMAGE ANALYSIS 
ImageJ (version 1.52n, Rasband, National Institute of Health, USA) was used to 
objectively quantify intracellular and extracellular enzyme velocities via change in 
pixel intensity following pharmacological cellular stimulation with and without 
enzymatic inhibition. Algorithms to extract numerical pixel intensity values from 
image batches and process these values for time-dependent frame averages, for 
individual time-lapse videos, were employed using ImageJ (version 1.52n, Rasband, 
National Institute of Health, USA) and MatLab (version 2015b) respectively. To 
calculate intracellular NAP signal maxima using ImageJ, extracellular pixel intensities 
were removed from each image, as values above a fixed threshold, producing 
binary masks of images. Binary masks underwent image multiplication with raw 
images and pixel intensity maxima were measured. The resultant images were 
divided into an 8x8 grid of square regions of interest. Region of interest 
measurements were averaged, to calculate frame averages at each timepoint, 
which were divided by frame cell number.  
2.3.0 SPINNING DISK CONFOCAL MICROSCOPY OF LEUKOCYTES 
In the following experiments cell suspensions were preincubated for 30 minutes at 
room temperature in PBS with cations and imaged, in z-stacked planes, using the 
Olympus IX83 spinning disk confocal laser scanning microscope (Carl Zeiss, Jena, 
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German). Black, Ibidi 96 well plates (Thistle Scientific, Glasgow, UK) were coated in 1 
µg/mL fibronectin (Sigma Aldrich) for 10 minutes and air-dried prior to the addition 
of cell suspensions.  
 
2.3.1 HNE-TARGETED PROBE DOSING 
This study was undertaken by Mr. Filip Angelov. 100 µL PMN suspensions (107/mL) 
were plated in PBS with cations. 100 µL VE200 in PBS with cations was added to 
wells (final [0.1, 0.2, 0.5, 1 and 2 µM]) with or without calcium ionophore  
(final [10 µM]). 
 
2.3.2 INTRACELLULAR NAP SIGNAL GENERATION UNDER BACTERIAL 
PRODUCT STIMULATION 
This study was undertaken by Mr. Filip Angelov. Altering the method for 
Intracellular NAP signal generation (Method 2.1.5), instead of calcium ionophore 
stimulation all PMN were treated with 25 ng/mL LPS for 30 minutes, followed by 






2.3.3 INTRACELLULAR NAP SIGNAL GENERATION UNDER INHIBITION 
This study was undertaken by Mr. Filip Angelov. Altering the method for 
Intracellular NAP signal generation (Method 2.1.5), PMN were stained with 
CellMaskTM Orange (1:10,000, ThermoFisher Scientific, Waltham, MA, USA) and 
three HNE inhibitor conditions (0.02 µM, 0.2 µM and 2 µM, GW447631, 
GlaxoSmithKline) were added, to the Sivelestat and uninhibited conditions.  
 
2.3.4 HNE LABELLING OF VIABLE, APOPTOTIC AND NECROTIC 
NEUTROPHILS 
This study was undertaken by Mr. Filip Angelov. 100 µL PMN suspensions (107/mL) 
PMN were plated in solutions of CellMaskTM Orange (1:10,000, ThermoFisher 
Scientific, Waltham, MA, USA) and DAPI (1 µM, ThermoFisher Scientific, Waltham, 
MA, USA). PMN were untreated or treated with GW447631 (final [10 µM]) or Q-VD-
OPh hydrate (final [15 µM], Sigma Aldrich, SML0063). At 0, 4 and 18 hrs following 
plating, solutions of NAP (final [3 µM]) and where relevant, VE200 (final [100 nM]) 
were added to wells with or without calcium ionophore (final [5 µM]).  At intervals 






2.3.5 NAP AND HNE-TARGETED PROBE MULTIPLEXED LABELLING  
100 µL PMN suspensions (107/mL) were plated and PBS with cations was replaced 
with reagent solutions of NAP (3 µM) and cyanine-based dyes (0.2, 2 µM) with or 
without calcium ionophore (final [1 µM], A23187) for 10 minutes before cells were 
washed in 100 µL PBS with cations and imaged. 
2.3.6 HNE PRESENCE AND ACTIVITY UNDER VARYING CHEMOKINETIC 
STIMULATION  
100 µL PMN (107/mL) incubated in PBS with cations or chemokine (LPS 25 µg/mL, 
IL8 3 nM, PAF 100 nM, LTB4 1 nM) for 30 minutes at, 37 oC, 5% CO2 after which, 
25 µg/mL LPS solution in one of the two LPS conditions was replaced with fMLF and 
all conditions were incubated for a further 15 minutes. PMN were fixed in 4% 
paraformaldehyde for 5 mins on ice and twice washed in PBS without cations. Fixed 
PMN were coated in 0.3 M glycine for 15 minutes at 37 oC, and blocked in 0.2 µM 
filtered, 10% goat serum for 30 minutes at 37 oC. After incubating in anti-HNE 
antibody (1:200, ab68672, Abcam Cambridge, UK) for 1 hour at room temperature 
and washed five times in PBS without cations. After primary antibody labelling PMN 
were then incubated in Cy5-labelled anti-rabbit antibody (1:1000 in PBS without 
cations, PA45004, Amersham Bioscience) for 1 hr at room temperature and washed 
four times in PBS without cations before its replacement with 50 µL DAPI (1 µM, 
ThermoFisher Scientific, Waltham, MA, USA) for 5 mins at room temperature. After 
secondary antibody labelling DAPI solutions were replaced by 50 µL CellMaskTM 
Orange (1:5000 in PBS without cations) 10 mins at 37 oC. NAP/HBSS (final [3] µM, 
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14175-053, ThermoFischer Scientific, Waltham, MA, USA) was added to wells with 
immunolabelled PMN. After 1 hr incubation at room temperature PMN were 
imaged.  
 
2.3.7 HNE PRESENCE AND ACTIVITY IN COPD NEUTROPHILS UNDER 
VARYING CHEMOKINETIC STIMULATION  
To investigate chemokinetic response in healthy young, COPD patient PMN, 50 µL 
PMN (107/mL) suspensions were preincubated with CellMaskTM Orange (1:10,000, 
ThermoFisher Scientific, Waltham, MA, USA) and DAPI (1 µM, ThermoFisher 
Scientific, Waltham, MA, USA) before plating. Unstained PMN were washed once. 
CellMaskTM Orange and DAPI solutions were replaced in the relevant conditions, 
directly before imaging, with NAP (3 µM) and VE200 (100 nM) solutions with or 
without chemokine (LPS 25 µg/mL, IL8 3 nM, PAF 100 nM, or LTB4 1 nM) or LTB4 
with Sivelestat (50 µM). Z-stacked images were acquired at 37 oC, 5% CO2, with 0, 
45 and 90 minute intervals and LPS/NAP/VE200 solution was replaced by  
fMLF/NAP /VE200 solution after 30 mins. 
 
2.3.8 IMMUNOHISTOCHEMISTRY OF  
PARAFFIN-EMBEDDED HUMAN TISSUES 
This study was undertaken by Miss. Lyndsey Boswell and the Shared University 
Research Facilities. Following dewax and rehydration samples were incubated in 
ER1 citrate buffer, ph6 (AR9961, Leica Biosystems, Milton Keynes, UK) for 20 
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minutes. Samples were treated with H2O2 1:10 (236220.260, VWR, Leicestershire, 
UK) for 10 minutes and incubated in normal goat serum 1:5 (GO-605/500 Biosera, 
Heathfield, UK) for 10 minutes. Samples were incubated with anti-HNE primary 
antibody 1:1000 (ab68672) for 60 minutes before incubation with goat anti-rabbit 
secondary antibody 1:500 (ab7171) for 30 minutes. For tyramide signal 
amplification, Cy3-labelled tyramide (PerkinElmer, MA, USA, NEL 744Boo1kt, 1:50) 
was added to samples for 10 minutes. Nuclei were stained by incubation with DAPI 
1:1000 (Sigma-Aldrich, D9542) for 10 minutes. Fluorescent stains were applied to 
samples using the BOND Max automated immunohistochemistry machine (Leica 
Biosystems, Milton Keynes, UK). 
2.4.0 FIBRED CONFOCAL ENDOMICROSCOPY OF LEUKOCYTES 
The following experiments were conducted using the Versicolour fibred 
endomicroscopic system, designed in house, and imaged via the catheterised 
Panoptes fibre. Versiplayer version 3.0 software provided a graphic user interface. 
 
2.4.1 FIBRED CONFOCAL HNE IMAGING IN VITRO 
100 µL PMN suspensions (107/mL) were plated into black, Ibidi 96 well plates 
(Thistle Scientific, Glasgow, UK), and PBS with cations was replaced with reagent 
solutions of NAP (3 µM) and cyanine-based dyes (2 µM) with or without calcium 
ionophore (final [1 µM], A23187) for 10 minutes before cells were washed in 100 µL 
PBS with cations and imaged. A catheterised Panoptes fibre was applied directly to 
the bottom of each well for point-of-contact imaging. 
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2.4.2 FIBRED CONFOCAL HNE IMAGING IN  
AN EX VIVO VENTILATED LUNG MODEL 
PMN were separated from whole blood by Percoll blood preparation and resuspend 
at 107/mL. Ex vivo human lungs were connected to ventilation apparatus and 
probed with a bronchoendoscope past the primary bronchi. A catheterised 
Panoptes fibre was inserted down the auxiliary port of the bronchoendoscope and 
into the alveolar airspace for imaging using the in-house Versicolour fibred confocal 
endomicroscope. Solutions of PMN, NAP (final [3 µM]) and VE200 (final [200 or 
400 nM]) were prepared with or without calcium ionophore 10 µM and instilled, via 
catheter, into the alveolar space of ex vivo human lungs, under ventilation. 
2.5.0 IMAGE ANALYSIS OF SPINNING DISK CONFOCAL MICROSCOPY OF 
LEUKOCYTES  
Image analysis was performed using ImageJ (version 1.52n, Rasband, National 
Institute of Health, USA) unless otherwise stated. Three-dimensional image stacks 
were converted to two-dimensional maximum projections and underwent mean-
limited thresholding. 
2.5.1 INTRACELLULAR NAP SIGNAL GENERATION UNDER BACTERIAL 
PRODUCT STIMULATION 




2.5.2 HNE TARGETED PROBE DOSING  
Following mean-limited thresholding images were analysed by two methods, firstly 
by whole frame mean fluorescence intensity whereby the sum of pixel intensities 
was divided by the number of pixels. Secondly by integrated density, whereby 
images were thresholded to include only intracellular pixels and these areas were 
measured. Each intracellular pixel area was multiplied by its mean fluorescence 
intensity. 
 
2.5.3 NEUTROPHIL APOPTOSIS AND NECROSIS  
Following mean-limited thresholding a binary mask for cellular pixel area was 
constructed using CellMaskTM Orange images and the percentile algorithm. The 
binary mask was applied to NAP, VE200 and DAPI images, measuring mean 











2.5.4 IMAGE CYTOMETRIC ANALYSIS 
Three-dimensional image stacks were converted to two-dimensional maximum and 
sum projections using ImageJ (version 1.52n, Rasband, National Institute of Health, 
USA). CellProfiler (version 2.2.0) maximum projections were used to identify 
individual cells as primary objects in the DAPI channel and secondary objects in the 
CellMaskTM channel respectively. Intensity, textural and positional features 
secondary object were measured and ranked using statistical analyses in Orange 
(version. 3.0), for objective feature selection. Data were visualised using GraphPad 
Prism (version 5.01, La Jolla California, USA) or Orange (version. 3.0).  
 
Figure 2.3 Diagram of a data analysis workflow for image cytometric analyses 
ImageJ, CellProfiler and Orange software are combined to create two-dimensional projections 
of three-dimensional image stacks, extract individual cellular data across several imaging 
features and objectively extract features for data visualisation. For complex classification tasks 
features are recombined, to visualise data clusters in multidimensional hyperplanes, using 





2.5.5 IMMUNOHISTOCHEMISTRY OF HUMAN TISSUES 
488 channel images were analysed in an image cytometric format using CellProfiler 
(version 2.2) and data was processed using Orange (version 3.0) for visualisation 
using GraphPad Prism (version 5.01, La Jolla California, USA). 
 
2.5.6 NEURAL NETWORK MODELLING 
This study was undertaken by Mr. Peter McGregor. Images were analysed in an 
image cytometric format using CellProfiler (version 2.2) describing 277 numerical 
features for six classes, each of approximately one thousand cells, imaged in four 
channels. Imaging data was class annotated and split into training and evaluation 
data sets. For each feature the standard score of the training set was calculated and 
data was normalized to the standard score. The training data set was used to train a 
neural network with a single hidden layer of size 20 and an output layer of size 6. 
The training was performed using stochastic gradient descent with a categorical 
cross entropy loss function for 100 epochs. Using the evaluation data set, the model 
was evaluated to determine the generalisation accuracy for each class, populating 
the confusion matrix. The neural network code was created with Python 3.6, using 





2.5.7 FIBRED CONFOCAL ENDOMICROSCOPY 
Using Versiplayer version 3.0 software consistent pixel minimum and maximum 
vales were applied to all images of a given data set to prevent image saturation. 
Framewise histogramming was applied to single-channel 630 or 470 nm images 
using ImageJ (version 1.52n, Rasband, National Institute of Health, USA).  
 
2.6.0. STATISTICAL ANALYSIS 
All experiments were performed at least three times unless otherwise stated and 
results expressed as mean ± SD where replicates from independent experiments are 
compared, or mean ± SEM where means of independent replicates were not 
assessed. Using GraphPad Prism (version 5.01, San Diego California USA) data was 
analysed by Student’s t-test for normally distributed data or Mann-Whitney U test 
or ANOVA and significance was determined as p<0.05 for all laboratory data. 
Principal components analysis and linear discriminants analysis of data were 




















ACTIVATION WITH NEUTROPHIL 

















NAP is a novel, dendrimeric SmartProbe designed to detect active HNE. This chapter 
aims to characterise the NAP-HNE interaction, evaluating NAP as a HNE biomarker. 
This chapter aims to address how NAP signal is affected by conditions that 
modulate HNE activity in vivo, HNE concentration, inhibition and pH change. NAP 
signal is evaluated as a result of neutrophil activation, due to both pharmacological 
and physiological stimuli, along with the influence of apoptosis and necrosis as 
these deviations from the quiescent state may provide clinically meaningful NAP 
signal. Of particular interest is NAP signal specificity for HNE, at the molecular and 
cellular level, evaluated in terms of co-released serprocidins and specific inhibition. 
NAP characteristics established in this chapter inform its utility as a biomarker and 







Figure. 3.0 Structure and Function of Neutrophil Activation Probe 
Structure of Neutrophil Activation Probe (NAP) A) before cleavage, showing fluorescein (green stars), 
amino acids (blue spheres) and linker (purple). B) In the presence of active human neutrophil 
elastase (HNE, grey, notched sphere) peptide sequences are cleaved alleviating fluorescein vertical 
quenching. 
A           B 
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3.1.0 PHARMACOLOGICAL NEUTROPHIL ACTIVATION 
Pharmacological stimuli commonly used to activate neutrophils include phorbol 
myristate acetate (PMA), calcium ionophore (A23187) and ionomycin. PMA is a 
potent protein kinase C (PKC) activator.146 Although PKC is typically calcium-
dependent, in the presence of PKC calcium ions are not required for PKC activation. 
Soluble PKC is auto-inhibited and located in the cytosol.147 Upon PMA-induced 
activation PKC undergoes conformational change and translocates from the cytosol, 
irreversibly inserting into the cellular endo-membrane and dissociating from 
calcium and PMA.146 Acting on several targets, activated PKC activates signalling 
cascades associated with neutrophil activation.148 In the absence of 
pharmacological stimulation, PKC isozymes are activated by calcium ions, diacyl 
glycerol and/or phosphatidyl serine, depending on the class of isozyme.149  
Ionomycin, a product of Streptomyces congloblatus, is a calcium ionophore which 
facilitates calcium efflux and influx.150 By increasing intracellular Ca2+ ionomycin 
triggers several neutrophil activation processes including reactive oxygen species 
generation and NETosis.151–153 Although PMA and ionomycin both activate PKC and 
are often used in conjunction in some assays this may prove counterproductive for 
neutrophil activation. When stimulating NETosis PMA has been found to counter 
ionomycin induced pro-NETotic signalling highlighting the importance of 
characterising activation responses in this peculiar cell-type.154,155  
A23187, referred to as calcium ionophore hereafter, is a calcium ionophore and an 
antibiotic derived from Streptomyces charteusensis fermentation.156 Stimulating 
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intracellular Ca2+ concentration increase by carrying Ca2+ across cell membranes, 
calcium ionophore relies on extracellular Ca2+ concentration to be effective.157 
Calcium ionophore and ionomycin are very hydrophobic and hence are readily 
rendered ineffective by binding to serum proteins.158 This technicality can be 
resolved by avoiding the use of serum proteins or increasing the concentration of 
calcium ionophores. Calcium ionophore has a long history of use as a stimulus of 
neutrophil degranulation, eliciting its effect rapidly and at low concentrations.159,160  
 
3.1.1 SERINE PROTEASES IN APOPTOSIS 
Gilligan et al. found that all granules translocate to the neutrophil plasma 
membrane during priming and late apoptosis, externalising total serine protease 
content. However Witko-Sarsat et al. demonstrated that PR3 is expressed on the 
surface of a subset of unactivated neutrophils, promoting vasculitis.161 The Witko-
Sarsat group found that PR3 exists in a granule-independent secretory vesicle pool 
which is externalized during apoptosis by PR3-phospholipid scramblase 1 
interaction.162 PR3 externalization impairs macrophage efferocytosis of neutrophil 
apoptotic bodies.162 PR-3 coated microvesicles enhance neutrophil respiratory burst 
and remove the inhibitory effect of apoptotic microvesicles on respiratory burst in a 
combination that may potentiate systemic oxidative endothelial cell damage.163 
Macrophage-mediated efferocytosis of neutrophil apoptotic bodies is hindered not 
only by PR3 but also HNE which cleaves phophatidyl serine receptor.164 
Efferocytosis stimulates anti-inflammatory cytokine release and is necessary for the 
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resolution of inflammation. Uncleared apoptotic bodies are prone to 
proinflammatory necrotic decay and further release of PR3 and HNE. Secretory 
leukocyte inhibitory protein (SLPI) inhibits cathepsin G and HNE. Following gene 
delivery Henriksen et al.’s macrophages overexpressed SLPI and regained 
efferocytotic function.165 HNE also impairs efferocytosis by cleaving surfactant 
protein-D.166 In addition to its effects on neutrophils, HNE promotes and smooth 
muscle cell apoptosis while inhibiting leukaemia and lung adenocarcinoma cell 
apoptosis.59,167,168 HNE also promotes lung epithelial cell apoptosis in a mechanism 
that may promote emphysema.169 And endothelial cell apoptosis and autophagy but 
not necrosis or necroptosis were stimulated by HNE.170 
Cathepsin G (CG) induces apoptosis of bone-marrow neutrophils in the absence of 
serpin B1, a PR3, HNE and CG inhibitor. This was demonstrated by Benefara et al. 
when their serpin B1 knockout mice developed CG-dependent neutropenia.171 The 
Benefara group also showed serpin B1 was necessary for neutrophil survival in a 
murine model of bacterial lung infection. The relative importance of CG, PR3 and 
HNE in neutrophil apoptosis and necrosis at the inflammatory site is less clear 
particularly as PR3 and HNE-mediated decrements in efferocytosis could potentiate 
neutrophil necrosis in vivo. It seems dis-regulated CG release can also lead to 
cardiomyocyte detachment-induced apoptosis (anoikis). A detailed mechanism for 
CG-mediated cardiomycotye anoikis has been elucidated by Rafiq et al. who show 




3.1.2 SERINE PROTEASE KINETICS  
For biomarker development, an important consideration is specificity. Off-target 
effects can generate false positive readouts or simply interfere with true positive 
signal generation. HNE is one of a family of enzymes known as serine proteases. The 
serine proteases are stored in the azurophil granules and released simultaneously. 
By measuring the effect of each serine protease on probe signal generation 
important concerns about probe specificity can be addressed. Understanding the 
relative activities of similar proteases may help to explain findings pertaining to 
activated neutrophil supernatants. HNE is the most abundant serine protease 
stored in neutrophils such that it is likely to outcompete protease 3 (PR3) and 
cathepsin G (CG) for common substrates upon degranulation. HNE’s rate of 
substrate cleavage (enzyme velocity) is often reported as faster than that of PR3 or 
CG. When Korkmaz et al. derived fluorescent substrates from the reactive site loops 
of endogenous inhibitors, alpha-1-protease inhibitor (α-1-PI) and serpin B1, HNE 
showed 14 and even 50 fold increases against the next fastest serine protease.132 
Such evidence supports the view that HNE is the “fastest” serine protease however 
relative enzyme velocities can be altered with changes in peptide sequences and 







3.1.3 NAP TOXICITY 
The toxicity of NAP was comprehensively assessed prior to the characterisation 
presented here, in preparation for an early phase 1 clinical trial. NAP toxicity was 
assessed via single dose studies in rats, In vitro genotoxicity and local tolerance in 
rat lungs as well as gathering information from studies of fluorescein and poly-
ethylene glycol constituents. NAP did not induce mortality, pathological events or 
mutagenesis and its constituents are non-toxic (unpublished results). The early 



















3.1.4 HYPOTHESIS AND AIMS:  
Hypothesis: Neutrophil Activation Probe can sensitively and specifically 
detect HNE activity in vitro and intracellularly in primary human neutrophils. 
Aims: 
1) Molecularly characterise NAP signal in terms of: 
i. Dose dependence 
ii. pH dependence 
iii. Temperature dependence 
iv. HNE selectivity  
 
2) Cellularly characterise NAP signal in terms: 
i. Neutrophil activation with 1 µM Calcium Ionophore 
ii.  Concomitant neutrophil activation and HNE inhibition 
iii.  Imaging intracellular HNE activity in Neutrophils 
a. by pharmacological stimulus 
b. by physiological stimulus 
iv. Detecting HNE activity in ageing, apoptotic, necrotic and activated 
neutrophils 
a. by whole-cell fluorescence via flow cytometry  





3.2.0 RESULTS  
3.2.1 CHARACTERISING THE DOSE-FLUORESCENCE RELATIONSHIP  
FOR NAP 
To establish a concentration of NAP which would be useful for enzymatic studies 
with HNE, 100 nM HNE was incubated with a range of NAP doses. At 0.5 μM NAP, 
enzyme activity was not readily observable after 60 minutes incubation at 37oC. 
Significant differences between all NAP concentrations developed after 20 minutes 
of incubation, in a dose dependent fashion, and the limit of detection in this system 
was 1 μM NAP. In agreement with previous work in the group and for practicable 


















Figure 3.1 NAP signal is dose dependent 
Dose-dependence of NAP signal was demonstrated by measuring fluorescence at 0.5, 1, 2.5 and 5 
µM of NAP incubated with 100 nM HNE. Values in the graph represent mean ± SEM, P values were 









3.2.2 CHARACTERISING NAP: TEMPERATURE-FLUORESCENCE 
RELATIONSHIP  
Prior to cleavage by active HNE, NAP emits dim, background fluorescence at 525 nm 
when excited by 488 nm light. Each molecule of NAP contains 3 fluorescein moieties 
and fluorescein is a pH indicator.61 To understand how fluorescein’s and hence 
NAP’s pH dependent quantum yield may influence subsequent measurements and 
to look for any temperature dependence in baseline fluorescence, the effect of pH 
and temperature variations were investigated. When uncleaved NAP was heated to 
20, 25 and 30 oC in pH 5, 7 and 9 solution, NAP fluorescence intensity in pH 5 
solution was similar to that of distilled water. Fluorescence emissions of NAP at pH 
7 and 9 were both significantly greater than that of pH 5 and the trend between 
temperature points indicates quantum yield is optimal at 25oC. pH produces the 
majority of variation between samples and only 0.2% variation can be attributed to 
effect of temperature in this assay. To further understand the effect of temperature 
on the fluorescent properties of NAP the amount of light NAP can absorb across a 
temperature range was measured. NAP absorption of 488 nm light at 26.1oC was 
significantly greater than that of higher temperatures. NAP quantum yield is most 





























Figure 3.2 Baseline NAP signal varies with pH and temperature 
A) NAP fluorescence was measured at 20, 25 and 30oC at pH 7. n=4 B) NAP absorbance at 485 nm 
was measured with increasing temperature.  
Values represented are mean ± SEM and P values were calculated using one-way ANOVA and 






3.2.3 CHARACTERISING NAP: THE PH-FLUORESCENCE RELATIONSHIP 
As seen in Fig. 1.2, alkali conditions increase NAP quantum yield, in addition, alkali 
conditions are reported to increase HNE catalytic rate61 and both these effects will 
promote increased NAP signal. To measure the effect of alkalinisation on HNE 
activity, a range of HNE concentrations were incubated at 37oC in pH 7 and 9 buffer 
with a coumarin labelled HNE substrate. Unlike NAP, a coumarin labelled HNE 
substrate can be taken as a measure of HNE activity alone because coumarin 
displays pH invariant fluorescence emission. HNE activity at pH 9 was significantly 
greater than that of pH 7 at each enzyme dose with a strict linear relationship 
(r2=0.98) whereby a 2-log increase in pH, from pH 7 to pH 9, produces a 4-fold 
increase in HNE activity (see equation, V = RFU at a given HNE concentration). 
Because of the significant differences in enzyme activity at pH 7 and 9, the relatively 
suppressed activity of HNE at pH 7 approaches maximal enzyme activity, for this 
concentration of coumarin-labelled substrate, at 100 nM HNE. HNE activity at pH 9 
shows direct proportionality between HNE concentration and HNE activity at these 
















Figure 3.3 HNE activity increases in alkali pH. 
Activity of 6.25, 12.5, 25, 50 and 100 nM purified HNE with 1 µM AAPV-AMC at pH 7 (green) and pH 
9 (blue). Values in the graph represent mean ± SEM, P values were calculated using two-way ANOVA 












3.2.4 CHARACTERISING THE SERPROCIDIN SPECIFICITY OF NAP:              
ABSOLUTE FLUORESCENCE 
In addition to temperature and pH fluctuation, competition with serprocidins is a 
physiologically relevant parameter to consider for NAP characterisation. Due to the 
effect of pH on serprocidin activity, HNE was compared to cathepsin G (CG) and 
proteinase 3 (PR3) at physiologically relevant HNE doses, 6.25 and 100 nM and at 
pH 5, 7 and 9 at 37oC. At 6.25 nM serprocidins elicit negligible NAP signals at pH 5, 7 
and 9, instead NAP background fluorescence (dotted lines) contributes the majority 
of measurements for each enzyme. At 100 nM CG and PR3 generate modest 
increases in NAP signal after background subtraction however HNE-derived NAP 
signal is significantly increased above that of CG and PR3 respectively by the 
following fold changes: 4.06 and 3.35 at pH 5, 2.41 and 3.86 at pH 7, 5.73 and 5.52 
























                                                               
Figure 3.4 NAP selects for HNE activity at high physiological enzyme concentrations 
Average of NAP fluorescence over 10 minutes, after 50 mins incubation with HNE, proteinase 3 or 
cathepsin G at A) 6.25 nM B) 100 nM at pH 9 (black bars), pH 7 (grey bars) and pH 5 (white bars). 
Dotted lines indicate uncleaved NAP signals of 2.5, 100 and 400 x102 RFU at pH 5, 7 and 9 
respectively in both graphs. Values represent mean ± SEM and P values were calculated using two-











3.2.5 CHARACTERISING THE SERPROCIDIN SPECIFICITY OF NAP: ENZYME 
ACTIVITY 
Investigating the enzyme selectivity of NAP among the serprocidins reveals that 
NAP can be cleaved by HNE, PR3 and CG. NAP is cleaved more rapidly by HNE than 
competing serprocidins in five of six cases where enzyme concentration and pH are 
comparable. When enzyme concentration or pH are increased to enhance the 
enzyme velocity of HNE, and competing serprocidins, HNE-selectivity increases. The 
ability to augment HNE selectivity in this manner is pertinent to the intracellular 
dynamics of phagocytosis during which phagolysosomal pH and serprocidin activity 
increase.61 At 6.25 nM all serprocidins demonstrate relatively slow enzyme 
velocities ranging from 0.5 – 171.7 RFU/min (Fig.3.5 A-C). Under these conditions, 
only one of the 9 comparisons of serprocidin-generated NAP signal (3 comparisons 
for pH 5, 7 and 9 respectively) is significant, the PR3 to CG comparison at pH 9 
(Fig.3.5 C). At the 100 nM serine protease concentration, NAP demonstrates a high 
degree of HNE-selectivity as HNE-derived NAP signals are significantly higher than 
PR3 and CG irrespective of pH (Fig.3.5 D-F). In contrast to HNE, there are no 
significant differences between PR3 and CG at 100 nM. 
 
Although 6.25 nM HNE-derived NAP signal is not significantly different from 6.25 
nM PR3 or CG-derived signals, there is a trend towards increased selectivity for 
HNE. 4 of the 6 possible HNE-PR3 or HNE-CG comparisons, trend towards increased 
NAP signal generation with HNE, with fold increases ranging from 1.4 - 2.6 (Fig.3.5 
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G). At 100 nM, these trends become significant fold-increases ranging from 2.7 to 
34, largely dependent on pH (Fig.3.5 G). 
At constant enzyme concentration pH also influences the rate of NAP cleavage. CG 
enzyme velocity decreased from 106.7 at pH 7 to 28.8 at pH 9, however in all other 
instances increasing pH, increased the enzyme velocity of the serprocidins, whether 
this increase was from pH 5 to 7 or pH 7 to 9. The influence of pH on fluorescein 
fluorescence can contribute to these measurements and was investigated with 
respect to HNE (see Fig. 3.3). Despite the pH sensitivity of fluorescein, increasing pH 
appears to increase NAP’s ability to select for HNE. There is a growing disparity 
between HNE-derived NAP signal and that of other serprocdidins as average fold 
increases increase with alkalinisation from 2.6 (pH5) to 6.3 (pH7) to 19.6 (pH 9). 
Finally, among the serprocidins, HNE demonstrates the greatest capacity to 
accelerate enzyme velocity in response to increased enzyme concentration. HNE’s 
greater intrinsic ability to cleave NAP is demonstrated across pH 5, 7 and 9 with fold 
changes that range from 9.9 at pH7 to 19.2 at pH9 (Fig.3.5 H). Five of the six fold 
changes generated by PR3 and CG are less than the lowest of the HNE fold changes. 
And the single PR3 fold increase which falls within the HNE range, relies on a low 
baseline, its enzyme velocity being 2.6-fold less than that of HNE at 6.25 nM (PR3 
=0.5 RFU/min, HNE= 1.3 RFU/min) as opposed to high enzyme velocity at 100 nM 




G  HNE enzyme velocity fold increase over other serprocidins 
            6.25 nM                                  100 nM 
PR3 CG Mean 
2.7 2.5 2.6 
6.1 6.5 6.3 
5.7 34.0 19.9 
 
H  Enzyme velocity fold increase between 6.25 and 100 nM conditions 
  
HNE PR3 CG 
17.3 16.9 7.3 
9.9 2.4 2.1 
19.2 1.5 0.9 
 
Figure 3.5   
HNE selectivity of NAP signal increases with increasing serprocidin concentration and pH  
The tangents of progress curves, describing enzyme activity over time, were averaged after 5 mins 
incubation with HNE, proteinase 3 or cathepsin G at A-C) 6.25 nM and D-F) 100 nM. G) Table 
showing fold-increase of HNE enzyme velocities over PR3 and CG. H) Table showing fold-increase 
between 6.25 and 100 nM enzyme velocities. Values represent mean ± SEM and P values were 
calculated using two-way ANOVA and Bonferroni multiple comparisons test, * P <0.05 *** P <0.001, 
n=3 
pH  PR3 CG Mean 
5  2.6 1.0 1.8 
7  1.5 1.4 1.5 







3.2.6 THE EFFECT OF CALCIUM IONOPHORE ON NEUTROPHIL ADHESION 
MOLECULE EXPRESSION 
From an initial MFI of 5 μg/mL CD11b expression and 5 μg/mL CD62L expression, 
neutrophils stimulated with 1 μM calcium ionophore showed 9.33 fold increase in 
CD11b expression and concomitant 3.10 fold decrease in CD62L expression by flow 
cytometric analysis. Following Percoll blood preparation there is a significant 








Figure 3.6 Percoll blood preparation derived neutrophils are sensitive to activation 
Median fluorescence intensities of neutrophil populations labelled for cell surface A) CD62L 
expression and B) CD11b expression, analysed by flow cytometry. Graph values represent mean ± 
SEM, P values were calculated by t test, *P<0.05 **P<0.01 n=3. 
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3.2.7 THE SENSITIVITY OF NAP  
TO PHARMACOLOGICAL HNE INHIBITION 
Following stimulation with calcium ionophore, NAP signal is detectable in 
neutrophil-derived supernatants over a range of active HNE concentrations. When 
Sivelestat, a small-molecule inhibitor, specific for HNE, is added to activated 
neutrophil derived supernatants dose dependent inhibition is detectable using NAP. 
As varying active HNE concentration in neutrophil-derived supernatants produces 
significant differences in NAP fluorescence, NAP can be used to distinguish between 














Figure 3.7 NAP detects HNE release and pharmacological inhibition 
Measuring HNE activity of 2x107/mL neutrophil supernatant under increasing pharmacological 
inhibition (Sivelestat). Values in the graph represent mean ± SEM, P values were calculated 
using repeated measures one-way ANOVA and Bonferroni’s multiple comparison test, 






3.2.8 INTRACELLULAR NAP SIGNAL KINETICS DURING 
PHARMACOLOGICAL NEUTROPHIL ACTIVATION 
Confocal microscopy reveals that in addition to extracellular fluorescence increase, 
NAP enters neutrophils upon calcium ionophore stimulation, generating bright 
intracellular puncta. NAP signal was blocked when calcium ionophore is added to 
cells preincubated with Sivelestat (100 μM), a specific and irreversible HNE 
inhibitor. Image analysis reveals that neutrophils incubated with and without 
Sivelestat show the same dim fluorescence prior to the addition of the calcium 
ionophore stimulus, which dilutes NAP to a 3 μM final concentration, decreasing all 
fluorescence values. Neutrophils without Sivelestat rapidly increase intracellular 
fluorescence, 0.047 – 0.463 mean pixel intensity (MPI), becoming significantly 
different from the Sivestat condition (0.010 – 0.011 MPI) at 2 minutes after adding 
stimulus. Neutrophils without Sivelestat continue to increase to a plateau of 0.824 
MPI over the next 3 minutes, stable for the duration of the 10-minute time course. 
Sivelestat inhibition prevents signals from exceeding 0.06 MPI over the time course 
so that differences between both conditions remain significantly different. The 
removal of NAP signal by the addition of Sivelestat alone, demonstrates that NAP 

















Figure 3.8 HNE is required for Neutrophil Activation Imaging using NAP  
Images represent 10-minute time lapse of neutrophils stimulated with 10 µM calcium ionophore A-
C) with and D-F) without 100 µM Sivelestat. G) Image analysis plotting mean intracellular 
fluorescence intensities of neutrophil populations at 30 second intervals. Graph values represent 
mean ± SEM, P values were calculated by two-way ANOVA and Bonferroni multiple comparisons 
test, *P<0.05 **P<0.01 ***P<0.001 n=3. 
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3.2.9 INTRACELLULAR NAP SIGNAL KINETICS DURING BACTERIAL 
PRODUCT-INDUCED NEUTROPHIL ACTIVATION 
The previous time lapsed, intracellular NAP signal experiment was modified to 
understand the implications of HNE imaging in neutrophils under more 
physiologically relevant conditions. All conditions appear similar in morphology and 
fluorescence prior to fMLF stimulation (Fig. 3.9.A,D,G). Image analysis of 
intracellular fluorescence revealed similar values across all conditions prior to fMLF 
stimulation (0.00 - 0.02 intracellular pixel maxima Fig. 3.9J) irrespective of LPS or 
LPS/fMLF/Sivelestat treatment. At 1-minute post stimulus, LPS/fMLF treated 
neutrophils develop 0.09 intracellular pixel maxima becoming significantly more 
fluorescent than untreated and LPS/fMLF Sivelestat conditions (<0.01 and 0.00 
intracellular pixel maxima respectively Fig. 3.9.J). Bright intracellular signals in 
LPS/fMLF neutrophils are maintained for 4.5 minutes, enabling discrimination 
between activated and untreated neutrophils. At 7.5 minutes, LPS/fMLF signals lose 
statistical significance, but these signals still exceed those of LPS/fMLF Sivelestat 
treated or untreated neutrophils allowing activation detection under more stringent 
thresholding (Fig. 3.9.J).  
Changes in neutrophil morphology (Fig.3.9.E,F and H,I), observed in concomitant 
brightfield images, showed all neutrophils becoming activated upon fMLF 






     




















Figure 3.9  
In response to bacterial products neutrophil activation is rapidly detectable with NAP 
Images represent 10-minute time lapse of A-C) unstimulated neutrophils, D-F) neutrophils primed 
with 25 ng/mL LPS and activated with 100 nM fMLF and G-I) 100 µM Sivelestat followed by 25 ng/mL 
LPS and 100 nM fMLF treatment. J) Image analysis plotting mean intracellular fluorescence 
intensities of neutrophil populations at 30 second intervals. Graph values represent mean ± SEM, P 




3.3.0 DETECTING NEUTROPHIL ACTIVATION ACROSS THE NEUTROPHIL 
LIFESPAN: WHOLE-CELL FLUORESCENCE  
To investigate the effects of changing cell viability on neutrophil activation 
detection, neutrophils were incubated with and without 1 µM calcium ionophore 
over a twenty-hour period so that untreated and activated viable, apoptotic and 
necrotic populations could be compared by NAP staining. NAP was added to 
samples immediately following Percoll blood preparation, a 2-hour protocol (2 hrs) 
and then at 4 (6 hrs) and 16 (20 hrs) hour intervals. Flow cytometric analysis reveals 
that, apoptotic and necrotic populations comprise 6.2 and 2.5% of neutrophils 
respectively at 6 hours and 36.9 and 28.8% of neutrophils respectively at 20 hours. 
Following activation, NAP signal in viable activated neutrophils begins to plateau at 
6 hours (173 MFI), achieving only slight increase at 20 hours (177 MFI, Fig. 3.10.D). 
By contrast NAP signal in viable untreated neutrophils remains low throughout the 
time course with NAP signals of 21.7, 21.0 and 37.0 MFI at 2, 6 and 20 hours 
respectively. Significant differences occur between activated and untreated viable 
neutrophils at 6 and 20 hours.  
Following activation, NAP signal in apoptotic activated neutrophils increases 41.7 
MFI/hr from 2 (53.8 MFI) to 6 (220.6 MFI) and then by 23.2 MFI/hr until the 20 hour 
timepoint (546.0 MFI, Fig. 3.10.E). Apoptotic untreated neutrophils show a similar 
trend in NAP staining to viable untreated neutrophils remaining low across the 
entire time course (24.1 MFI at 2 hrs, 23.9 MFI at 6 hrs) but increasing at 20 hours 
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(54.7 MFI). Despite the 9.3-fold increase in NAP signal at 6 hours, the only 
significant difference is observed at 20 hours.  
Following activation, NAP signal in necrotic activated neutrophils shows the least 
variation in NAP signal generation over time (Fig. 3.10.F) increasing 20.4 MFI/hr 
from 2 hours (107.2 MFI) to 6 hours (188.6 MFI) and then 33.5 MFI/hr until the 20-
hour timepoint (657.8 MFI). Although NAP signals in necrotic untreated neutrophils 
are the highest of the untreated populations (at 56.9, 58.3 and 90.0 MFI for the 2, 6 
and 20-hour timepoints respectively) these are still relatively low values compared 
to activated viable and apoptotic cells. Significant differences occur between 
activated and untreated necrotic neutrophils at 6 and 20 hours. 
Confocal microscopy of ageing neutrophil populations activated with 1 µM calcium 
ionophore in 3 µM NAP solution reveal distinct intracellular signal patterns for 
stimulated (Fig. 3.10.H bright intracellular puncta, green arrow), necrotic (whole-
cell dim fluorescence, red arrow) and neutrophils before responding to stimulus, 































Figure 3.10 NAP continues to report activation as activated neutrophil populations age 
Representative dot plots showing viable, apoptotic and necrotic neutrophil populations by 
propidium (1:300) iodide and annexin-V-AF647 (1:200) staining at A) 2 B) 6 and C) 20 hrs. Bar charts 
of 3 µM NAP staining in D) viable E) apoptotic and F) necrotic neutrophil populations, as determined 
by flow cytometry, show median fluorescence intensities of neutrophil populations with and without 
1 µM calcium ionophore treatment at 2 hours. Values represent mean ± SEM, P values were 
calculated using two-way ANOVA and Bonferroni multiple comparisons test, * P <0.05, *** P <0.001, 
n=3. G) representative confocal image of activated neutrophils at 6 hrs H) magnified example of 
unactivated (grey arrow) activated (green arrow) and activated necrotic (red arrow) neutrophils. 
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3.3.1 DETECTING NEUTROPHIL ACTIVATION ACROSS THE NEUTROPHIL 
LIFESPAN: INTRACELLULAR FLUORESCENCE  
Neutrophils accumulate NAP signal in different patterns of intracellular distribution 
when activation as opposed to necrosis leads to neutrophil staining (see Fig. 
3.10.H). Confocal microscopy and image analysis were combined to interrogate the 
effect of changing neutrophil viability on NAP signal, specifically with regard to 
intracellular maxima pixels. Membrane impermeant DAPI staining shows significant 
increase in cell death in the untreated population by 20 hours generating 730, 994 
and 2922 RFU at 2, 6 and 20 hrs respectively (Fig. 3.11.M). The untreated 
population is increasingly composed of apoptotic and necrotic neutrophils over 
time (see Fig. 3.10.A-C) and this increase in DAPI staining is blocked by the addition 
of a pan-caspase inhibitor (QVD). Stimulating neutrophils with 1 µM calcium 
ionophore significantly increases DAPI staining immediately (at the 2-hour 
timepoint) with (1987 RFU) and without (2212 RFU) pan-caspase inhibitor 
treatment. 
 
NAP signal shows a similar pattern of low staining in untreated and QVD treated 
neutrophils and high staining with 1 µM calcium ionophore treatment. These 
differences are much more pronounced such that a log scale is necessary to 
represent changes in NAP signal over time. By intracellular pixel maxima, increases 
in NAP signal in the mixed untreated population can be appreciated over time (1.9, 
6.1 and 225.7 RFU and 2, 6 and 20 hours respectively) such that the 20-hour signal 
is significantly greater than the earlier timepoints.  Activated to untreated 
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neutrophil NAP signal comparisons are also much clearer with 16.8- and 9.4-fold 
increases in NAP signal with activation at 2 and 6 hours respectively. At 20 hours 
untreated neutrophils show 1.6 times more NAP signal than activated neutrophils. 
Decrements in the fold change between untreated and activated NAP signals over 
time demonstrate increasing refractoriness to stimulus over time. 
 
Although NAP signal shows increasing trends in both the QVD and QVD + calcium 
ionophore treatment groups over time, these groups show low fluorescence (⩽10 
RFU and ⩽31 RFU respectively) across the time course. These large reductions in 
NAP signal with the addition of QVD demonstrates a role for apoptosis in 





































Figure 3.11 NAP detects neutrophil activation in stimulated, ageing neutrophil populations 
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Figure 3.11 NAP detects neutrophil activation in stimulated, ageing neutrophil populations 
Images represent neutrophils incubated A-C)  without treatment D-F) with 15 µM QVD pan-caspase 
inhibitor G-I)  with 1 µM calcium ionophore and J-L) with 15 µM QVD + 1 µM calcium ionophore at 
A,D,G,J)2 B,E,H,K) 6 and C,F,I,L) 20 hrs. Roman numerals represent i) merge ii) DAPI and iii) NAP 
images. Image analysis of M) DAPI images N) NAP images are shown, plotting mean intracellular 
fluorescence intensities of neutrophil populations. Values represent mean ± SEM, P values were 




3.3.2 SUMMARY  
Neutrophil activation probe (NAP) is environmentally sensitive, principally to pH but 
also to temperature. 3 μM was identified as the standard NAP dose for use in 
subsequent experiments and although PR 3 and CG have some potential to 
influence NAP signal at this dose, in plate-reader assays, their contribution is 
negligible in confocal imaging assays in which HNE alone generates NAP signal. With 
neutrophil activation NAP fluorescence increases within 2 minutes, allowing 
activated neutrophils, now marked by bright intracellular puncta and extracellular 
fluorescence, to be parsed from dark untreated neutrophils. Neutrophil activation 
detection is reliable over the neutrophilic lifespan and NAP also affords the 
segregation of viable, apoptotic and necrotic neutrophils. 
3.4.0 DISCUSSION 
3.4.1 NAP CHARACTERISATION STUDIES WITH  
PURIFIED HUMAN NEUTROPHIL ELASTASE 
NAP signal acquired from a system with active HNE depends on NAP and HNE 
concentrations, temperature, pH and the detection apparatus. Titrating NAP 
concentration has a proportional effect on its signal. NAP limit of detection could be 
considered in a variety of experimental set-ups however these permutations can be 
refined by considering appropriate restraints. Physiological restraints, such as a 
pathophysiological HNE concentration range (0-100 nM173) and practical restraints 
such as comparing data from subsequent assays. Within these limits, 0.5 μM is the 
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lowest concentration by which 100 nM HNE can be detected within one hour, by 
spectrometric analysis. There are many experimental alterations that may improve 
the limit of detection such as buffer alkylinization and the use of a more sensitive 
detection system such as afforded by confocal microscopy. However, the purpose 
of the limit of detection study was simply to understand spectrometric NAP signal 
detection over time, establishing experimental conditions for future studies. A 
concentration of 3 μM NAP was taken forward for further experimentation. 
 
Temperature change can affect numerous cellular and experimental properties. The 
consistent effect of temperature on NAP signal between 35 and 40oC may limit its 
ability to interfere with deep tissue measurements of HNE activity in vivo. However, 
the signal variability that temperature introduces around 26oC could be an 
important consideration for HNE measurements at superficial or exposed surfaces 
and is important for several assays conducted at room temperature. Nonetheless, 
with an appropriate negative control, the effects of temperature and enzyme 
activity can be separated. One parameter that will impact all HNE measurements, in 
vitro or otherwise is pH. HNE is stored at pH 5 in neutrophil azurophil granules and 
alkalinisation to pH 9 takes place following the formation of the phagolysosome.62 
Therefore it is important to understand the effect of pH on HNE activity, particularly 
at pH 9 and under neutral conditions, under which the majority of extracellular HNE 
activity may take place. By measuring fluorescent emission of a coumarin-labelled 
substrate, the linear relationship between HNE activity and HNE concentration at 
pH 7 and 9 could be described by the following equation 𝑉𝑝𝐻7 =
𝑉𝑝𝐻9
4
 where V is the 
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fluorescent emission for a given concentration of HNE between 0 and 100 nM. This 
simple relationship may facilitate the use of mathematical tools, in understanding 
HNE dynamics in addition to fluorescence measurement. In the case of NAP, a 
similar mathematical relationship could not be revealed, and this may be due to the 
complexity introduced by fluorescein’s pH-dependent quantum yield. Although 
alkalinisation was shown to promote HNE activity, the experiment could have been 
improved by finding the pH at which HNE activity achieves an upper limit and 
demonstrating the inverse effect due to acidification. 
The effect of acidification on HNE activity was considered in subsequent 
experiments (Fig 3.4 and 3.5) which demonstrate reduced HNE activity at pH5 as 
expected. These experiments also demonstrate the low levels of NAP cleavage 
achieved by CG and PR3 and the minimal effect their activity has on NAP signal. HNE 
outcompetes CG and PR3 in the generation of NAP signal to the point that 
appropriate measurement thresholding could remove any contribution from 
competing enzymes as noise. In practice a clinical imaging biomarker would ideally 
provide readouts as quickly as possible and under 30 minutes. Measurements 
within these timeframes could favour the generation of HNE-specific NAP signal 
over other serprocidins which are slower to generate signal.  
The effects of increasing dose on enzyme velocity provide mechanistic insight into 
NAP’s selectivity for active HNE. There are 3 mechanisms for HNE’s enhanced 
activity compared to other serprocidins, greater affinity for NAP, greater catalytic 
rate and increased sensitivity to alkalinisation. Serprocidins demonstrate a non-
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linear relationship with substrate. HNE velocity is faster than that of PR3 or CG for 
the same change in NAP concentration, this indicates that HNE has either a higher 
affinity for NAP, a faster active site or both, when compared to other serprocidins. 
By taking the ratio of enzyme velocities at different serprocidin concentrations the 
effect of alkalinisation can be seen independently of affinity and catalytic constants. 
These ratios show that, in its interaction with NAP, HNE is more sensitive to 
alkalinisation-induced increased activity than other serprocidins. 
 
Of the serprocidins, HNE has been demonstrated to have the fastest catalytic rate 
constant on interaction with endogenously derived substrates.132 These differences 
help to explain NAP’s HNE selectivity. Further work can be done to investigate the 
contributions of affinity and catalytic rate to this selectivity.  
3.4.2 NAP CHARACTERISATION STUDIES WITH  
PRIMARY HUMAN NEUTROPHILS 
By studying changes in adhesion molecule expression a clear indication of the 
extent of activation possible in primary human neutrophil assays was gained. 
Neutrophils acquired by Percoll blood preparation were suitably untreated to 
separate untreated populations from those stimulated by calcium ionophore. There 
is such a large difference between these untreated and pharmacologically 
stimulated groups indicates that the effects of weaker stimulation, as may be 
expected with physiological stimuli, may also be detected. The ability of NAP to 
report differences between the HNE activity of neutrophil-derived supernatants 
102 
 
with varying degrees of specific HNE-inhibition, also supports the concept of 
discerning between different physiological neutrophil populations which may be 
stimulated to release HNE and its inhibitors (such as elafin174, SLPI175 and 
serpinB1171) at varying concentrations. This work could have been furthered by 
determining if similar distinctions between neutrophil-derived supernatants could 
be made with endogenous inhibitors under physiological conditions. Although 
blocking NAP signal with Sivelestat, a specific inhibitor of HNE, supports the claim 
that NAP signal is selective for HNE activity, a full-block condition with a higher dose 
of Sivelestat would have done more to support this claim. Instead this was 
addressed in an imaging assay, where intracellular NAP signal was tracked over 
time. Despite a maximal stimulus of 10 μM calcium ionophore, full block was 
achieved with constant, 100 μM Sivelestat co-incubation. The rapid evolution of 
significant differences between uninhibited and 100 μM Sivelestat conditions 
demonstrate how quickly activated neutrophils can be separated from neutrophils 
without NAP signal. The two classes of neutrophils without NAP signal in this assay 
are Sivelestat inhibited activated neutrophils and, prior to stimulus, untreated 
neutrophils which were shown to be indistinguishable. The ability to distinguish 
between untreated and activated neutrophils rapidly and with a sustained 
difference between treatment groups may prove useful characteristics of NAP as a 
clinical biomarker. This work was repeated under more physiological experimental 
settings with 25 ng/mL LPS/ 100 nM fMLP stimulated neutrophils compared against 
untreated neutrophils across the entire time-course. It was important to use 
sufficiently low concentrations of bacterial products to recapitulate a physiologically 
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relevant bacterial inflammatory stimulus. Data following LPS/fMLF stimulation 
shows more variability between donors and loss of significance after 2.5 minutes of 
exposure to activating stimulus. The physiological data set also reported neutrophil 
activation 1 minute faster, and with a larger initial fold change, than the 
pharmacological setting. Comparisons between the pharmacological and 
physiological data sets are difficult to interpret as the later was collected on a 
spinning disk confocal microscope when the microscope used to collect the former, 
the Zeiss LSM 510 META confocal microscope, was replaced. To improve this assay, 
cell tracking could be used to isolate activated neutrophils for analysis, following the 
initial activity peak.  
Finally, the effects of apoptosis and necrosis on activated neutrophil identification 
were considered. Image analysis revealed a consistent ability to discriminate 
between untreated and activated neutrophils despite ageing and the accrual of 
necrotic cells over a 20-hour time course. Imaging data also demonstrated different 
spatial and fluorescence patterns for untreated, activated and necrotic neutrophils. 
Flow cytometric analysis was used to confirm the ability to identify necrotic and 
activated viable neutrophils. Neutrophil populations can be segregated into 










































ACTIVATION USING VE200  















HNE-targeted probes are designed to detect HNE and enable neutrophil labelling. 
This chapter aims to select a lead HNE-targeted probe and characterise probe-HNE 
interactions in terms of the dose and temporal dependence. Whether binding is 
irreversible is of interest as this is a necessary mechanistic requirement for targeted 
probes. The specificities of the lead targeted probe, binding neutrophils at the 
cellular level and HNE at the molecular level, are of particular interest. Satisfying 
these aims and interests, VE200 becomes an exciting candidate for multiplexed 
imaging with NAP. However, these two probes generate signal via mutually 
exclusive mechanisms relying on HNE active site inhibition or continuous activity 
respectively. The possibility of multiplexed NAP and VE200 imaging is evaluated 
with an emphasis on finding experimental optimal conditions. Finally, this chapter 
aims to understand whether VE200 has any ability to generate different signals for 












4.1.0 IRREVERSIBLE INHIBITORS OF HNE  
The oxidation of methionine 358 in α-1-PI reduced it’s inhibitory effect against HNE 
2000 fold and such a change may be achieved by reactive oxygen species release by 
activated neutrophils. α-1-PI and elaffin are susceptible to HNE cleavage-
inactivation. To achieve more robust inhibition of HNE small molecule inhibitors 
which form irreversible bonds, have been synthesized. Sivelestat (ONO-5046) is an 
inhibitor of HNE which has been approved for clinical use in Japan and South 
Korea.176,177 Sivelestat’s relatively low affinity for HNE (Ki = 200 nM) and conflicting 
evidence concerning its clinical efficacy have kept this, the only clinically approved 
HNE inhibitor, out of other countries.178 Squaretam and GW447631 are irreversible 
HNE inhibitors with inhibitory constants of 1.21 nM and 14 pM respectively.130,179 
Structure-activity relationship studies of 4-Oxo-β-lactams indicate that large effects 
on squaretam’s inhibitory potency may be effected by linking a benzyl group to the 
lactam. Whether benzylation leads to improvement or reduction of inhibitory 
potency may rely on the moiety being replaced.179 
 
4.1.1 SERINE PROTEASES  
HNE is a serprocidin stored at millimolar concentrations in the azurophil granules of 
neutrophils.180 Although HNE is chiefly a microbicidal protease, its broad substrate 
specificity allows neutrophils to use it intracellularly, extracellularly and in 
membrane-bound form for a variety of purposes. Phagocytosis, extravasation,181 
extracellular matrix remodelling,182–184 cell-signalling,185 mucus production,186 
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mucocilliary function187 and NETosis64 all have roles for HNE and a host of further 
interactions give the enzyme utility for other cell-types including monocytes, 
endothelial and adenocarcinoma cells. When released by activated neutrophils HNE 
can be used to destroy pathogens and promote neovascularization as part of tissue 
repair however sustained HNE release contributes to the pathophysiological 
sequalae of acute respiratory distress syndrome, lung adenocarcinoma, 
atherosclerosis and other chronic inflammatory diseases.   
Craven et al. recently reported a probe that revealed neutrophil activation. This was 
designed to detect the serine proteases (serprocidins) using a pan-serprocidin 
substrate. A tri-branched probe was developed which maintains an optically super-
silent ground state with a methyl red and fluorescein FRET pair on each of its three 
branches (Figure 4.1.A).81 The structure facilitates internalisation by activated 
neutrophils and once in the phagolysosome, active serprocidins cleave the peptide 
sequences to remove the methyl red quenchers and generate a large fold increases 
in fluorescence (Figure 4.1.B). The probe generates bright intracellular puncta, in 
human neutrophils, within seconds of activation with pharmacological stimulus or 
bacterial coincubation. By adding the probe to whole blood in a simple, no-wash, 
no-lyse, flow cytometric assay, activated neutrophils could be profiled. Combining 
rapid signal generation and detailed cell-type specific analysis situates this pan-
serprocidin probe as a promising patient-stratification biomarker for several chronic 


























Figure 4.1 Activable FRET HNE Probe 
Structure Craven et al.’s Probe A) before and B) after cleavage by active HNE and indicating 
associated FAM fluorescence. C) In a no-wash, no-lyse whole blood flow cytometric assay, 
neutrophils activated with bacterial products take up probe and upregulate CD11b. Fluorescent 
signal is blocked in activated neutrophils with 100 µM Sivelestat co-incubation, CD11b signal is not 
and neither signal is enhanced above untreated controls in lymphocytes or monocytes. Copyright 
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The neutrophil elastase probe NE680 is a near-infrared multi-branched probe which 
is sensitive to cleavage by murine NE and HNE, amongst others (Figure 4.2).120 It 
consists of a peptide sequence (PMAVVQSVP) flanked by a NIR fluorophores and 
conjugated to a poly-lysine dendrimer, which lengthens its plasma and tissue half-
lives and results in internal quenching. Upon cleavage by proteases, NIR 
fluorescence emission is generated. NE680’s quantification of NE activity was 
demonstrated in vivo, using LPS/fMLF challenged mice and by incubating murine 
lung sections in increasing doses of the NE-specific inhibitor, Sivelestat (Figure 
4.2.C-D). Non-invasive, quantitative NE imaging was demonstrated using 
fluorescence molecular tomography.120 Wang et al. demonstrated a similar dose 
dependent reduction in NIR fluorescence of NE680 could be achieved under more 
physiologically relevant conditions, using recombinant α-1-PI instead of 
Sivelestat.188 Further studies using NE680 have revealed roles for NE in promoting 
neutrophil accumulation in atherosclerotic plaques, insulin resistance and arthritic 
pain, in murine models.189–191 Although NE680 cleavage by HNE has been 
demonstrated in vitro, structural differences between the murine and human NE 
active sites and functional differences between murine and human neutrophils 
mean the clinical utility of NE680 has yet to be demonstrated.  
Although a wealth of neutrophil probes have not reached in vivo studies, exciting 
developments in optical probe design are beginning to provide discriminatory 
power between related proteases. Despite their concomitant release from 
degranulating neutrophils, the various serprocidins perform distinct molecular 
functions.192 Screening combinations of natural and unnatural amino acids by their 
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kinetic affinity and rate constants, Kasperkiewicz et al. designed a HNE probe with a 
100-fold sensitivity surpassing the previous champion substrate designed by 
Korkmaz et al., 100-fold.193 The group’s combinatorial substrate library technique 
generated substrate-based activatable probes and inhibitory, targeted probes and 
they have extended their approach to included counter selection which biases 
against the interference of substrate cleavage from similar protease families.194,195 
Finally, the recently synthesized fluorogenic toolbox contained unique substrate-
fluorophore combinations for each of the four neutrophil serine proteases (HNE, 
proteinase 3, cathepsin G and neutrophil serine protease 4) and revealed for the 

































Figure 4.2 Schematic and in vivo function of NE680 FAST  
Schematic representation of NE680 FAST before A) and after B) cleavage by active NE which 
alleviates fluorescence quenching. C) Fluorescence molecular tomography of NE680 FAST (4 nM 
intranasal) instilled into control, LPS/fMLP and LPS/fMLP mice treated with inhibitor. NIR signal is 
absent in untreated controls and reduced in sivelestat (5mg/kg intranasal) treated controls D) and 
mean concentration of fluorescence (in nM) was quantified in the lung area ROIs (orange cubes) for 
control (N=12), LPS/fMLP (N=16) and sivelestat (N=12) groups. C-D) Copyright 2011 Kossodo et al. 
and adapted under the CC BY 3.0 license.120 
 
To enable clinical, functional neutrophil imaging via HNE activity at inflammatory 
sites a NAP was developed.121 Using static quenching NAP’s tribranched structure 
holds fluorescein moieties in close proximity limiting fluorescence. Each of these 
SmartProbe’s three branches contain a HNE substrate sequence cleaved by the 
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active enzyme to generate large fold increases in fluorescent intensity. Encouraging 
results with NAP came from synthesising the SmartProbe to GMP standards and 
endomicroscopically imaging neutrophil activation in ventilated and perfused ex 
vivo human lungs.197 
 
4.1.2 MONOCYTE ELASTASE AND PROBE SPECIFICITY  
HNE is a fascinating enzyme acting intracellularly, extracellularly and at plasma 
membranes where it demonstrates broad substrate specificity (see 6.3.1 Substrates 
of HNE and the effects of their cleavage) autocatalysis and inhibitor cleavage. 
Another quirk lay in the discovery of HNE within monocytes. Hatice et al. found 
approximately 40% of monocytes contained HNE but there are some important 
differences between this and neutrophilic HNE.137 Monocytes were found to store 
10-15 fold less HNE than neutrophils.137  And the acidic, monocyte phagolysosome 
will produce far dimmer fluorescence than the alkalinised neutrophilic 
phagolysosome since both fluorescein fluorescence and HNE activity are reduced by 
acidification. These differences highlight biological and chemical mechanisms for a 
cell-type specific imaging technique however a third factor, the detector sensitivity 
of the imaging instrument, is also pertinent. Flow cytometry is more robust and 
sensitive technique for quantifying HNE-probe interactions than 20th century 
immunogold staining and electron microscopy. But flow cytometry is so sensitive 
that it may yield false positives across a large patient cohort. In a clinical setting in 
situ fibred microscopy may be the most relevant to clinical decision-making tool.   
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4.1.3 HNE-TARGETED PROBE TOXICITY 
VE136 and VE200 were synthesized and tested for cytotoxicity by Dr. Vikki Evans. 
These probes were found to produce less than 2% cytotoxicity at 5 µM which is 12.5 
and 50-fold in excess of the doses proposed for final phenotypic classification (see 
results section 5.3.1) and FCE (see results section 5.4.2-3) applications respectively. 
Furthermore no significant morphological changes were observed after neutrophils 
were incubated with VE200 for ninety minutes (see figure 5.12 Xii). These targeted 
probes are therefore sufficiently non-toxic to warrant further investigation of their 














4.1.4 HYPOTHESIS AND AIMS:  
Hypothesis: A HNE ligand-based probe can sensitively and specifically detect 
intracellular HNE activity enabling multiplexed imaging with NAP. 
Aims: 
1) Develop an assay for incomplete intracellular HNE inhibition using GW447631 
i. Determine the Michaelis-Menton and catalysis constants for the HNE – 
AAPV interaction. 
ii. Drawing on (i) kinetic understanding of the HNE-AAPV interaction use AAPV-
AMC substrate to characterise GW447631 intracellular inhibition of HNE 
iii. Drawing on (ii) understanding of GW447631 intracellular inhibition, 
determine the kinetics of HNE – GW447631 interaction in the presence of 
NAP. 
2) Identify a lead HNE-targeted probe for multiplexed imaging with NAP in 
primary human neutrophils 
i. Describe the fluorescent properties of the HNE targeted probe panel 
ii. Select the lead HNE-targeted probe 
iii. Describe the mechanism of VE200 interaction with HNE 
iv. Determine the optimal VE200 imaging concentration 
v. Identify an appropriate VE200 dose for multiplexed VE200 and NAP imaging in 
primary human neutrophils 
vi. Determine if apoptosis and necrosis readouts can be achieved using 




4.2.1 KINETICS OF THE HNE – AAPV SUBSTRATE INTERACTION 
To understand the relationship between HNE enzyme velocity and AAPV-pNA 
concentration, kinetic constants were derived from a Michaelis-Menten curve. The 
Michaelis and catalysis constants are 172.5 nM and 25.3 s-1 respectively showing a 
































Figure 4.3 Kinetics of the HNE-AAPV interaction 
Michaelis-Menten plot to determine the Michaelis constant and catalysis constant, measures of 
affinity and turnover rate respectively for the interaction between 10 nM HNE and AAPV-pNA 













4.2.2 GW447631 POTENCY IN PRIMARY HUMAN NEUTROPHIL LYSATES 
By measuring enzyme activity across a broad GW447361 concentration range  
(0 – 1000 nM), a 50% inhibitory constant of 12.9 nM was interpolated. GW447361 
shows a typical sigmoidal relationship between inhibitor concentration and enzyme 
velocity. Approximately 295 nM GW447631 fully inhibits a HNE concentration 
equivalent to the contents of five hundred thousand neutrophils. Importantly this 






























Figure 4.4 GW447631 dose dependently inhibits HNE in neutrophil lysates  
Dose dependent inhibition of HNE was demonstrated by measuring AAPV-coumarin fluorescence in 
2x107/mL neutrophil-derived lysates after stimulation with 5 μM calcium ionophore. Lysates were 










4.2.3 GW447631 KINETIC ANALYSIS IN LIVE NEUTROPHILS 
Further understanding of the GW447631 interaction with HNE was gained by time-
lapse imaging of neutrophil activation under varying HNE inhibition. Visualising HNE 
activity with NAP shows large, bright, intracellular puncta in the absence of 
GW447631 and bright extracellular signal throughout the well (Fig 4.5.A). With 
increasing GW447631 concentration intracellular puncta decrease in size and 
number and extracellular fluorescence intensity decreases (Fig 4.5.G).  At 10 μM 
GW447631 intracellular and extracellular signals of HNE activity are completely 
abrogated (Fig 4.5.J) by specific HNE inhibition198 and neutrophils resemble the 100 
μM Sivelestat condition. GW447631’s dose dependent inhibition of HNE apparently 
occurs intracellularly and extracellularly, with readily detectable changes in signal 
intensity over time. Quantifying these changes shows a constant rate of NAP signal 
generation in the uninhibited condition and decreasing NAP signal over time in all 




















































Figure 4.5 GW447631 displays dose dependent intracellular HNE inhibition  
Spinning disk confocal microscopy of neutrophils incubated for 10 minutes with 3 μM NAP A-C) 
without HNE inhibitors, D-F) with GW447631 at 0.1 μM, G-I) 1 μM or J-L) 10 μM or M-O) with 100 
μM Sivelestat. 10 μM calcium ionophore was added to all conditions immediately prior to the 120 s 
time point (dotted line). P) Image quantification shows intracellular NAP signal over time. Graph 
values represent mean ± SD and P values were calculated using one-way ANOVA and a Bonferroni 












4.2.4 FIBRONECTIN COATED WELLS AFFECT NEUTROPHIL ACTIVATION  
Data from neutrophils that were incubated in wells for 15 mins, followed a gaussian 
distribution and showed an increased rate of NAP signal generation than those 
incubated for 5 mins (Fig 4.6.A slopes) which were non-parametric. However, these 
effects were reversed following pre-incubation with GW447631 so that neutrophils 
with only 5 mins incubation in wells demonstrated faster and parametric NAP signal 
generation, albeit from initially dimmer starting points than non-parametrically 
distributed, 15 mins counterparts (Fig 4.6.B-D). Differences between neutrophils 
following 5 and 15-minute well-incubations were significant under in each 
treatment group however there was a trend of dose-dependence with increased 












Figure. 4.6  
GW447631 reverses the co-stimulatory effect of well-incubation on neutrophil activation    
NAP signal over time for neutrophils incubated for 10 minutes with 3 μM NAP A) without HNE 
inhibitors, B) with GW447631 at 0.1 μM C) 1 μM or D) 10 μM or E) with 100 μM Sivelestat. 10 μM 
calcium ionophore was added to all conditions immediately prior to 120 s time point (dotted line). 
Neutrophils were adherent in wells for 5 mins (black dots) or 15 mins (grey dots). Graph values 
represent mean ± SD and P values, showing the difference between timepoint matched data, were 
calculated using two-way ANOVA and a Bonferroni post-test *** P <0.001. A D’Agostino and Pearson 






4.2.5 HNE ACTIVITY AFFECTS NEUTROPHIL SHAPE-CHANGE  
When neutrophil radius was measured, across neutrophil populations, a trend of 
decreasing cell spreading was observed with increasing GW447631 dose. Untreated 
neutrophils maintained the widest mean radii across the 10-minute time-course 
and rapidly spread between 1.5 minutes, when stimulated, and 3.5 minutes before 
plateauing at 6 minutes.  Neutrophils treated with 0.1 or 1 μM GW447631, or 100 
μM Sivelestat, showed more gradual, linear cell spreading across the 10-minute 
time course. 10 μM GW447631 was the most potent HNE inhibiting condition and 




























































Figure. 4.7 High GW447631 dose reduces neutrophil activation dependent spreading  
Mean neutrophil radius over time of neutrophils incubated for 10 minutes with 3 μM NAP without 
inhibitors, with 0.1, 1 or 10 μM GW447631 at or 100 μM Sivelestat. 10 μM calcium ionophore was 
added to all conditions immediately prior to 120 s time point (dotted line). Graph values represent 










4.2.6 SPECTRAL CHARACTERISTICS OF THE HNE-TARGETED PROBE PANEL   
Three targeted probes for HNE labelling were synthesized. Cy5 fluorophore was 
bound to either GW447361, a 4-oxo-β-lactam ring or a phenylated 4-oxo-β-lactam 
ring to synthesize VE136, VE200 and VE135 respectively. The emission and 
excitation spectra of the 3 targeted probes are similar with excitation/emission 
maxima of 650/675 (VE136), 650/665 (VE200) and 655/680 (VE135). Although 
emission spectra are very similar between probes, VE200 has a narrower excitation 
peak (RFU = 0.2 at 584 and 674 nM) than VE135 (RFU = 0.2 at 528 and 690 nM) or 













Figure 4.8 Structures and spectral properties of candidate HNE-targeted probes 
Schematics showing inhibitor structure and fluorescence excitation and emission spectra for 10 μM 
cyanine-labelled HNE-targeted probes A) VE200 B) VE135 and C) VE136. Graph values represent 
mean ± SEM, n=3. 
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4.2.7 NEUTROPHIL SPECIFICITY OF HNE-TARGETED PROBES   
To select a lead probe for further study, percentage labelling, after five minutes, 
was compared across PMN and PBMC populations of untreated and activated cells. 
Although it is possible for some 40% percent of monocytes to store and release HNE 
in quantities approximately 3% of the levels achieved by neutrophil 
degranulation,137 this low level of HNE was undetectable in this assay. VE200 
achieved the highest percentage labelling at 68%, and this occurred in the presence 
of neutrophils activated with 1 μM calcium ionophore. VE200 also displayed good 
selectivity for activated neutrophils demonstrating a 13.5-fold increase between 
untreated and activated neutrophils and less than 10% labelling of both PBMC 
conditions. Although not statistically significant, fluorescence fold increases of 1.6 
and 2.9 for VE135 and VE136 respectively show a trend of neutrophil activation-
induced fluorescence increase. With the lowest untreated to activated neutrophil 
labelling fold change and the highest percentage PBMC labelling, VE135 is not a 





















Figure 4.9 Cell-type specificity of HNE-targeted probes 
Flow cytometric analysis showing percentage labelling cells, with 2 μM targeted probe, in A) PMN B) 
PBMC populations with and without calcium ionophore treatment. Graph values represent mean ± 













4.2.8 VE136 SENSITIVELY DETECTS NEUTROPHIL ACTIVATION 
Although VE200 outperformed VE136 for neutrophil activation detection, 
GW447631’s high affinity HNE-binding revealed subtle and HNE-dependent changes 
in neutrophil activation (Fig. 4.6 and 4.7). To understand whether VE136, Cy5-
labelled GW447631, could sensitively detect HNE release neutrophils were 
incubated with varying concentrations of PMA, for forty-five minutes, in the 
presence of VE136. Dose dependent labelling was achieved with neutrophils and 
not PBMCs, indicating neutrophil-specific VE136 labelling. Neutrophil-specificity of 
VE136 is further corroborated by the percentage-labelling after forty-five minutes 
of calcium ionophore incubation, this positive control data shows 94.5% of 
neutrophils are labelled and only 5.0% of PBMCs. However, the VE136 labelling 
interaction does not involve fluorescence unquenching and this necessitates 
comparisons of VE136 HNE labelling against false positive signals which can occur 
with free Cy5. When comparing PMA and calcium ionophore induced labelling in 
both groups to free Cy5 controls, neutrophil staining by VE136, in the presence of 
10 and 50 nM PMA is less than that of Cy5 staining at 2000 nM PMA but VE136 
staining from all other conditions (100, 200, 500, 1000 and 2000 nM PMA) exceed 
Cy5 staining, even at the maximal 2000 nM dose of PMA. There is no change in 
PBMC staining regardless of whether comparisons are made between 
pharmacological stimuli (PMA and calcium ionophore) or stain (VE136 and free 





























Figure 4.10 PMN specific VE136 is sensitive to varying PMA stimulation 
Flow cytometric analysis showing percentage labelled PMN and PBMC, with 1 μM VE136 and 0, 10, 
50, 100, 200, 500, 1000 or 2000 nM PMA. VE136 labelling is also compared to 10 μM calcium 
ionophore treatment positive controls. n=2. This experiment was not repeated further due to the 





4.2.9 NEUTROPHIL-SPECIFIC TARGETED PROBES ARE HNE-SPECIFIC 
VE136 and VE200 labelling were compared after 10 minutes of incubation with or 
without calcium ionophore (10 μM) treatment or calcium ionophore and Sivlestat 
(50 μM) treatment. In neutrophil populations, both probes showed increased 
labelling with stimulus which was abrogated by Sivelestat co-incubation. In PBMC 
populations, both probes show no variation between untreated, stimulated and 
stimulated/inhibited treatments. There is a trend toward more efficient neutrophil 
labelling with VE136 (65.6%, Fig. 4.11.E) over VE200 (58.0% Fig. 4.11.F), however 
the ratios of stimulated to untreated and stimulated to inhibited fluorescence also 
affect labelling efficiency. When comparing stimulated and untreated neutrophils, 
VE200 demonstrates a 34.2-fold increase in labelling efficiency with stimulation, as 
compared to 4.9-fold with VE136. When comparing stimulated and Sivelestat-
treated, stimulated neutrophils, the trend is similar with VE200 demonstrating a 
35.7-fold increase in labelling efficiency, without HNE-inhibition, as compared to 
4.10-fold with VE136. These ratios demonstrate good HNE-specificity for both 
probes and more sensitive labelling with VE200. For both probes, all PBMC labelling 
falls below that of untreated neutrophils (13.8% VE136, 2.6% VE200, Fig. 4.11.E and 
F), a background level of neutrophil staining, demonstrating the neutrophil 
specificity of both probes. For its spectral compatibility with NAP (Fig 4.7) and its 
neutrophil and HNE-specific binding, (Fig 4.9 and 4.11) VE200 was selected as the 





Figure 4.11 Cellular and molecular specificity of HNE-targeted probes 
Flow cytometric analysis showing percentage labelled cells in PMN and PBMC populations with and 
without 10 μM calcium ionophore and 50 μM Sivelestat treatment. A) 1 μM VE136 specificity, n=4. 
B) 1 μM VE200 specificity, biological replicates shown individually, n=3. Graph values represent 
mean ± SEM of individual experiments. Graph values represent mean ± SEM and P values were 





4.3.0 VE200 DEMONSTARTES IRREVERSIBLE INHIBITOR KINETICS 
In the previous three comparative assays VE200 demonstrated best performance. 
VE200 fluorescence excitation characteristics which limit excitation from non-640 
nm light compared to VE135 and VE136. And VE200 cellular and molecular 
specificity exceeded that of VE135 and VE136. Therefore, VE200 was selected for 
further characterisation and imaging experiments. VE200 shows dose dependent 
HNE binding when incubated with purified HNE (10 nM) and AAPV-AMC (1 mM). 
The 4-oxo-β-lactam ring inhibitor moiety should confer irreversible VE200 binding 
by suicide inhibition. According to Michaelis Menten phenomenology, the rate of 
inhibited product is proportional to the concentration of unbound VE200 remaining 
over time.199 The goodness of fit (R2= 0.93, Fig. 4.12.A) for the dose-dependence 
curve in A), is indicative of a two-phase exponential decay in agreement with the 
mechanism of suicide inhibition. At 10 μM, VE200 inhibition of HNE activity 
increases with incubation time, this phenomenon is expected with irreversible 
inhibitors and does not occur with reversible inhibitors, which establish an 
equilibrium between bound and unbound forms to sustain a constant inhibitory 













Figure 4.12 VE200 binds purified HNE irreversibly and with dose dependence 
A) Dose dependent inhibition of 10 nM purified HNE by VE200 at 0.1, 0.5, 5 and 10 μM n= 3  
B) Time-dependent inhibition of 10 nM purified HNE by 10 μM VE200 at 0, 2, 4, 6, 8 and 10 mins. 





4.3.1 ESTABLISHING AN OPTIMAL IMAGING DOSE FOR VE200  
VE200 labels neutrophils treated with 10 µM calcium ionophore (Fig. 4.13F-J) and 
remains excluded from untreated neutrophils (Fig. 4.13A-E) across a 100 – 2000 nM 
concentration range. Following pharmacological stimulation, VE200 labelling is dose 
dependent in neutrophils with a trend of exponential increase. Although untreated 
conditions yield low VE200 signal, this signal increases with neutrophil activation at 
each dose to facilitate activated neutrophil detection. The VE200 dose with the 
largest stimulation fold change is 500 nM in (Fig. 4.13L), when signal is quantified 
using a whole-frame histogram method and 200 nM in (Fig. 4.13K), when 













































Figure 4.13 200 nM VE200 optimally enables activated neutrophil detection 
Confocal microscopy of neutrophils incubated for 10 minutes with A-E) 0.1, 0.2, 0.5, 1 and 2 μM 




4.3.2 VE200 LABELS NEUTROPHILS VIA ITS HNE-INHIBITOR MOIETY  
Having established that VE200 labels stimulated neutrophils more efficiently than 
free Cy5 dye by flow cytometric analyses (Fig. 4.9 and 4.11), confocal microscopy 
was utilized to gain a subcellular understanding of VE200 labelling in neutrophils. 
After a single wash step, both VE200 and free Cy5 dye adsorb to and are 
endocytosed by neutrophils. Upon cellular stimulation, both labels are also capable 
of becoming concentrated in intracellular compartments in a punctate manner 
resembling NAP signalling. Image analysis was executed as described in Chapter 2, 
2.2.7 and showed no labelling with 0.2 μM free Cy5 irrespective of neutrophil 
activation status. Dose dependent increases in labelling occur in untreated and 
activated, Cy5 and VE200 treatment groups when compared at 0.2 and 2 μM. VE200 
conditions consistently generate brighter cellular signals than their free Cy5 
comparators, at both doses, with or without neutrophil activation. Stimulated 
neutrophils stained with VE200 showed significant fluorescence increase over all 
other conditions at 0.2 and 2 μM with fold-changes over the next brightest 
condition of 22.7 and 6.7 respectively.    
 
When comparing across treatments, 2 μM free Cy5 labelling of stimulated 
neutrophils which have taken up dye, was not significantly different from untreated 
neutrophils labelled with 2 μM VE200, which have not yet taken up dye. Despite 
being the brightest of the four free Cy5 conditions, stimulated neutrophils labelled 
with 2 μM free Cy5 were still 1.8-fold dimmer than stimulated neutrophils labelled 







Figure 4.14 VE200 labels neutrophils more efficiently than Free Cy5  
Confocal microscopy of neutrophils incubated for 10 minutes with A-C) free Cy5 dye and 10 μM 
calcium ionophore (CaI), D-F) VE200 and 10 μM calcium ionophore or G-I) VE200 alone. Cyanine-
based reagents are at 0, 0.2 and 2 μM. Image quantification shows extent of cyanine-dye labelling in 
untreated and stimulated neutrophils for J) 0.2 and K) 2 μM incubations. Graph values represent 




4.3.3 VE200 TITRATION ALLOWS MULTIPLEXING WITH NAP 
NAP and VE200, as substrate- and inhibitor-based probes respectively, compete for 
active HNE. To evaluate the utility of multiplexed, NAP and VE200 imaging, VE200 
was titrated to determine a concentration which would minimally block NAP signal 
while providing sufficient VE200 signal for the detection of neutrophil activation. 
Due to the bright and punctate nature of NAP signal, significant signal can be 
blocked before loss of signal becomes readily visible, highlighting the importance of 
image analysis techniques for objective, quantitative comparisons. An image 
analysis technique employed previously (see Chapter 2, 2.2.7) was re-applied. 
Although indistinguishable to the eye, NAP signal differences between untreated 
neutrophils in 3 μM NAP solution with 0 μM VE200 (1.1 kRFU), 0.2 μM VE200 (0.2 
kRFU) and 2 μM VE200 (0.1 kRFU) were detectable (Fig. 4.15G), significant and 
VE200 dose dependent according to image analysis. As NAP signal is suppressed in 
the presence of an inhibitory probe, there may be a low level of neutrophil 
activation in the untreated population, image analysis therefore provides a sensitive 
measure of neutrophil activation in this assay. Importantly, NAP signal from calcium 
ionophore treated neutrophils show a 21.3-fold fluorescence increase (23.4 kRFU, 
Fig. 4.15G) over untreated neutrophils without VE200 co-incubation. Stimulated 
neutrophils co-incubated with 3 μM NAP and 0.2 μM or 2 μM VE200 display 71.1 % 
and 34.6 % full NAP signal respectively. This data implies a relationship of 
exponential decay between VE200 dose and NAP signal reduction whereby each log 
increase in VE200 dose halves NAP signal.  
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For the purposes of multiplexing in future experiments a dose of 200 nM VE200 will 













































Figure 4.15 Low nanomolar VE200 doses enable multiplexed neutrophil labelling with NAP  
Confocal microscopy of neutrophils incubated for 10 minutes with A-C) 3 μM NAP, D-F) 3 μM NAP 
and 10 μM calcium ionophore, in the presence of 0, 0.2 and 2 μM VE200. Image quantification shows 
extent of NAP signal elicited from untreated and stimulated neutrophils at varying VE200 
concentrations. Graph values represent mean ± SEM and P values were calculated using one-way 
ANOVA and a Bonferroni post-test. *** P <0.001, n=3 
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4.3.4 DETECTING NEUTROPHIL ACTIVATION ACROSS THE NEUTROPHIL 
LIFESPAN: INTRACELLULAR FLUORESCENCE 
Neutrophils are typically short-lived leukocytes. To evaluate VE200 staining in 
apoptotic and necrotic neutrophil populations, 100 nM VE200 was added to an 
imaging assay measuring DAPI staining over time (see Fig. 3.11). VE200 shows 
similar staining for untreated neutrophils at 2 (35.5 RFU) and 6 (45.9 RFU) hours, 
increasing 4.2-fold at 20 hours (194.2 RFU). Neutrophils treated with 1 µM calcium 
ionophore, at each timepoint, increase from 199.8 RFU at 2 hours to 356.7 RFU at 6 
hours without increasing further at 20 hours (319.0 RFU). In the 15 µM QVD pan-
caspase inhibitor (QVD) treatment group, VE200 signal is low at 24.9 RFU at 2 hours 
and peaks at 6 hours (7.2-fold increase from signal at 2 hours) before falling at 20 
hours (2.0-fold increase from signal at 2 hours). With 15 µM QVD + 1 µM calcium 
ionophore treatment VE200 fluorescence rises at each time point from 2 (132.6 
RFU), to 6 (202.8 RFU), to 20 hours (422.8 6 RFU). No VE200 signal is observed at 
any time point when neutrophils are pre-treated with 15 µM GW447631. Although 
membranous and intracellular fluorescence increases over time when ageing 
neutrophil populations are stained with either 3 µM NAP alone or with 100 nM 
VE200, differences in the rate of signal generation between timepoints create 
different trends of increasing signal for VE200 as compared with NAP (see Fig. 3.11). 
NAP staining reveals more distinctions between the various neutrophil populations 
in this assay. However, VE200 and NAP show different temporal patterns of 
increasing signal in untreated neutrophils, and neutrophils prevented from initiating 
































Figure 4.16 NAP and VE200 multiplex to report activation in ageing neutrophil populations 





































































































Figure 4.16 NAP and VE200 multiplex to report activation in ageing neutrophil populations 





































































































Figure 4.16 NAP and VE200 multiplex to report activation in ageing neutrophil populations 





































































































Figure 4.16 NAP and VE200 multiplex to report activation in ageing neutrophil populations 
 










































































Figure 4.16 NAP and VE200 multiplex to report activation in ageing neutrophil populations 
Images represent neutrophils incubated A-C) with 10 µM GW447631 D-F)  without treatment G-I) 
with 1 µM calcium ionophore J-L)  with 15 µM QVD pan-caspase inhibitor and M-O) with 15 µM QVD 
+ 1 µM calcium ionophore at A,D,G,J,M) 2 B,E,H,K,N) 6 and C,F,I,L,O) 20 hrs. Roman numerals 
represent i) merge ii) DAPI and iii) NAP iv) VE200 images. P) Image analysis of VE200 images are 
shown, plotting mean intracellular fluorescence intensities of neutrophil populations. Values 
represent mean ± SEM, P values were calculated using two-way ANOVA and Bonferroni multiple 










4.3.5 HNE-PROBE MULTIPLEXING ACROSS THE NEUTROPHIL LIFESPAN 
To understand the effect of probe multiplexing on functional neutrophil imaging 
over time, 3 µM NAP and 100 nM VE200 were concomitantly added to ageing 
neutrophil populations at the point of imaging. Trends in NAP signal over time 
varied when 3 µM NAP was used to image HNE activity in ageing neutrophil 
populations, with and without 100 nM VE200 co-stain (see Fig. 3.11). Whether 
neutrophil populations aged untreated or under 15 µM pan-caspase inhibitor (QVD) 
treatment or 1 µM calcium ionophore treatment, 100 nM VE200 significantly 
reduced NAP staining at 20 hours (Fig. 4.17.B and C). The trend of NAP staining in 
the 15 µM QVD treatment group changed from increasing to decreasing at each 
timepoint when VE200 was added (Fig. 4.17.B). However, when neutrophils 
incubating in 15 µM QVD were challenged with 1 µM calcium ionophore at each 
timepoint there were no differences between NAP signal with or without the 

















Figure 4.17 VE200 reduction of NAP signal is most pronounced at 20 hours  
Image analysis of NAP images are shown, plotting mean intracellular fluorescence intensities of A) 
untreated, B) 15 µM QVD pan-caspase inhibitor C) 1 µM calcium ionophore (CaI) and D) 15 µM QVD 
pan-caspase inhibitor and 1 µM calcium ionophore treated neutrophil populations. Values represent 
mean ± SEM, P values were calculated using two-way ANOVA and Bonferroni multiple comparisons 









4.3.6 HNE-PROBE SIGNALS ARE NOT CORRELATED IN NEUTROPHIL 
APOPTOSIS  
NAP and VE200 signals are least correlated when 10 µM GW447631 is present as 
this irreversible HNE inhibitor successfully outcompetes 100 nM VE200 without 
abrogating NAP signal. Probe signal decorrelation is most pronounced at the 20-
hour timepoint (r2=0.17). The conditions that show the highest correlations at 2, 6 
and 20 hours are the 15 µM QVD conditions with (r2=0.98, 0. 98 and 0.96 
respectively) and without 1 µM calcium ionophore (r2=0.92, 0. 88 and 0.83 
respectively). At 2 and 20 hours, the untreated (r2=0.97 and 0.80) and 1 µM calcium 
ionophore (r2=0.94 and 0.78) conditions show high probe signal correlation 
however this falls at 6 hours to r2=0.49 for untreated neutrophils and r2=0.58 for 


































































Figure 4.18 Correlation between NAP and VE200 signal decreases at 6 hours 
NAP fluorescence is plotted against VE200 fluorescence for neutrophils A) without treatment 
(orange), under 1 µM calcium ionophore (yellow) treatment, under 10 µM GW447631 (blue) 
treatment B) under 15 µM QVD pan-caspase inhibitor, 15 µM QVD pan-caspase inhibitor + 1 µM 
calcium ionophore and 10 µM GW447631 (blue) treatment. Symbol shapes represent the 2 (circle) 6 
(triangles) and 20-hour (crosses) timepoints. C) Correlations between NAP and VE200 signal for each 











4.3.7 INITIAL KINETIC CHARACTERISATION OF  
GW447631 INHIBITORY CONSTANT 
Determining the inhibitory constant of GW447631 proved technically difficult and 
will briefly be described. Initially progress curves were used to measure enzyme 
activity in a discontinuous measurement protocol. These curves have rectangular 
hyperbolic trends and their initial linear gradients (tangeants) must be extracted to 
begin the data reduction process for determining inhibitory constant. A curve-fitting 
approach using MatLab version R2017b can improve tangent measurements, fitting 
entire progress curves and interpolating tangent values. However, the approach via 
MatLab requires initial constants of a rectangular hyperbolic equation to be 
deduced individually, for numerous curves.  
 
A fully automated data reduction approach for inhibitory constant measurement 
was developed using specialist enzyme kinetics curve-fitting software, GraFit 
version 7. In GraFit version 7, inputting the Michaelis Menten equation can be used 
to determine unknown values of inactivation constant and inhibitory constant. 
While using GraFit version 7 the technical parameters of enzyme kinetics 
experiments were re-evaluated leading to a continuous measurement assay. 
Implementing a continuous method significantly simplified work flow and reduced 
the risk of human error present in the discontinuous method. Using a continuous 
measurement assay, it became apparent that the combination of substrate and 
detection system, AAPV-AMC and BioTek II plate-reader, was not sensitive enough 
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for the purposes of this kinetic characterisation. AMC proved insufficiently bright to 
produce the fluorescent changes required to measure low enzyme velocities from 
1-10 nM HNE. Increasing HNE concentration was not feasible because this 
necessitates exponential increase in substrate concentrations, as change in 
substrate concentration must be negligible throughout the experiment, to ensure 
the accuracy of data reduction.  
 
A rhodamine labelled substrate was evaluated for its superior quantum yield 
compared to coumarin, this would increase the sensitivity of measurements, 
however the new substrate was found to be poorly water soluble and solubilising 
agents can reduce enzyme activity. Finally using AAPV-pNA in a continuous 
measurements assay and analysing data via GraFit version 7 proved to be the most 
useful method for an inhibitory constant assay.  
The inhibitory constant of VE136 can be approximated at 14.3 nM. However, the 
combination of HNE concentration and AAPV-pNA remained suboptimal indicated 
by a slight increase in enzyme velocity over time in the plateau phase. This suggests 
that 10 nM HNE affected a non-negligible reduction in AAPV-pNA concentration, 







VE200 was the lead HNE-targeted probe candidate of a three-probe panel. VE200 
has excellent cellular and molecular specificity and can be appropriately visualized 
at a 200 nM concentration. VE200 inhibits HNE irreversibly but the ability to image 
HNE with VE200 at low doses, limits its inhibitory effect such that multiplexing with 
NAP, an activity-based probe, is possible. Multiplexed NAP and VE200 imaging are 
useful in categorising neutrophils of varying ages and viability states with 
appropriate image analysis. 
4.4.0 DISCUSSION 
4.4.1 CHARACTERISATION OF GW447631 50% INHIBITORY CONSTANT 
At 12.9 nM the IC50 of GW447631 in the lysate inhibition assay seems to indicate 
high binding affinity within the context of this assay. Importantly, neutrophil lysate 
HNE inhibition studies demonstrated that GW447631 is capable of inhibiting HNE 
derived from primary human neutrophil lysates. HNE is stored in neutrophil 
azurophil granules, complexed with sulfonated proteoglycan,62 this physical barrier 
has to be overcome to inhibit HNE in this assay. Lysate preparation may be 
liberating proteoglycan from HNE active sites and allowing for interaction with 
GW447631. Alternatively, GW447631 may displace proteoglycan to bind HNE. 
Enzyme inhibition, by GW447631 follows the so-called suicide inhibition 
mechanism, a two-step process requiring HNE active site occupancy and inhibitor 
cleavage. Demonstrating that both steps of suicide inhibition can occur in 
neutrophil lysate is an encouraging outcome, meaning that this may be possible 
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with HNE-targeted probes. Neutrophil degranulation and neutrophil necrosis will 
also release HNE into the surrounding supernatant, however these processes are 
likely to liberate less HNE per second than the freeze-thaw cycles of lysate 
preparation. Hence the relatively high efficacy of GW447631 bodes well for its use 
as a sensitive and inherently safer optical probe, when fluorescently tagged, as low 
nanomolar concentrations of probe could be introduced to label neutrophils with 
minimal effects on other cellular processes.  
4.4.2 INTRACELLULAR KINETIC IMAGING OF GW447631 INHIBITION 
The ability to describe intracellular rates of enzyme activity may enable studies of 
HNE kinetics in cellular imaging assays. A variety of imaging platforms could 
facilitate this, including high-throughput screening in vitro and fluorescent 
endomicroscopy in vivo. Neutrophils transition between quiescent, primed and 
activated states and the ability to detect intracellular HNE rates may facilitate 
detecting these transitions. For example, following neutrophil priming, de-priming 
may occur. Neutrophil de-priming is understood to take place principally in the 
human lung200 and may have significant impact on pulmonary inflammatory disease 
progression and the spreading of potentially harmful, activated neutrophils to 
distant organs following reverse transendothelial migration (rTEM).18 Will deprimed 
neutrophils yield a different HNE rate than the more harmful rTEM neutrophils? If 
so, these rates could prove useful in assessing clinical disease. Future HNE kinetic 
imaging studies have the potential to answer this question. The current studies 
demonstrate that neutrophils are capable of increasing and decreasing NAP 
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fluorescence following LPS priming and fMLF stimulation. Characterising signal 
deceleration could prove useful in identifying different signal-loss mechanisms, so 
that LPS/fMLF treatment can be distinguished from de-priming by HNE imaging.  
 
The effect of well dwell-time, prior to stimulation, may be expected to produce 
imperceptibly subtle changes in HNE activity however these are detectable with 
image-processing and sensitive NAP signalling. Longer incubation times may 
facilitate greater extents of integrin engagement in fibronectin coated wells, 
upregulating the extent of HNE release.201 The trend of decreasing magnitude of 
well incubation effect with increasing GW447631 dose may be due to increased 
intracellular HNE inhibition, at higher doses, prior to degranulation. HNE inhibition 
also effects neutrophil spreading upon stimulation which implies the cleavage of 
fibronectin by HNE23 facilitates cell-spreading. The effect on cell spreading does not 
appear to be due simply to the presence of drug since 100 μM Sivelestat had less 
effect than 10 μM GW447631. GW447631 has a more potent Ki than Sivelestat 
(0.014 nM vs. 200 nM) so that it can affect greater inhibition at lower doses than 
Sivelestat. The effects of these two drugs on cell-spreading also show GW447631 
having greater effects than Sivelestat, despite a, log-fold, higher Sivelestat 
concentration.  Because decrements in cell radius are on the scale of nanometres 
relatively large standard error is measured in this small sample size, increasing 
sample size could help to overcome this limitation.  
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4.4.3 FLOW CYTOMETRIC ANALYSIS OF  
HNE-TARGETED PROBE LABELLING 
An important finding of the labelling efficiency experiments (Fig. 4.11) was the 
trend towards increased PBMC labelling with exposure to calcium ionophore. 
Although some increase in labelling may occur passively with calcium ionophore 
stimulating endocytosis there is some potential for this labelling to represent a HNE 
specific mechanism. 40% of monocytes contain and release HNE at concentrations 
that correspond to 3% degranulation from neutrophils.137 It is possible for a very 
limited number of activated PBMCs to achieve HNE-specific VE200 labelling, 
however these quantities of HNE are very limited and prove undistinguishable from 
untreated conditions by flow cytometry. Another possible explanation for the PBMC 
trend is the presence of a very small number of neutrophils in the PBMC sample. A 
3% neutrophil impurity would fall within the acceptable limits of PBMC purity 
following the Percoll blood preparation (95% purity limit) and enable 3 x 104 
neutrophils to potentially influence fluorescent changes in PBMC staining upon 
activation. A small percentage of degranulating neutrophils may have released HNE 
onto the surfaces of PBMC where HNE can adhere by charge.202 Finally, simple 
endocytosis may have led to the background levels of PBMC fluorescence. Increased 
with activation, endocytosis-dependent labelling can produce negligible levels of 
background fluorescence as Fig. 4.14C demonstrates with neutrophils and free Cy5 
stain. Because there was no noticeable difference between monocyte-derived and 
lymphocyte-derived VE200 labelling a neutrophil impurity, seems the most plausible 
explanation for the statistically insignificant increase in HNE labelling with calcium 
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ionophore exposure. The most important conclusions for these studies are that 
VE136 and VE200 show good neutrophil specificity by virtue of specific HNE binding. 
VE200 showed the best cellular specificity and was taken forward.  
 
4.4.4 SENSING GRADED NEUTROPHIL RESPONSES WITH  
HNE-TARGETED PROBE SIGNALS 
The range of fluorescence intensities acquired by varying PMA dose indicates that 
targeted probes are capable of generating distinct signals for distinct levels of 
neutrophil activation. Appropriately titrated so as not to obfuscate NAP signal-
related information, targeted probes could provide an additional layer of 
information for classifying neutrophils activated with varying stimulus intensities. 
This titration would be a trade-off between NAP signal and targeted probe signal 
detection. Because VE200 was taken forward for further experimentation, its signal 







4.4.5 LIVE CELL VE200 DOSING AND IMAGE ANALYSIS 
In Fig. 4.13.K and L VE200 signal of activated neutrophils is compared by whole-
frame histogramming and intracellular puncta measurement respectively and these 
are both valid means of relaying the VE200 signal in images of activated neutrophils. 
In Fig. 4.13.K extracellular changes in VE200 signal are captured which contribute to 
the exponential rise in signal with increasing concentration. Intracellular 
measurements are more relevant than combined intracellular and extracellular 
measurements, for signal generation per cell. The subtle difference between 
measurements captured by the two image analysis techniques demonstrate the 
importance of appropriate use of image analysis to address the pursuit of specific 
hypotheses. With an understanding of VE200 specificity and optimal dose, it’s 
ability to be multiplexed with NAP was considered. 
 
4.4.6 CHARACTERISING VE200 AND NAP MULTIPLEXING  
The enhanced labelling of VE200 over free Cy5 with neutrophil activation, 
demonstrates that the irreversible inhibition (see Fig 4.12) affected by its 4-oxo-β-
lactam moiety, is responsible for increased activated neutrophil labelling. Combined 
with the similarities in the appearance and intracellular distribution of VE200 signal 
puncta and NAP signal puncta, VE200 seems effective in elucidating HNE in 
stimulated neutrophils. In untreated conditions, the increased fluorescence of 
VE200 compared to free Cy5 at 2 µM may be due to HNE-specific probe 
accumulation, in a minority of activated neutrophils. However, because Cy5 is 
163 
 
sensitive to photobleaching even under ambient light conditions, this difference 
could be due to more photobleaching in the free Cy5 condition at baseline. 
Although care is taken to protect both dyes from ambient light, making use of a 
more photo-stable fluorophore would resolve this concern. In the case of 
contaminating activated neutrophils, the addition of Sivelestat can be used to 
remove the unwanted effect. In the case of disproportionate photobleaching, a 
spectrometer reading taken at baseline could have compared detected and 
quantified any such difference.  
The Olympus IX83 confocal spinning disk microscope enables each pixel to have a 
value from 0 to 65,535. The ability of NAP to detect low nanomolar HNE activity 
combined with such sensitive optical detection means that information inaccessible 
to the human eye, can be reported from imaging systems, with appropriate image 
analysis. Although most neutrophils are not in an activated state at the start of each 
experiment there is potential for a limited amount of neutrophil activation and/or 
death to occur during the three-hour Percoll blood preparation. The dose 
dependent suppression of NAP signal with VE200 co-incubation in untreated 
neutrophil populations indicates the presence of an activated neutrophil minority. 
Although baseline neutrophil activation was not investigated further in the context 
of probe multiplexing, the homogeneity of the untreated neutrophil population has 
been demonstrated by flow cytometry above (Fig. 3.6) and the 21.3-fold increase in 
NAP signal between untreated and activated neutrophil populations provides a 
sufficient assay window for the assessment of probe multiplexing. Normalising 
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activated conditions to untreated controls could remove the effects of different 
untreated baselines from the data.  
 
4.4.7 NAP AND VE200 SIGNAL DECORRELATION FROM AGEING PMN 
POPULATIONS  
Although both probes act on HNE, apoptosis appears to decorrelate NAP and VE200 
probe signals. When neither caspases or HNE are inhibited, the greatest decreases 
in probe signal correlation are detected at 6 hours. In the untreated and 1 µM 
calcium ionophore stimulated populations probe signal correlation falls, by 50% and 
48% respectively, at 6 hours. Similarly, 60% decorrelation occurs in the 10 µM 
GW447631 condition at 6 hours. Flow cytometric analysis shows the greatest 
difference between the 6 and 2-hour time points is in their apoptotic neutrophil 
content (see Fig.3.10). Importantly the necrotic population which may overwhelm 
apoptotic cell contributions, at 20 hours, cannot significantly affect signals, at this 
earlier time point. When apoptosis is reduced with 15 µM pan-caspase inhibitor 
correlation remains high (r2>0.80) throughout the time course irrespective of 
stimulation with 1 µM calcium ionophore. It may be that HNE is inhibited in 
apoptotic neutrophils as intracellular membranes degrade and endogenous HNE 
inhibitors mix with HNE. At 20 hours, probe signal correlation is restored, in 
uninhibited, untreated and activated neutrophil populations, consistent with the 
complete loss of lipid membrane integrity associated with these predominantly 
necrotic neutrophil populations (see Fig.3.10). When neutrophils are untreated 
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both probes are dark and when neutrophils are activated/necrotic, both probes are 
at their brightest. Decorrelation may help specifically with apoptotic neutrophil 
detection when multiplexed imaging is implemented. Being able to distinguish 
between healthy, apoptotic and necrotic neutrophils using morphological and 
fluorescent information could provide meaningful patient stratification information 
for quantifying cell viability via fibred confocal endomicroscopy (FCE) in vivo. 
Immune cell functions such as efferocytosis could be analysed using this technique 




































HNE IMAGING AS A NEUTROPHIL 
















The novel activable and targeted probes, NAP and VE200 are specific for and 
sensitive to HNE activity. FCE should therefore enable the enumeration of activated 
neutrophils using these probes. The work of this chapter is to establish if that is the 
case and to understand how much information can be derived from multiplexed 
HNE-imaging. More specifically, aiming to determine if statistical and machine 
learning techniques can be applied to imaging datasets such that neutrophils can be 



















5.1.0 THE STUDY OF HNE UNDER FIXATION 
The protease-antiprotease hypothesis was formed from four observations 1) the 
marked potential of elastases to digest extracellular matrix producing macroscopic 
loss of function203,204 2) the identification of proteases that could be used to model 
pulmonary emphysema in animals205 3) the realization that α-1-antiprotease (α-1-
PI) provides essential and specific regulation of neutrophil elastase206 and 4) the 
association of α-1-PI deficiency with pulmonary emphysema.207 This was the 
hypothesis that stimulated so much interest in neutrophil protease dysregulation in 
disease states which has lead to many clinical trials. Unfortunately the hypothesis 
was not complete and many clinical trials investigating the effects of synthetic HNE 
inhibitors have produced negative data, even in diseases with established protease 
dysregulation and even with evidence of in vivo elastolysis.208–210 Major caveats to 
the assumption that increased HNE inhibitor administration will therapeutically 
correct HNE activity have arisen, these are mechanisms by which HNE escapes 
inhibition. Membranous HNE is resistant to endogenous inhibition and this is 
believed to be a steric hindrance effect.211,212 As HNE molecules bind the external 
plasma membrane via electrostatic charge, these molecules can bind in orientations 
which obfuscate the active-site, preventing interaction with inhibitors. Perhaps 
more importantly, adherent neutrophils create interfaces with the substratum from 
which inhibitor molecules are largely excluded.202 This exclusion is an important 
mechanism for utilising active HNE in the presence of HNE-inhibitors, as neutrophils 
can degranulate onto their substratum, concentrating HNE there. Although there is 
still much uncertainty surrounding the spatiotemporal dynamics of membranous 
170 
 
HNE accumulation and clearance, neutrophil fixation studies have helped to 
develop the current understanding. 
Owen et al. produced the first report of membranous HNE and cathepsin G using 
fixed neutrophils and immunogold microscopy. In addition to finding cell-surface 
HNE inhibition-resistant Owen et al. found that fMLF and C5a stimulated two to 
three-fold increases in plasma membrane protease expression, whereas LPS 
concentrations as low as 100 fg/mL produced a ten-fold increase.212 Korkmaz et al. 
synthesised a sensitive fluorogenic HNE substrate and used it to demonstrate full 
inhibition of membranous HNE. At equimolar concentrations, α-1-PI effectively 
blocked the HNE activity of unfixed neutrophils in solution but fixed samples 
retained their activity.213 Korkmaz et al. also found that α-1-PI binding caused 
dissociation of HNE-α-1-PI from neutrophil plasma membranes.213  Although 
Dwenger, Tost and Holle’s dissociation experiments proved the existence of cell-
surface binding sites for HNE214, their claims of a specific receptor were perhaps 
disproven by Owen et al.’s identification of charge-based interactions with 
membranous heparin and chondroitin sulfate-containing proteoglycans, for HNE 
and cathepsin G.215 A small fraction of proteoglycan associated serine proteases can 





5.1.1 DIFFERENTIAL HNE RELEASE  
Neutrophils respond in a myriad of ways to their various stimuli. Neutrophils may 
be primed or activated in response to stimuli, or both in response to sequential 
stimuli and they may be de-primed, all states that are distinguishable from 
neutrophil quiescence. Neutrophil priming is not a generic response but 
demonstrates cytokine-specificity. For example, platelet activating factor (PAF) and 
interferon γ (IFN-γ) both promote neutrophil adhesion217,218, phagocytosis219,220, 
degranulation34,221 and inflammatory cytokine release222,223 but they have opposite 
effects on chemotaxis224,225 (PAF promoted) and apoptosis226,227 (IFN-γ promoted). 
This is not surprising when we consider that the increased lipid-A content of Re-LPS 
primed neutrophils with increased ROS generation compared to the S-LPS 
glycoform, prior to fMLF stimulation.228  
Rainger et al. found that C5a, fMLF and IL8 but not PAF were capable of eliciting 
HNE release. Although fMLF and PAF trigger cell adhesion pathways only the former 
lead to autocrine LTB4 signalling, stimulating HNE.229 Although adherence was not 
necessary for HNE-release, adherent neutrophils, engaging CD11b/CD18 β2-
integrins had a significantly increased degranulation response. Adhesion-mediated 
increases in degranulation may be quantal in nature such that the adhesion of 
priming stimuli and activating stimuli combine to elicit maximal degranulation. 
Because integrin expression and hence firm adhesion is a quantal process, different 
stimuli may promote varying extents of integrin expression, effecting stimulus-
specific HNE release. This is not the case for all priming agents, PAF-mediated 
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superoxide production is CD11b independent.230 The quantal release of protease 
inhibitors (elafin, SLPI and serpin B1) from neutrophils may provide a secondary 




Figure 5.0 Signalling pathway for adhesion-enhanced chemokinetic degranulation 




5.1.2 FIBRED CONFOCAL ENDOMICROSCOPY  
Optical imaging apparatus have been developed to address a range of experimental 
requirements: super-resolution techniques more precisely describe subcellular 
dynamics, image cytometry improved the throughput of high-resolution imaging 
techniques, and the use of optical fibres enabled new confocal laser scanning 
microscopy paradigms in vivo (see Chapter 1.2.1 - 1.2.4). The Food and Drug 
Administration have approved one fibred confocal endomicroscopic system for 
human imaging, the CellVisio system, developed by Mauna Kea. However there are 
many experimental prototypes143,231–234 for fibred confocal endomicroscopy (FCE) 
and the PROTEUS project have developed a system which incorporates chemical 
sensing and direct sampling/instillation interaction with the field of view.235 Several 
hardware modifications enable different outcomes with FCE. Fibre bundles housing 
~100, 000 fibres can form an image whereby each individual fibre contributes 1 
pixel and acts as a confocal pinhole for proximal scanning confocal imaging.236   
A single-mode fibre has a diameter of <10 µM and, surrounded by an outer 
cladding, transmits light by total internal reflection.237 Single-mode fibres were 
advantageous for exceeding the limits of miniaturization and flexibility inherent in 
fibre-bundle imaging and delivering greater imaging resolution.238 But single-mode 
fibre imaging had its own limitations including increased speckle noise, loss of 
multimodal light and a loss of field depth. Double-clad fibres have a fibre core, inner 
cladding and outer cladding, each with their own refractive index.239 This improved 
on single-mode imaging limitations by using the inner-cladding to capture 
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multimodal light. Increasing light collection efficiency was useful for fibred Raman 
spectroscopy and multi-photon imaging but increasing field depth deviates from a 
confocal imaging regime. 238,240  
Multi-mode imaging was also described using a single imaging fibre the so called, 
single multi-mode imaging (SMMI). SMMI can image three-dimensional volumes at 
high resolution without the need for physical depth scanning making it a fast 
imaging paradigm for clinical applications.241 SMMI can generate confocal images by 
digitally processing the image-volume.242 Unfortunately this technique is not 
amenable to fibre-bending which is often necessary in a clinical imaging setting.241 
With this in mind, fibre bundles are currently the most clinically relevant FCE 
platform. 
 
5.1.3 IMAGE ANALYSIS  
The analysis of imaging data has become a field in its own right. Nuclear and plasma 
membrane stains added to the experimental set-up enable cell segmentatiaon and 
image cytometery. Fluorescence intensity is quantifiable using grayscale pixel values 
and comparable across images taken under identical conditions. Textural 
information is a particular advantage of image analysis as positional information 
may be imperceptible to the human eye and relay unique descriptors of cellular 
dynamics. Hundreds of variables can be measured by as variants of positional, 
fluorescence intensity and textural features within images and cells can be imaged 
and quantified under high-throughput conditions such that big data analysis 
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techniques may be required to approrpiately summarize data sets and visualize 
informative changes. 
 
5.1.4 NEURAL NETWORKS  
Artificial neural networks are sets of statistical algorithms inspired by neurobiology. 
Human neurons have input processes called dendrites and an output process, the 
axon which may branch for multiple connections to other neurons. These processes 
conduct the flow of information between the soma of connected neurons, where 
signals are integrated to control each neurons behaviour. With sufficient rules for 
action potential integration and firing the brain is capable of complex problem 
solving and image recognition was one area in which the human brain 
outperformed computer programs, until recently. Using the same principles, a 
neural network is comprised of input nodes, hidden layers, and output nodes. 
Digital images are in fact numbers with specified positions, vectors that lend 
themselves to mathematical manipulations such as thresholding, co-occurrence 
matrixes and non-linear functions. In a neural network, features of the original 
vectors can be taken as inputs, multiplication can be applied connections between 
nodes (weights) and non-linear functions can be applied at nodes (activation 
functions). Like the brain, multiple inputs can be received by each node in the 
network, in fact all the nodes of one layer interface with the nodes of immediately 




Figure 5.1 Schematic of an Artificial Neural Network 
A) Classified input data B) Training on 50% of the sample, a single-layer perceptron, combined 2 
features in 2 neurons to achieve an evaluation accuracy of 99.6% in 703 epochs. Line thickness 
indicates weight. Adapted from a tensor flow neural network online tool.243 
 
There may be many hidden layers of nodes between the input and output layers 
resulting in a multilayer perceptron or none, a single layer perceptron. A training 
data set is used to inform the neural network of the vectors it should arrive at and 
this allows an error, a difference between the predicted and actual vectors to be 
calculated. Backpropagation allows the network to intelligently fine-tune each of its 
connections in a direction that minimizes error for the next epoch, a complete pass 
through the training set. Backpropagation minimizes the number of epochs 
required to generate a model with maximal classification accuracy for a given neural 
network architecture.  
The inputs of traditional neural networks have been hundreds of features 
generated by image analysis software such as CellProfiler (Broad Institute, 
Cambridge, MA, USA). More recently, convolution neural networks have integrated 
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image analysis as a first.244 This means that convolution neural networks can 




















5.1.5 HYPOTHESIS AND AIMS 
Hypothesis: Dual ligand and substrate-based HNE imaging can be used to 
functionally classify neutrophils with clinically meaningful sensitivity and specificity. 
Aims:  
1. Develop a data-rich HNE-phenotyping assay 
i. Determine the effect of fixation on the NAP signal of purified HNE  
ii. Determine the effect of fixation on the membranous NAP signal of primary 
human neutrophils  
iii. Develop an immunofluorescence assay for functional HNE imaging using 
physiologically relevant stimuli 
2. Describe the level of resolution attainable between HNE-phenotypes  
i. Identify neutrophil activation via image cytometry using imaging textures 
and fluorescence intensities in univariate and bivariate analyses 
ii. Functionally classify neutrophil treatment groups via image cytometry using 
imaging textures and fluorescence intensities:  
a. in univariate and bivariate analyses. 
b. in multivariate analyses of activation gated neutrophils combining 
principle components analysis and linear discriminants analysis. 





iii. Characterise the influence of time on phenotypic resolution 
a. in univariate analyses of activation gated neutrophils  
b. in multivariate analyses: Neural network classification of whole 
neutrophil populations by stimulus 
 
Hypothesis: Neutrophil activation detection, via HNE-imaging, can be used to detect 
and quantify pulmonary adenocarcinoma.    
1. Detect neutrophil activation in human adenocarcinomatous pulmonary 
tissues using immunohistological patient slides. 
2. Determine if any correlation exists between local activated neutrophil and 
Glut1 overexpressing cell counts using immunohistological patient slides. 
 
Hypothesis: Multiplexed probe HNE-phenotyping can be used to identify separate 
autologous neutrophil populations in the human lung. 
1. Detect neutrophil activation using FCE to image dual NAP and VE200 
stained neutrophils 
i. In a 96-well plate formant  
ii. In an ex vivo ventilated lung model  





5.2.1 THE EFFECT OF FORMALDEHYDE FIXATION  
ON PURIFIED HUMAN HNE 
To investigate the feasibility of detecting HNE using NAP on fixed neutrophils, 
formaldehyde was added to purified HNE at 6 dilutions. At 2, 4, 8 and 16% 
formaldehyde, the degree of HNE inhibition was significant compared to an 
untreated control (0% formaldehyde). HNE inhibition with formaldehyde 
demonstrates a relationship of one-phase exponential decay, with an asymptote 
tending towards 48% HNE activity. This indicates that formaldehyde fixation can 
achieve a maximum inhibitory effect of 52% HNE inhibition, within 10 minutes. 4% 
formaldehyde rendered 63% HNE activity compared to an untreated control and is a 
commonly used dilution. This level of inhibition was similar to 100 nM Sivelestat 
(61% activity) and incomplete inhibition at this dose informs the use of high 
Sivelestat concentrations in other studies (see Fig 4.11 and. 5.12). The 4% dilution 
informed the selection of a 4% PFA fixation condition for further fixed neutrophil 















Figure 5.2 Formaldehyde can be titrated to preserve HNE activity 
1 μM AAPV-AMC was co-incubated with 10 nM HNE and 100 nM Sivelestat (dotted line) or the 
following paraformaldehyde titrations 16, 8, 4, 2, 1 and 0% for 10 mins. AAPV-AMC fluorescence was 










5.2.2 THE EFFECT OF FORMALDEHYDE FIXATION ON NEUTROPHILIC HNE 
ACTIVITY AND IMMUNOFLUORESCENCE 
When neutrophils are treated with bacterial products, CD11b upregulation is 
detectable using flow cytometry. Although the differences in NAP signal between 
untreated and activated neutrophil populations are statistically insignificant in this 
assay, a 2.8-fold increase in NAP fluorescence with neutrophil activation without 
fixation (Fig. 5.3.C) and a 1.9-fold increase with fixation (Fig. 5.3.D), both show NAP 
signal increasing with neutrophil activation. Previously discussed data demonstrates 
the ability to detect neutrophil activation, via confocal microscopy, when cells are 
stimulated with bacterial products (see Fig.3.9) and via flow cytometry, when cells 
are stimulated with calcium ionophore (see Fig. 3.8).  Furthermore, the concomitant 
increase of NAP with CD11b-Alexa Fluor 647 fluorescence corroborates previous 
data that NAP signal detects neutrophil activation (Fig. 5.3.A and B). Fixation 
appears to increase NAP fluorescence (4.7-fold, Fig. 5.3.E) before neutrophil 












Figure 5.3 NAP can detect neutrophil activation after fixation 
Flow cytometric analysis of untreated and activated (25 ng/mL LPS and 100 nM FMLF treated) 
neutrophil populations, with and without 4% paraformaldehyde fixation. Graph values represent 
mean of median fluorescence intensities ± SEM and P values were calculated using one-way ANOVA 




5.2.3 IMMUNOFLUORESCENT STAINING OF MEMBRANOUS HNE 
In addition to its antimicrobial role within the phagolysosome, active HNE is 
degranulated into the extracellular space and onto plasma membranes. To assess 
the extent to which HNE becomes localized to neutrophil plasma membranes, 
following calcium ionophore stimulation, anti-HNE antibody was added to 
stimulated, fixed neutrophils. Despite showing large variations in shape, activated 
neutrophils are often wider at their basal surfaces (Fig. 5.4.A) than their apices (Fig. 
5.4.D). CellMaskTM orange fluorescence intensity is dimmer at basal surfaces and 
brighter at apical surfaces. By scanning through confocal image slices and 
measuring CellMaskTM orange fluorescence intensity, a profile is generated which 
represents the distribution of plasma membrane in the z dimension. Changes in 
anti-HNE antibody fluorescence co-register with changes in CellMaskTM orange 
fluorescence, indicative of a spatial relationship between active HNE and plasma 
membrane from the basal to apical cell surfaces. The high degree of similarity 
between z profiles for both anti-HNE antibody and CellMaskTM orange demonstrates 
their colocalisation across groups of cells which suggests HNE is membranous in 
these samples. 












Figure. 5.4 Spatial Relationship between HNE and Plasma Membrane 
A-D) Confocal microscopy of neutrophils, scanning through Z planes, incubated in 1 µM calcium 
ionophore, 2.5 µg/mL CellMaskTM orange, fixed, incubated with 1 µM DAPI and immunolabelled with 
1:200 anti-HNE antibody (abcam 68672). E-G) Graphs show image analysis measurements of 










5.2.4 COMPARING HNE RELEASE AND ACTIVITY  
BY CHEMOKINETIC STIMULUS 
To investigate whether neutrophils could be categorized into untreated, primed, 
activated, primed-activated categories by imaging HNE presence and activity, 
neutrophils were incubated under six conditions, fixed and compared via confocal 
imaging. For forty-five minutes neutrophils were incubated untreated (UT), or 
treated with 25 ng/mL Lipopolysaccharide (LPS), 100 nM platelet activating factor 
(PAF), 3 nM interleukin 8 (IL8), 1 nM or leukotriene B4 (LTB4). In a sixth condition 
neutrophils were incubated for thirty minutes with 25 ng/mL LPS before a fifteen-
minute 100 nM N-formyl-Met-Leu-Phe incubation (FMLF). Although four percent 
PFA fixation introduced artefactual NAP signal in all conditions, untreated 
neutrophils (Fig. 5.5 U-X) are visibly dimmest in NAP signal. Neutrophils of the FMLF 
condition which were primed and subsequently activated are the brightest, by NAP 
staining. Individual neutrophils from each image were analysed and treatment 
populations compared by median relative fluorescence units. Image analysis 
revealed HNE immunofluorescence increased across treatment groups starting with 
UT and LPS as the dimmest, then PAF, IL8, LTB4 and FMLF as the brightest (Fig. 5.5 
Y). NAP signals show the same trend with the exception of reduced NAP 
fluorescence under 3 nM IL8 stimulation (Fig. 5.5 Z). Logistic regression analyses 
show that HNE immunofluorescence and NAP fluorescence produce more accurate 
binary classification (between untreated and each treated neutrophil group) when 
combined with DAPI and CellMaskTM orange fluorescence and cell shape 
descriptors. Receiver-operator curves describe more accurate binary classification 
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when the classifier is trained with all imaging features than with HNE-imaging 
features only (Fig. 5.5.Ai-Ji). However, when reduced to HNE-imaging features only, 
true positive rate (TPR) decreases more for the LPS vs. UT distinction (-0.206 and -
0.177 TPR for LPS and UT respectively Fig. 5.5.Ai and Fi) than for all other 
distinctions, (average for PAF, IL8, LTB4, FMLF = -0.110 ± 0.021  TPR Fig. 5.5.Gi – Ji 
and for their respective UTs = -0.050 ± 0.008 TPR Fig. 5.5.Bi – Ei). LPS fluorescence is 



































































Figure. 5.5 HNE Immunofluorescence and NAP fluorescence are insufficient for binary classification 
Primary human neutrophils were pre-treated with A-D) 25 ng/mL LPS / 100 nM FMLF E-H) 1 nM LTB4 
I-L) 3 nM IL-8 M-P) 100 nM PAF Q-T) 25 ng/mL LPS or U-X) untreated, fixed with 4% PFA and stained 
with a DNA stain (DAPI), a HNE activity probe (NAP) and immunolabelled with antibodies directed 
against HNE release. Y-Z) Data points represent fluorescence intensities of individual cells, red bars 





5.2.5 NEUTROPHIL ACTIVATION DETECTION  
BY HNE TEXTURAL FEATURES 
Following chemokinetic stimulation, images of neutrophils were subjected to an 
image analysis pipeline for textural feature extraction. Textural features were 
statistically ranked to select the highest ranking or, optimal, texture feature. 
Optimal textural features were selected from each of the four imaging channels 
such that information from NAP, HNE antibody (HNE.ab), CellMaskTM Orange and 
DAPI staining could be compared. The ability of NAP to enter and fluorescently stain 
activated neutrophils to the exclusion of untreated neutrophils has been 
demonstrated previously (see Fig. 3.8-10, 4.9 and 4.10), this allows neutrophils with 
untreated levels of NAP or HNE.ab signal to be classed as “NAP dim” or “HNE.ab 
dim”. Fluorescently dim neutrophils do not have a clear activation phenotype based 
on HNE staining. Neutrophils with supra-untreated fluorescence were classed as 
“HNE.ab bright” or “NAP bright”, indicative of unambiguous neutrophil activation. 
The bright subgroups represent 2.6% and 6.3% of NAP and HNE.ab stained 
neutrophils respectively. HNE.ab bright neutrophils cannot be identified by NAP, 
DAPI or CellMaskTM Orange textural features, although CellMaskTM Orange texture 
distributions showed the least overlap between HNE.ab bright and dim neutrophil 
populations. NAP bright neutrophils cannot be identified by DAPI texture, although 
CellMaskTM Orange and HNE.ab textures produced bimodal distributions with 
relatively large separability for this data set: 2x106 and 2.5x106 units separate NAP 
dim and NAP bright medians for HNE.ab and CellMaskTM Orange distributions 
respectively. In the case of the HNE.ab texture distributions, the pronounced left-
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skew of NAP dim neutrophils helps to distinguish this population from NAP bright 
cells. With inseparable dim and bright neutrophils across all textural features the 
probability of detecting only activated neutrophils less than 20% by all six strategies 





































Figure. 5.6 Textural features exhibit insensitive identification of neutrophil activity  
Image cytometric analysis of fixed untreated, primed and activated neutrophils. A fluorescence 
intensity threshold is applied to all neutrophil populations to distinguish between untreated and 
activated fluorescence in the A) HNE.ab and E) NAP channels individually.  Neutrophils above and 
below the fluorescence threshold are represented as bright (red) or dim (blue) relative density 
histograms respectively, for untreated vs. activated neutrophil comparisons of B) NAP F) HNE.ab C 
and G) DAPI and D and H) CellMaskTM Orange optimal textural features. The following neutrophil 
treatment groups are gated to contribute to bright (red) or dim (blue) histograms: untreated, 
25ng/mL LPS, 1 nM LTB4, 25ng/mL LPS / 100nM FMLF, 3nM IL8 and 100 nM PAF, with dotted lines of 




5.2.6 NEUTROPHIL ACTIVATION DETECTION  
BY HNE INTENSITY FEATURES 
Following chemokinetic stimulation, images of neutrophils were subjected to an 
image analysis pipeline for fluorescence intensity feature extraction. Optimal 
intensity features were objectively selected and gated for the identification of 
activated neutrophils as with textural features (see section 5.2.4). The “bright” 
neutrophil subgroups represent 2.6% and 6.3% of NAP and HNE.ab stained 
neutrophils respectively (Fig 5.7.A and E). Using simple thresholding, HNE.ab bright 
neutrophils cannot be reliably identified by DAPI or CellMaskTM orange intensity 
features (Fig. 5.7.C and D). The probability of accurate HNE.ab bright neutrophil 
classification follows a trend of increase with increasing DAPI fluorescence (Fig.5.7.C 
red dotted line, maximum 50% probability at 1.7x105 DAPI fluorescence). 
Probability and hence classification accuracy of HNE.ab bright neutrophils ranges 
from 70% to 100% between NAP fluorescence values of 1.1 - 1.4x106 so that HNE.ab 
bright neutrophil can be identified by their NAP staining (Fig. 5.7.B). NAP bright 
neutrophil cannot be identified with DAPI or CellMaskTM Orange (Fig.5.6.G and H) 





























Figure. 5.7 Intensity features exhibit moderately sensitive identification of neutrophil activity  
Image cytometric analysis of fixed untreated, primed and activated neutrophils. A fluorescence 
intensity threshold is applied to all neutrophil populations to distinguish between untreated and 
activated fluorescence in the A) HNE.ab and E) NAP channels individually. Neutrophils above the 
fluorescence threshold are represented as histograms in terms of their B) NAP F) HNE.ab C and G) 
DAPI and D and H) CellMaskTM Orange optimal textural features. The following neutrophil treatment 
groups are gated to contribute to bright (red) or dim (blue) histograms: untreated, 25ng/mL LPS, 1 
nM LTB4, 25ng/mL LPS / 100nM FMLF, 3nM IL8 and 100 nM PAF with dotted lines of the same colour 
showing classification probabilities. Histograms show all image cytometric data points, n=4. 
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5.2.7 STIMULUS-DEPENDENT NEUTROPHIL CLASSIFICATION  
BY HNE TEXTURAL FEATURES 
To understand whether bivariate analyses would improve activated neutrophil 
identification, images of neutrophils were subjected to an image analysis pipeline 
for textural feature extraction. Activated neutrophils were gated out of the relevant 
treatment groups and analysed by optimal textural features, which were objectively 
derived as explained previously (see section 5.2.4). The optimal textural features of 
NAP or HNE.ab bright neutrophils, from each imaging channel, were analysed for 
each treatment group. Although all textural features of all activated neutrophil 
distributions are multimodal, the presence of LTB4 or IL8 stimulation is somewhat 
distinguishable from other stimuli by their pronounced peak bifurcation via DAPI 
and CellMaskTM Orange texture analysis respectively (Fig. 5.8.C and D). PAF priming 
may be distinguishable from other activating stimuli by the relative inability of PAF 
to drive neutrophils into the NAP bright gate (Fig. 5.8.F-G). However, these 
distinctions are obscured by similarities between the ranges and medians of all 
activated neutrophil distributions. More robust classification of LTB4, HNE.ab bright 
neutrophils may be made at high values of DAPI texture (≥80% at values > 9x104, 
Fig. 5.8.C) and CellMaskTM Orange texture (≥80 % at values >107, Fig. 5.8.D). LTB4 
stimulated, HNE.ab bright neutrophils are also identifiable at low DAPI texture 
(≥80% at values <2x106, Fig. 5.8C). NAP bright, LTB4 neutrophils can be identified at 
high DAPI textures (≥90% at values >11x106, Fig. 5.G) as well as high or low 
CellMaskTM Orange textures (≥95% at values >9.5x106 or <5.5x106, Fig. 5.8.H).  
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NAP bright LPS/FMLF neutrophils can be classed as such with 90% accuracy at 








































Figure. 5.8 Textural features exhibit insensitive classification of neutrophils by stimulus 
Image cytometric analysis of fixed untreated, primed and activated neutrophils. A fluorescence 
intensity threshold is applied to all neutrophil populations to distinguish between untreated and 
activated fluorescence in the A) HNE.ab and E) NAP channels individually.  Neutrophils above the 
fluorescence threshold are represented as histograms in terms of their B) NAP F) HNE.ab C and G) 
DAPI and D and H) CellMaskTM Orange optimal textural features. The following neutrophil treatment 
groups are plotted as histograms: untreated (blue), 1 nM LTB4 (yellow), 25 ng/mL LPS/ 100 nM FMLF 
(pink), 3 nM IL8 (orange) and 100 nM PAF (green) with dotted lines of the same colour showing 
classification probabilities. Histograms show all image cytometric data points, n=4. 
198 
 
5.2.8 STIMULUS-DEPENDENT NEUTROPHIL CLASSIFICATION                                            
BY HNE INTENSITY FEATURES 
To understand whether bivariate analyses would improve activated neutrophil 
identification, images of neutrophils were subjected to an image analysis pipeline 
for textural feature extraction. Activated neutrophils were gated out of the relevant 
treatment groups and analysed in terms of optimal fluorescence intensity features, 
which were objectively derived as explained previously (see section 5.2.4). The 
optimal intensity features of NAP or HNE.ab bright neutrophils, from each imaging 
channel, were analysed for each treatment group. Although all the intensity 
features yield activated neutrophil distributions which are multimodal, the presence 
of LTB4 or IL8 stimulation is somewhat distinguishable from other stimuli by their 
pronounced peak bifurcation via DAPI and CellMaskTM Orange texture analysis 
respectively. PAF priming may be distinguishable from activating stimuli by the 
relative inability of PAF to drive neutrophils into the activated gate. Classifying 
distinctions are obscured by varying degrees of overlap between the ranges of all 
activated neutrophil distributions. 
HNE.ab bright, IL8 stimulated neutrophils can be classified with 80% accuracy 
between 0.3 and 0.7 x106 NAP fluorescence units (Fig. 5.9.B). At 1x106 and between 
1.2 and 1.3 x106 NAP fluorescence, HNE.ab bright neutrophils can be identified as 
LTB4 and LPS/FMLF stimulated respectively with 70% accuracy (Fig. 5.9.B). DAPI 
fluorescence units of 0.5 or ≥2.0 x106 can be used to classify HNE.ab bright 
neutrophils with 80% (LPS/FMLF) and 100% (LTB4) accuracy respectively (Fig. 5.9.C). 
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LPS/FMLF neutrophils can also be classified with high accuracy (80-100%) at low 
CellMaskTM Orange fluorescence intensity (0-0.5x105, Fig. 5.9.D). And HNE.ab bright 
IL8 neutrophils can be identified with 70% accuracy between 1 and 1.2x105 
CellMaskTM Orange fluorescence (Fig. 5.9.D).  
NAP bright neutrophils also demonstrate high classification accuracies particularly 
when HNE.ab fluorescence is measured. NAP bright neutrophils in all 3 activated 
populations were identifiable with 70% accuracy or more, with PAF and LTB4 
neutrophils reaching 100% accuracy at low and high fluorescence ranges 
respectively. Other classification strategies (Fig. 5.9.B-D, G,H showed low accuracy 






































Figure. 5.9 Intensity features exhibit sensitive classification of neutrophils by stimulus 
Image cytometric analysis of fixed untreated, primed and activated neutrophils. A fluorescence 
intensity threshold is applied to all neutrophil populations to distinguish between untreated and 
activated fluorescence in the A) HNE.ab and E) NAP channels individually.  Neutrophils above the 
fluorescence threshold are represented as histograms in terms of their B) NAP F) HNE.ab C and G) 
DAPI and D and H) CellMaskTM Orange optimal intensity features. The following neutrophil treatment 
groups are plotted as histograms: untreated (blue), 1 nM LTB4 (yellow), 25ng/mL LPS / 100nM FMLF 
(pink), 3nM IL8 (orange) and 100 nM PAF (green) with dotted lines of the same colour showing 
classification probabilities. Histograms show all image cytometric data points, n=4. 
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5.2.9 STIMULUS-DEPENDENT NEUTROPHIL CLASSIFICATION  
BY MULTIDIMENSIONAL HNE IMAGING FEATURES 
Using linear combinations of the eight optimal features, eight principal components 
were produced which could be used to effectively cluster HNE.ab bright or NAP 
bright activated neutrophils, by chemokinetic treatment. Performing linear 
discriminant analysis on the eight principal components showed that distinct 
features spaces describe the activated neutrophils of each chemokinetic treatment. 
In eight-dimensional hyperplanes a gating strategy could be applied to HNE.ab 
bright neutrophils to identify LTB4, LTB4+SIV or LPS/FMLF neutrophils as distinct 
activated neutrophil populations. NAP bright neutrophils could be similarly 


















Figure. 5.10 Optimal textural and intensity features are sufficient for NAP and HNE.ab bright 
activated neutrophil subclassification 
Image cytometric analysis of fixed untreated, primed and activated neutrophils. A fluorescence 
intensity threshold is applied to all neutrophil populations to distinguish between untreated and 
activated fluorescence in the A) HNE.ab and C) NAP channels individually. Linear discriminant 
analysis of principal components generates multidimensional score plots which show the 
clustering of neutrophils above the B) HNE.ab and D) NAP fluorescence thresholds respectively. 
The following neutrophil treatment groups are plotted: untreated (blue), 1 nM LTB4 (yellow), 
25ng/mL LPS / 100nM FMLF (pink), 3nM IL8 (orange) and 100 nM PAF (green). All data points 







5.3.0 STIMULUS-DEPENDENT CLASSIFICATION OF ENTIRE NEUTROPHIL 
POPULATIONS BY NEURAL NETWORK MODELLING 
To evaluate the performance of machine learning algorithms when classifying not 
only supra-threshold neutrophils but entire neutrophil populations a neural 
network was modelled on image cytometric data sets generated by CellProfiler 
version 2.2. When classifying the six treatment groups the neural network achieved 
evaluation accuracies between 76.15% (PAF) and 81.49% (IL8) (Fig. 5.11.A) and an 
average evaluation accuracy of 79.01% across all classes (Fig. 5.11.B). Importantly 
accurate predictions, true positive rates, exceed false positive rates for all classes by 
at least 7.6-fold (false positive predictions which range from 0.84% - PAF 
misclassified as LPS/FMLF, to 10% - LPS misclassified as PAF, Fig. 5.11.A). Organised 
in order of stimulus intensity, the confusion matrix (Fig. 5.11.A) shows similar 
treatment groups are more readily confused. False positive rates are generally low, 
with an overall specificity of 94.98% (Fig. 5.11.B) and they are lowest at the corners 
of the confusion matrix where classes are most functionally distinct (untreated vs. 
LPS/FMLF activated). The greatest proportion of false positive untreated 
neutrophils (8.37%) are identified as primed (PAF) and the two strongest activating 
conditions, LTB4 and LPS/FMLF are associated with the least false positives (Fig. 
5.11.A). Similarly, more PAF neutrophils are misclassified as LPS than any other 
class, both PAF and LPS are priming treatments. LTB4 and LPS/FMLF are more 
readily misclassified as each other than any other class. The strongest activating 
treatment, LPS/FMLF is most different from the untreated and priming classes 







Figure. 5.11 Neural network classification of six distinct classes neutrophils following fixation 
A) Confusion matrix, arranged by stimulus intensity, showing neural network classification 
performance. Image cytometric analysis of fixed untreated, 25ng/mL LPS, 100 nM PAF, 3nM IL8, 1 
nM LTB4 and 25ng/mL LPS / 100nM FMLF treated neutrophils produced data for neural network 
classification. Evaluation accuracies are heat-mapped using a dark red (low) to dark green (high) 
colour scale, shown. Percentages for accurate classification are highlighted in black-bordered cells. 









5.3.1 COMPARING HNE RELEASE AND ACTIVITY  
BY CHEMOKINETIC STIMULUS OVER TIME 
To understand if classifying neutrophils by their HNE-phenotypes might be applied 
to COPD blood profiling in a live-cell formant, neutrophils were stained with VE200 
and NAP and imaged at zero, forty-five and ninety minute time points. When 
neutrophils are co-stained with 100 nM VE200 and 3µM NAP, extracellular 
membranous and intracellular NAP fluorescence fluctuate in response to different 
stimuli (Fig. 5.12.G and Gii, S and Sii) whilst VE200 generates membranous and 
intracellular signals only (Fig. 5.12.H and Hii, P and Pii). Sivelestat in the LTB4+SIV 
condition blocks NAP signal across a ninety-minute timespan (Fig. 5.12.C, Ci and Cii) 
whereas VE200 signal decreases Fig. 5.12.D, Di and Dii), Sivelestat. Neutrophil 
morphology appears less rounded at forty-five and ninety minutes in FMLF, LTB4 
and LTB4+SIV conditions (Fig. 5.12.Cii and Ciii, Gii and Giii, Kii and Kiii), than at zero 

































































































Figure. 5.12 Chemokinetic stimuli elicit varying HNE patterns in COPD patient neutrophils. The DNA 
of primary human neutrophils was labelled (Hoechst) before treatment with A-D) 25 ng/mL LPS / 100 
nM FMLF E-H) 1 nM LTB4 I-L) 1 nM LTB4 / 100 μM Sivelestat M-P) 100 nM PAF Q-T) 25 ng/mL LPS or 
U-X) untreated. During treatment incubations neutrophils were concomitantly labelled with 100 nM 
HNE targeted probe (VE200) and 3 µM HNE activity probe (NAP). Imaging occurred at A-X) 0, Ai-Xi) 
45 and Aii-Xii) 90 minutes, n=3. 
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5.3.2 QUANTIFYING NAP AND VE200 FLUORESCENCE OVER TIME 
Comparing VE200 and NAP signal across all timepoints shows the effect of time on 
activated neutrophil staining. Increasing incubation time has little effect on VE200 
fluorescence intensity. From zero to ninety minutes, median fluorescence increases 
12.5 % from a lower quartile pixel value of 1.6 x108 to 1.8 x108 (Fig. 5.13A), similarly 
the interquartile range increases by only 4% of the range at baseline (1.5 x107 pixel 
values). Changes in NAP fluorescence over time more clearly follow trends of 
increasing median brightness and widening range. Pooling all treatment groups for 
comparisons across time, the median NAP fluorescence increases by 166%, and 
interquartile range increases by 23% over ninety minutes (Fig 5.12B).  
 
The proportion of neutrophils, which exceed the maximal fluorescence of the 
untreated group at zero minutes, was analysed to understand the individual 
contributions of different chemokinetic treatment to the overall trends in A) and B). 
This analysis corroborated previous findings with fixed neutrophils in which HNE-
derived fluorescence increased from untreated to primed to activated conditions 
(see Fig. 5.4). The treatment group analysis also revealed that the LTB4+SIV 
condition has the highest proportion of activated neutrophils at zero and forty-five 
minute, by VE200 staining, with a mean activated percentage of 62.7% at zero 
minutes (Fig. 5.13C). However, at forty-five minutes VE200 staining had only 
increased by 0.7% and a 34.2% decrease was evident after ninety minutes. Other 
conditions that demonstrated greater increases in activated cell proportion at forty-
five minutes. The untreated, LPS and LTB4 conditions showed increases of 9.4, 8.5, 
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and 34.2% respectively and these conditions went on to become more completely 
activated by ninety minutes, increasing by 13.8, 6.5 and 4.9% respectively. PAF 
activation seemed to decrease within the first forty-five minutes of incubation 
before increasing by 43.7% between the forty-five and ninety minutes timepoints, 
the largest change in activated neutrophil proportion detected by VE200 staining 
(Fig. 5.13C). LPS/FMLF neutrophils seemed to decrease at both intervals, by 9.9% 
and then 16.1%.   
 
Measuring the proportion of NAP bright neutrophils produced more homogenous 
results with all populations bar the LTB4+SIV condition showing their greatest 
increases from zero to forty-five minutes, and significant increases in percentage 
activated neutrophils (compared to zero minutes) for untreated and PAF conditions 
(see Fig. 5.13D). The proportion of activated neutrophils increased by similar 
amounts across conditions, so that the order of least to most completely activated 
population was maintained. LPS and LTB4+SIV treatment were the exceptions to 
this trend, in order of decreasing HNE activity. The addition of Sivelestat renders the 









Figure. 5.13 VE200 and NAP label neutrophils with different temporal patterns 
Image cytometry histograms of all neutrophils pooled at 0 (blue) 45 (red) and 90 mins (green) and 
plotted by optimal intensity A) VE200 and B) NAP features. All raw data is represented cumulatively. 
Line graphs showing individual chemokinetic treatment groups, imaged at 0 (solid black line), 45 
(solid grey line) and 90 mins (dashed black line), in terms of optimal intensity C) VE200 and D) NAP 
features. The following neutrophil treatment groups are plotted: untreated (UT), 25ng/mL LPS, 100 
nM PAF, 1 nM LTB4 with 100 µM Sivelestat, 1 nM LTB4 and 25ng/mL LPS / 100nM FMLF. Line graph 
values represent mean ± SD, P values were calculated by two-way ANOVA and Bonferroni multiple 








5.3.3 COMPARING NAP AND VE200 RATE OF LABELLING                                                 
BY CHEMOKINETIC STIMULUS 
In addition to measurements of fluorescence intensity and textural imaging 
features, imaging neutrophil responses to different chemokines over time yields 
information on the rate of change of measurements. Image analysis (see Methods 
2.5.5) reveals the rate of change of NAP and VE200 fluorescence over 90 minutes. 
The LTB4+SIV condition constistently demonstrates the least change in NAP and 
VE200 signal overtime (Fig. 5.14A and C). Measuring NAP fluorescence rates, 
untreated, FMLF, LTB4 and LTB4+SIV conditions tended to plateau over the time 
course and untreated neutrophils display the shallowest, uninhibited rate of 
fluorescence increase (Fig. 5.14A and B). Unlike plateauing conditions, PAF 
fluorescence continues to accelerate across the time course even exceeding FMLF 
fluorescence at ninety minutes (Fig. 5.14 B). By VE200 rate of staining, PAF and LTB4 
trends are similar to NAP rate of staining showing increasing and plateauing rates 
respectively (Fig. 5.14 D). FMLF staining however, follows opposing trends when it’s 
rate of staining is measured, increasing over time with NAP and decreasing over 
time with VE200. Both HNE stains show FMLF rates plateauing at ninety minutes 











Figure. 5.14 Rate of HNE labelling may vary with chemokinetic specificity 
Rate of neutrophil labelling is represented as A,B) NAP and C,D) VE200 optimal intensity feature 
measurement over time. untreated (black circles), 25ng/mL LPS (grey squares), 1 nM LTB4 and 100 
µM Sivelestat (grey circles), 1 nM LTB4 (black diamonds) and 25ng/mL LPS / 100nM FMLF (grey 








5.3.4 STIMULUS-DEPENDENT NEUTROPHIL CLASSIFICATION  
BY MULTIDIMENSIONAL HNE FEATURES OVER TIME 
When the eight most discriminatory features were used to generate principal 
components, linear discriminant analysis was performed as before (see Fig. 5.10) to 
cluster activated neutrophils by chemokinetic condition. VE200 fluorescence was a 
more stringent selection criterion than NAP fluorescence, yielding less bright 
neutrophils for cluster analysis, in fact LTB4, PAF and LPS treated neutrophils are 
completely lacking from the zero, forty-five and ninety-minute timepoints (bar 1 
PAF neutrophil at zero minutes Fig. 5.15D,E,F) but these populations are 
represented by NAP bright neutrophil selection (Fig. 5.15A,B,C). Cluster analysis of 
NAP bright neutrophils achieves good clustering characteristics with clear 
delineation between chemokinetic treatment groups for most populations. 
Although limited, there is some ambiguity between priming conditions (PAF and 
LPS) at forty-five minutes (Fig. 5.15B) and between strong activated conditions 
(LTB4 and LPS/FMLF) at forty-five and ninety minutes (Fig. 5.15B and C). VE200 
bright neutrophils (brighter than all untreated neutrophils at zero minutes) are 
clearly clustered with no ambiguity between untreated, LPS, PAF, LTB4, LTB4 + 
Sivelestat, or LPS/FMLF neutrophils (Fig. 5.15 D,E,F). Despite being abstracted by 
principle components analysis into an 8 dimensional hyperplane, which lacks clear 
relationship to a feature-space described by NAP and VE200 axes, treatment groups 
in the eight-dimensional principal component hyperplane are ordered by HNE 
release. The trend at ninety minutes for NAP and VE200 bright neutrophils, and at 
forty-five minutes for NAP bright neutrophils (with slight deviation from linearity for 
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VE200 bright neutrophils) show treatment groups are arranged linearly, in order of 
stimulus intensity, untreated, LPS, PAF, LTB4, LPS/FMLF neutrophils and the LTB4 
with Sivelestat condition is aligned with LTB4 neutrophils perpendicular to this 











































Figure. 5.15  
VE200 classifies activated COPD neutrophils more specifically than NAP over time  
Image cytometric analysis was applied to neutrophil populations to distinguish between untreated 
and activated fluorescence in the A-C) VE200 and D-F) NAP channels individually. Multidimensional 
score plots show neutrophil population clustering of at A,D) 0 mins, B,E) 45 mins and C,F) 90 mins. 
The following neutrophil treatment groups are plotted: untreated (blue), 25ng/mL LPS (red), 100 nM 
PAF (green) 1 nM LTB4 and 100 µM Sivelestat (purple), 1 nM LTB4 (yellow) and 25ng/mL LPS / 
100nM FMLF (orange). All data points for each treatment group are shown, n=3. 
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5.3.5 STIMULUS-DEPENDENT CLASSIFICATION OF ENTIRE NEUTROPHIL 
POPULATIONS OVER TIME BY NEURAL NETWORK MODELLING  
High classification accuracies and biologically relevant inferences were derived 
when fixed neutrophil populations were modelled using a neural network. To 
understand how neural network classification techniques might extend to live cell 
data, images from live neutrophils responding to physiologically relevant doses of 
stimulus were processed for neural network evaluation. All evaluation accuracies 
are above 79% bar the PAF class at 72.14%, the neural network demonstrates an 
overall sensitivity of 84.24% in this dataset (Fig. 5.16B). LTB4+SIV neutrophils are 
the most accurately identified with a true positive rate of 99.02% and all false 
positive rates below 0.77% across the remaining 5 neutrophil classes (Fig. 5.16A). 
The neural network shows a clear ability to identify functionally similar treatment 
groups with most false positives in each class falling in functionally similar classes, 
eg. 6.47% of untreated neutrophils are misclassified as the LPS neutrophils (Fig. 
5.16A), the nearest to untreated in NAP and VE200 signal at each timepoint (see 
Fig. 5.13C and D) and all other classes have less than 2% false positive rates (Fig. 
5.16A). Similarly, LPS/FMLF and LTB4 are more readily confused for each other and 
PAF neutrophils (6-9%) than for classes with low HNE release (0.22 – 2.73%, Fig. 
5.16A). With an evaluation accuracy of 72.14% PAF neutrophils were the most 
difficult to classify (Fig. 5.16A). With each class representing all neutrophils from the 
zero, forty-five and ninety-minute timepoints, PAF neutrophils fall into the priming 
category at some timepoints (zero and forty-five minutes VE200, zero minutes NAP) 
and the activated category at subsequent timepoints by HNE response (see Fig. 
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5.13B and D). False positive analysis from the confusion matrix helps to highlight 






























A neural network classifies six neutrophil populations by chemokinetic stimulus using live-cell 
imaging data 
A) Confusion matrix, arranged by HNE activity, showing neural network classification performance. 
Image cytometric analysis of fixed untreated, 1 nM LTB4 + 100 µM Sivelestat, 25ng/mL LPS, 100 nM 
PAF, 1 nM LTB4 and 25ng/mL LPS / 100nM FMLF treated neutrophils produced data for neural 
network classification. Data for each class was pooled across zero, forty-five and ninety-minute 
timepoints. Evaluation accuracies are heat-mapped using a dark red (low) to dark green (high) colour 
scale, shown. Percentages for accurate classification are highlighted in black-bordered cells.  









5.3.6 STIMULUS-DEPENDENT CLASSIFICATION OF ENTIRE NEUTROPHIL 
POPULATIONS BY TIME-GROUPED NEURAL NETWORK MODELLING  
A final machine learning analysis was undertaken to understand the effect of time 
on neural network classification. When data is organised by timepoint each 
individual class is more accurately classified leading to greater neural networks 
sensitivities at each timepoint than in the timepoint pooled analysis. Interestingly 
specificity improves less than sensitivity at each timepoint showing 0.9-2.1% 
increases whereas sensitivity increases by 3-9.2% (Fig. 5.17B). The distribution of 
false positives becomes increasingly limited to classes of the same activation state 
with the progression of time. At zero minutes the distribution of false positives 
through the confusion matrix shows little preference for cells in the grid, away from 
the green diagonal, the adjacent cells of which are functionally similar. By forty-five 
minutes there is a clear pattern of highest false positives along the diagonal with 
more distant false positive rates falling to <2.5%. Finally, at ninety minutes only 8 of 
the 30 false positive rates are >1% and these slightly higher rates identify two 
functional categories of low and high HNE activity (Fig. 5.17A). However, evaluation 
accuracy/sensitivity is >88% at each timepoint and at ninety minutes this reaches 





     
 
Figure. 5.17 Neural network classification improves with time-resolved image sets  
A) Confusion matrix, arranged by HNE activity, showing neural network classification performance. 
Image cytometric analysis of fixed untreated, 1 nM LTB4 + 100 µM Sivelestat, 25ng/mL LPS, 100 nM 
PAF, 1 nM LTB4 and 25ng/mL LPS / 100nM FMLF treated neutrophils produced data for neural 
network classification. Data is arranged by class and timepoint. Evaluation accuracies are heat-
mapped using a dark red (low) to dark green (high) colour scale, shown. Percentages for accurate 






5.3.7 NEUTROPHIL ACTIVATION DETECTION IN HUMAN LUNG 
ADENOCARCINOMA HISTOLOGICAL SAMPLES 
To understand how HNE imaging may enable distinctions between quiescent and 
activated neutrophils in human tissues immunohistochemistry was performed on 
human spleen and lung adenocarcinoma tissue samples. The characteristic lobular 
nuclei of these polymorophonuclear granulocytes help to identify neutrophils, (Fig. 
5.18B and E) coupled with bright HNE staining (Fig. 5.18C and F). In an 
adenocarinomatous setting, neutrophils show a trend of staining more brightly for 
HNE by immunohistochemistry (Fig. 5.18G) than in normal, healthy spleen. 
Morphological changes may provide more precise detection of neutrophil activation 
in human tissues. Neutrophils from lung adenocarcinoma tissue display a less 
circular morphology when compared to healthy splenic neutrophils (Fig. 5.18C and 
F). In cancerous lung tissue neutrophils appear to reorganise HNE into smaller 
regions such that the relationship between circularity and maximum diameter is 































Figure 5.18  
Immunohistological HNE imaging enables multiparametric neutrophil activation detection  
Images show confocal microscopy of human A-C) spleen and D-F) lung adenocarcinoma cross-
sections with nuclear staining (DAPI) and HNE immunostaining enhanced by tyramide signal 
amplification. Cross sections are shown as A,D) merge B,E) DAPI, C,F) HNE immunofluorescent 
images. G) Image analysis shows HNE fluorescence of individual neutrophils and H) correlation 




5.3.8 SIGNIFICANCE OF NEUTROPHIL INFILTRATION IN HUMAN LUNG 
ADENOCARCINOMA HISTOLOGICAL SAMPLES 
To understand how imaging neutrophil activation might contribute to lung 
adenocarcinoma detection, samples of human lung adenocarcinoma were acquired, 
sectioned and immunostained for HNE and the GLUT-1 glucose transporter, which is 
overexpressed on malignant epithelial cells. A correlation of 0.74 was found 
between HNE stained neutrophils and GLUT-1 bright cells. GLUT-1 bright cells in 
these sections were identified as highly likely to be malignant lung epithelial cells by 





































Figure 5.19 HNE staining correlates with GLUT1 staining in Human Lung Adenocarcinoma  
Images show confocal microscopy of human lung adenocarcinoma cross-sections stained with DAPI 
(blue) and anti-GLUT-1 (red) and anti-HNE (green) antibodies. Sections with A) low B) medium and C) 
high numbers of GLUT-1 bright cells are shown. D) Image analysis shows the extent of correlation 
between the number of neutrophils and GLUT-1 bright cells in lung adenocarcinoma tissue, with 










5.3.9 DUAL-PROBE NEUTROPHIL ACTIVATION DETECTION BY FIBRED 
CONFOCAL ENDOMICROSCOPY IN VITRO 
The fibred confocal imaging endomicroscope, Versicolour, (Fig. 5.20.A) was 
developed in-house. These images demonstrate the ability of Versicolour to detect 
neutrophil activation by NAP and VE200 staining in vitro. 3 µM NAP and 2 µM VE200 
can be multiplexed for dual imaging of HNE presence and activity in neutrophils 
activated with 1 μM calcium ionophore (Fig. 5.20.F-H). Untreated neutrophils 
showed no staining in the 470 nm or 625 nm channels and 2 µM free Cy5 did not 
stain neutrophils regardless of calcium ionophore treatment (Fig. 5.20.D and E). All 
wells were re-imaged on a spinning-disk confocal microscope confirming the 
presence of neutrophils in all conditions and the increased NAP and VE200 
fluorescence with activation (Fig. 5.20.J). NAP and VE200 co-localized staining and 
the absence of passive free Cy5 staining are confirmed by spinning-disk confocal 
microscopy. The apparent reduction in NAP signal with 2 µM VE200 co-staining is 












Figure 5.20 Activated neutrophils are visible via Versicolour fibred confocal endomicroscopy with 









Figure 5.20 Activated neutrophils are visible via Versicolour fibred confocal endomicroscopy with 
multiplexed NAP and VE200 
A) Electro-optical architecture of Versicolour, in-house fibred confocal endomicroscope and B) 
triggering sequence for 25-ms exposure time for each channel with 10 fps imaging speed for 
combined three-color imaging. A minor delay is introduced between pulses so that the camera 
hardware can accommodate image transfer.245 
Images from Versicolour, showing C-E) untreated and F-H) 1 μM calcium ionophore stimulated 
neutrophils in C,F) merged, D,G) NAP and E,H) VE200 channels.  
I-Z) Neutrophils that were imaged using Versicolor were subsequently imaged using spinning disk 
confocal microscopy: I-N) Merged, O-T) NAP and U-Z) VE200/Cy5 images are shown. Images 
compare untreated and 1 μM calcium ionophore stimulated neutrophils (I,O,U and J,P,V 
respectively) incubated with 3 μM NAP and 2 µM VE200, 3 μM NAP (K,Q,W and L,R,X respectively) or 








5.4.0 LOW SPATIAL RESOLUTION DUAL-PROBE NEUTROPHIL ACTIVATION 
DETECTION IN AN EX VIVO VENTILATED HUMAN LUNG 
To evaluate how applicable in vitro versicolour imaging results are to a clinically 
relevant, pulmonary OMI scenario, neutrophils were acitvated and imaged in a 
human ex vivo lung ventilation (EVLV) model. Low reagent doses facilitate the 
relevance of EVLV to a clinical use case and a 200 nM VE200 dose, effecive in 
previous imaging experiements (see Fig. 4.10-12) was chosen rather than the 2 µM 
dose used in in vitro OMI experiments. At this low 200 nM VE200 dose, NAP signal 
was not obstructed by the presence VE200 and punctate NAP fluorecence is visible 
in calcium ionophore treated neutrophils. VE200 fluorescence was useful in 
indicating neutrophil activation as frames containing calicium ionophore stimulated 
neutrophils demonstrate bright fluorescence in the 625 nm channel, however the 
spatial relationship of VE200 signal to stimulated neutrophils is ambiguous with 
large regions of pixels at high values around regions that appear neutrophil-dense 
by NAP staining. Image processing clarifies the spatial resolution of both the 470 
and 625 nm channels such that background signals are removed and contrast is 
increased and yet VE200 still has reduced low spatial resolution when compared to 
the precise puncta identifiable via EVLV NAP imaging. One advantage to VE200 
neutrophil imaging is the complete lack of background signal in the absence of 
neutrophil activation whereas NAP signal is in constant competition with 

























Figure 5.21 At 200 nM VE200, optical molecular imaging shows activated neutrophils are rapidly 
detected with low spatial resolution 
Representative images from within an ex vivo ventilated human lung showing allogeneic neutrophils  
coated onto the interior alveolar surface. A-D) Merged images of 3 µM NAP and 200 nM VE200 
images. E-H) NAP images, I-l) VE200 images.  Untreated A,E,I) and B,F,J) 10 µM calcium ionophore 
stimulated neutrophils are shown A,B,E,F,I,J) before and C,D,G,H,K,L) after image processing, n=1. 




5.4.1 COMPARING TARGETED AND ACTIVABLE PROBE DETECTION 
SENSITIVITY IN AN EX VIVO VENTILATED HUMAN LUNG 
Although activated neutrophils are more discretely resolved when imaged using 
NAP than VE200, frames containing activated neutrophils are instantly and 
unambiguously recognisable with 200 nM VE200 staining. Elastin fibres contribute a 
consistently low autofluorescence in the 470 nm channel  and not in the 625 nm 
channel. Activated neutrophils stained with NAP appear distinctly brighter (median= 
47 RFU, Fig. 5.22.A white squares) than lung tissue strcutures (median= 12 RFU, Fig. 
5.22.A black circles), even via framewise image quantitifacition (histogramming and 
fluorescence thresholding) which does not individuate cells. In the presence of 
supraphysiological concentrations of activated neutrophils, VE200 appears to 
adsorb to surrounding lung structures with a similar level of fluorescence as 
activated neutrophils (median= 35 RFU, Fig. 5.22.B and A white squares), unless 
neutrophils have not been activated in which case there is no VE200 signal 
(Fig.5.21.B black circles). Interestingly, the magnitude of fluorescence increase 
when frames with activated neturophils are compared to those without is the same  






























Figure 5.22 200 nM VE200 detects activated neutrophils despite low spatial resolution 
Histograms of processed video frames acquired using Versicolour, optical molecular imaging. 
Images of neutrophils from within an ex vivo human lung were compared in untreated (black 
circles) or 10 μM calcium ionophore (white squares) stimulated states, n=1. This experiment 




5.4.2 HIGH SPATIAL RESOLUTION DUAL-PROBE NEUTROPHIL ACTIVATION 
DETECTION IN AN EX VIVO VENTILATED HUMAN LUNG 
By increasing VE200 dose to 400 nM, activated nuetrophils become recognisable 
with spatial resolution of similar the to that of NAP. NAP signals persist in the 
presence of 400 nM VE200 and the multiplexing of these signals allows the 
identification of colocalized HNE labelling on calcium ionophore treated neutrophils 
in the EVLV model. As opposed to the complete lack of background in the 625 nm 
channel at 200 nM VE200, at 2400 nM there is a low level of featureless, 
background fluorescence. Comparing the maxima of the untreated and 10 µM 
calcium ionophore treated neutrophil conditions have comparable signal to noise 
ratios of 1.41 and 1.67  for NAP and VE200 respectively. Imporantly, these 
conditions allow for image thresholding to reduce untreated, background 
information to zero while maintaining signal from activated neutrophils. Activated 
neutrophils stain brightly and display a fluorescence blinking phenomenon, in both 
channels, as they pass between imaging core and inter-core cladding withing the 
multi-core imaging fibre. Background signals do not demonstrate blinking. Taking 
these imaging characterstics together, the spatial and temporal relationships of 
activated neutrophil signals combined with sharp differences in fluorescence 
intensity create an imaging paradigm in which activated neutrophils are readily 






























 NAP and VE200 signals colocalize at sites of neutrophil activation in an ex vivo human lung  
Representative images, acquired with Versicolour, from within an ex vivo ventilated human lung, of 
interior surface of an alveolus surface coated in allogeneic neutrophils. Neutrophils are instilled into 
the alveolar space A,C,E) untreated or B,D,F)  stimulated with 10 µM calcium ionophore. Images are 
shown A,B) merged C,D) NAP E,F) VE200, n =1. This experiment could not be repeated as human 
lungs are infrequently available for experimentation. 
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5.4.3 SEPARATING ACTIVATED NEUTROPHILS POPULATIONS  
IN AN EX VIVO VENTILATED HUMAN LUNG 
With 3 µM NAP and 400 nM VE200, the spatial resolution of HNE imaging was 
sufficiently high to distinguish separate waves of infused neutrophils in the EVLV 
model. When neutrophils, 10 µM calcium ionophore and NAP were co-administered 
to the alveolus, followed by neutrophils, 10 µM calcium ionophore and VE200, an 
elastin fibre was observed bearing clustered neutrophils, stained in alternating 
stripes of NAP and VE200 signal. A pattern of inverse proportion was observed as 
both probes varied in precisely opposite patterns of high and low signal intensity 
Fig. 5.24.G. It is likely that activated, adherent neutrophils covered the entire elastin 
fibre in continuous, bright NAP fluorescence after the first infusion. The second 
infusion, imaged within sixty seconds, could have introduced neutrophils with of 
approximately 400 nM VE200 removing NAP signal only where they contacted the 
elastin fibre Fig. 5.24E. Two populations of neutrophils are observed by differential 
































Figure 5.24 NAP signal is sensitive to VE200-mediated inhibition in human lung ex vivo 
Representative images, acquired with Versicolour, from within an ex vivo ventilated human lung, of 
interior surface of an alveolus surface coated in allogeneic neutrophils. Neutrophils stimulated with 
10 µM calcium ionophore are instilled into the alveolar space and shown as A) NAP only B) VE200 
only and C) merge. Magnified D) NAP only E) VE200 only and F) merge images of a neutrophil coated 
elastin fibre (grey rectangle) are shown and G) analysed to plot fluorescence intensity across 





VE200, the HNE-targeted probe holds significant advantages over 
immunofluorescent HNE detection as a means of targeted HNE labelling. VE200 
stains in minutes and it stains neutrophils without fixation, enabling dynamic 
imaging and improving NAP signal in multiplexed assays. The targeted and activable 
probes, VE200 and NAP combine to produce significant volumes of imaging data, 
accessible on a per cell basis. With multivariate analysis and neural network 
modelling, the dense network of information associated with individual images can 
be effectively mined to produce phenotypic classifiers. Combining chemistry, 
biology and data science techniques, neutrophils can be classified not just into 
untreated or activated classes but activated neutrophils can be subdivided by 
stimulus, neutrophil priming is detectable and subdivided by stimulus, so that 
nuanced neutrophil behaviour can be accurately described. In short, a versatile 
classification tool has been devised which describes a spectrum of neutrophil 
activation using live-cell imaging data. Finally, the ability to detect and quantify 









5.5.1 HNE ACTIVITY FOLLOWING FORMALDEHYDE FIXATION 
Formaldehyde forms polymeric cross-links between proteins such as HNE and hence 
may interfere with HNE activity, reducing NAP signal. However, the inhibitory effect 
of fixation can be titrated. That neutrophils can be fixed without completely 
abrogating HNE activity is not a novel finding. Korkmaz et al. clearly demonstrate 
decreases in antibody affinity (andit-C63 and anti-CD16b) following 3% PFA/ 0.25% 
glutaraldehyde fixation but no change HNE activity213. Evidently NAP signal can be 
increased by gentle fixation conditions (Fig. 5.2.E) despite a reduction in HNE 
activity and this may have several explanations: 1) fixative may displace fluorescein 
moieties from the NAP dendrimer, 2) cleaved NAP fragments may interaction with 
fixative to accumulate on the surface of fixed neutrophils, 3) By cross-linking NAP 
molecules, fixative may increase the rate of NAP cleavage by allowing HNE to 
interact with NAP aggregates instead of isolated NAP molecules. The later may 
explain the appearance of a minority of neutrophils with a log-fold increase in NAP 
fluorescence, (Fig. 5.2.D) particularly as centrifugation may have concentrated NAP 
aggregates.  
Because HNE activity is largely preserved and the effects of fixation on NAP signal 
generation present a systematic error, fixation artefacts can be removed from 
analysis by subtracting the fluorescence of a fixed untreated neutrophil control. Zin-
based fixatives which may not require antibody-retrieval, may enhance fixed HNE 




5.5.2 MEMBRANOUS HNE IMMUNOFLUORESCENCE 
Measuring HNE presence by immunofluorescence serves as a sensitive standard for 
validating NAP signals. Both methods enable signal amplification, detecting HNE 
under physiologically-relevant stimulation conditions, where individual neutrophils 
are expected to yield membranous HNE (mHNE) in the femtomolar to picomolar 
range.212,213 Although the mHNE was discovered more recently than the 
degranulated and endosomal forms, mHNE contributes in a non-trivial manner to 
neutrophil activity. In addition to the sheer quantity of HNE that can be stored on 
the plasma membrane (in equilibrium with HNE in solution) mHNE is more resistant 
to alpha-1-antiprotease inhibition than degranulated HNE. As HNE is believed to 
adhere to plasma membranes by charge, the enzyme’s active site may be less 
accessible to alpha-1-antiprotease when membrane bound than when in 
solution.213 mHNE therefore presents an important caveat to the protease-
antiprotease hypothesis by ensuring motile neutrophils can constantly evade HNE-
inhibition, employing active mHNE at the plasma membrane-substrate interface. At 
this interface, inhibitor concentrations may fall to negligible levels. Clinical HNE 
biomarkers stand to be more informative when sensitive to mHNE and this 
sensitivity can be evaluated by correlation with immunofluorescence. This assay 
may have been improved descriptions of the extent to which mHNE was displaced 
by fixation. This contextualising data could have been gained by removing 




5.5.3 CHARACTERISING AND CLASSIFYING FIXED NEUTROPHIL 
POPULATIONS BY CHEMOKINETIC RESPONSE 
NAP fluorescence and immunofluorescence increased with stimulus intensity under 
physiological doses of LPS, PAF, IL8, LTB4 and LPS/fMLF. The ability to categorize 
neutrophil activation into functional groups (untreated, primed, activated and 
primed-activated) by univariate analyses testifies to the precise control neutrophils 
exert over HNE release and activity. HNE release is tightly matched to the extent of 
activation a stimulus elicits, even at physiological doses which are often below the 
limit of detection of functional assays. This correlation highlights 1) the neutrophil’s 
quantal release of granule contents, HNE  and HNE inhibitor, modulating presence 
and activity of the protease in the inflammatory milieu.174 2) The sensitivity of 
image cytometry. 
 
Image cytometry is the quantification of cellular populations from images, on a per 
cell basis, using image analysis. Often classification algorithms can be trained on 
information-dense images with high accuracy.247 NAP enables image cytometry. 
HNE antibody and NAP fluorescence show the same overall pattern of increasing 
fluorescence intensity from untreated, to primed, to activated, to primed-activated 
neutrophils, validating the assertions that NAP can 1) detect increasing 
concentrations of HNE release under physiological stimulation 2) be used to identify 
neutrophils of different functional groups 3) describe neutrophil populations in 
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high-throughput assays. Taken together NAP imaging could inform a neutrophil 
classifier for automated neutrophil phenotyping.  
Although textural features could be used to provide a more categorical rationale for 
classification than stronger or weaker fluorescence intensity, they make weaker 
distinctions between treatment groups. HNE may be localized to neutrophils in 
different treatment groups with similar patterns at the population level. The 
subtlety of HNE-derived textures may be compounded by the relatively small 
amounts of HNE released in response to physiological concentrations of stimulus, 
indeed over 90% of neutrophils resembled untreated cells in their HNE-staining 
under these conditions (see Fig. 5.5.A and B).  
Similar trends help to validate NAP staining claims but differences in trends 
between stains are useful too. As HNE antibody staining and NAP staining relay 
subtly different pictures of neutrophil activation, a more nuanced phenotypic 
analysis is generated by their combination, enhancing the discriminatory power of 
classifiers. DAPI and CellMaskTM orange staining were added to the 
immunofluorescence assays to enable cell identification and segmentation for the 
image analysis pipeline. However, DAPI and CellMaskTM orange fluorescence 
intensity also displayed meaningful variance between treatment groups. Combining 
different sets of imaging data bivariate analyses had improved classification 
accuracies than univariate analyses (Fig. 5.8). This principle extends or greater 
accuracy with more information extends to higher order multivariate analyses. 
Principal components and linear discriminants analyses can create highly 
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informative multivariate data visualizations compared to univariate data 
visualization such as histograms and scatter graphs. With minor contributions from 
weakly segregating variables and greater contributions for variables that explain 
more sample variation, these orthogonal transformation techniques summarize 
large datasets in more informative, combinatorial axes.  In this manner phenotypic 
clustering and classification accuracy can be optimized, creating the most 
appropriate multi-dimensional feature-space for data visualization. 
Linear combinations of variables produce comprehensible and marked 
improvements in the informativeness of data visualisations and classification 
accuracy. However, machine learning techniques are not limited to linear 
transformations of data. Neural networks are capable of computing linear and 
nonlinear data transformations in parallel, estimating class identity, calculating 
estimation error and re-iterating along the fastest route to greatest accuracy. A 
simple neural network, outperformed linear classifiers, separating entire neutrophil 






5.5.4 CHARACTERISING LIVE NEUTROPHIL POPULATIONS  
BY PERCENTAGE ACTIVATION 
Removing neutrophils within limits for untreated fluorescence from each treatment 
group allows the neutrophils with the most pronounced phenotype for each 
treatment group to be compared. There is a large degree of variation between 
donors by this method. It is important to visualise this variation as it highlights the 
varying degree to which neutrophil populations retain an “untreated” contingent 
when stimulated sub-maximally.  Removing this large proportion of the data 
amplifies variation between treatment groups.  
VE200 staining reveals less obvious neutrophil population differences than NAP and 
the two probes behave differently over time. VE200 staining could be amplified by 
increasing the concentration of probe used as only 100 nM is used compared to 
3000 nM for NAP, however these doses minimize NAP signal reduction. Making use 
of the two different temporal patterns of VE200 and NAP will help to classify 







5.5.5 CHARACTERISING RATE OF SIGNAL ACCUMULATION IN 
NEUTROPHIL POPULATIONS  
Untreated and LPS treated neutrophils are difficult to separate by univariate 
analyses, however the temporal traces of these two populations deviate markedly 
between forty-five and ninety minutes. Similarly, 100 nM PAF elicited HNE 
responses akin to LTB4 and LPS/fMLF treatment groups in magnitude. Despite their 
similarities, PAF treated neutrophils arrive at these fluorescence intensities by a 
different means showing signal acceleration over time whereas the LTB4 and 
LPS/fMLF conditions show deceleration and plateauing. Stimulus-dependent signal 
deceleration may be related to differences in HNE degranulation. When Cepinskas 
et al. stimulated neutrophils with 100 nM PAF, with or without attachment to a 
HUVEC monolayer, HNE activity could not be detected in the surrounding 
supernatant, however HNE was released onto neutrophil plasma membranes.17 
Cepinskas et al. acknowledge that their inability to detect extracellular HNE release 
stands against the work of others such as Furuno et al.248 and that this may be 
explained by their relatively shorter measurement interval (30 vs. 120 mins).17 PAF-
stimulated degranulation may occur in a delayed fashion compared with to 
LPS/FMLF-stimulated degranulation. If this is the case, HNE-staining acceleration 
may reflect HNE degranulation from a population of neutrophils.  Differences in rate 
of signal generation could also be accounted for by differential corelease of 
endogenous inhibitors, such as elafin.174 Alterations in HNE-release make NAP and 
VE200 signal generation kinetics an important element in classifying neutrophil 
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populations, particularly those that are rendered similar by absolute fluorescence 
measurements. 
Decreasing the imaging interval and collecting data at more timepoints would 
clearly add clarity and robustness to this assay however this would require a more 
high-throughput imaging platform than the spinning-disk confocal microscope used, 
or reduction in the number of treatment groups. Importantly this technique is 
limited in its applicability to patient sample analysis. With an approximately three-
hour Percoll blood purification step and the use of a confocal bench-top microscope 
sample analysis would not be performed in real time. As these probes demonstrate 
neutrophil specificity a whole blood sample may be analysed, significantly reducing 
readout lag-times. Because these measurements were taken in vitro they lack 
relevance to in vivo cell biology and this could be rectified with fibred confocal 
endomicroscopy (FCE) techniques of sufficient resolution and throughput.  
5.5.6 CLASSIFYING LIVE NEUTROPHIL POPULATIONS  
BY CHEMOKINETIC RESPONSE  
Principle components analysis and linear discriminants analysis combined make it 
possible to distinguish between a highly activated minority of neutrophils from 
untreated, primed, activated and a primed-activated treatment groups. The great 
advantage of these techniques is the generation of a multi-dimensional feature-
space (taking combinatorial features as axes instead of raw features) in which 
neutrophils can be gated by their HNE-phenotype. Using neural network modelling 
HNE-phenotyping could be performed across entire neutrophil populations. The 
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neural network more readily confused neutrophils of the same functional mode (eg. 
one primed class for another) than other modes and ascribing less false positives to 
those modes which are most different in terms of HNE release. Therefore, the 
neural network demonstrates some ability to describe functional groups for HNE-
phenotypes a priori. 
Organization of neutrophil treatment groups into inhibited, primed and activated 
categories highlights the ability of machine learning to objectively reveal meaningful 
patterns in the data. 100 nM PAF stimulation seemed similar to activated 
neutrophils, eliciting similar levels of NAP staining as LTB4 and LPS/FMLF treatment 
at forty-five and ninety minutes (see Fig. 5.13D) and the fastest signal generation 
rates for both probes (see Fig. 5.13B and D). This may explain the increased 
confusion between this typically priming condition and the other activating 
treatment groups. Although losses in evaluation accuracy are minimal, the neural 
network seems to find PAF neutrophils most difficult to accurately identify because 
of their similarities to activated neutrophils. 100 nM PAF represents an interesting 
primed neutrophil population as it has been shown to increase neutrophil mHNE 
with undetectable release of HNE into the extracellular milieu.17  However in this 
dataset strong PAF-dependent HNE responses indicate these cells are activated and 
hence PAF neutrophils are more accurately grouped with activating conditions than 
primed or untreated conditions. With an average evaluation accuracy of 84.24% for 
timepoint pooled data, temporally distinct waves of infiltrating neutrophils may still 
be accurately stimulus-classified irrespective of the duration of exposure to 
stimulus. This may be particularly useful in understanding chronic inflammatory 
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disease in which neutrophils may infiltrate a tissue at different times due to varying 
chemoattractants.  
 
Neutrophils from COPD patients were prepared for this neural network analysis and 
a limitation of this study was the lack of willing, age-matched, healthy, smoking, 
volunteers, this would have elucidated disease-specific changes in HNE-phenotype, 
a tendency for increased PAF response in COPD neutrophils for example. However, 
comparison against healthy controls was not required to evaluate neural network 
classification between distinct neutrophil populations. Neural network data analysis 
could have also been improved by increasing the sample size or by collecting more 
complex data sets such as the use of fluorescence lifetime imaging might have 
allowed. For reasons of practicality neither of these approaches were pursued. 
Further work assessing the effect of neutrophil ageing, apoptosis and necrosis on 
stimulus-specific classification would provide useful insight into the stability of 
neural network performance over time. This neural network grouped HNE-
phenotypes into functional modes a priori which lends credence to the idea that 
neutrophils can be classified via unsupervised machine learning techniques, but this 






5.5.7 NEUTROPHIL ACTIVATION DETECTION IN HUMAN LUNG 
ADENOCARICNOMA SAMPLES   
Immunohistochemstry was used to identify activated neutrophils in human lung 
adenocarcinoma (LAC) samples, both by increased fluorescence intensity and shape 
change (see Fig. 5.18). As shown previously, neutrophils immunostained for HNE 
accrue NAP staining, post fixation (see Fig. 5). Hence the ability to detect neutrophil 
activation via immunostaining sets a precedent for NAP based neutrophil activation 
detection in LAC. The correlation between neutrophil count and GLUT-1 bright cell 
count in LAC samples is not surprising given that neutrophils are recruited to the 
tumour milieu and promote neutrophil recruitment. Neutrophil counting is 
understood to have prognostic significance with respect to many solid tumours 
including LAC however quantitation in the tumour milieu and image cytometric 
analyses (Fig. 5.18) may enhance the generalization and accuracy of quantitation 
techniques which currently rely on systemic circulation counts without classifying 
neutrophil activation. This study was limited by the single-marker identification of 
malignant epithelium.  Although a clinical pathologist confirms the proposed 
identification is highly likely, transcription terminator factor 2 stain could have 
helped to corroborate malignant epithelial cell identification in these samples.  
GLUT-1 overexpression precedes GLUT-3 overexpression, in LAC, making it the 
earlier marker, both of which indicate intensifying tumour growth and poor 
survival.249  Demonstrating a correlation between HNE and GLUT1 may therefore be 
sufficient to enable HNE stains to relay GLUT-1 prognostic information.  
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5.5.8 FIBRE-BASED NEUTROPHIL ACTIVATION DETECTION  
WITH MULTIPLEXED NAP AND VE200 
When 3 µM NAP and 2 µM VE200 were multiplexed in vitro for neutrophil activation 
detection (Fig. 5.20) a key limitation was the lack of near-infrared plasma 
membrane stains. The three-colour imaging system, Versicolour was limited to two-
colour imaging in practice. To confirm that Versicolour was detecting stained 
neutrophils, samples were imaged with 488 nm, 641 nm and brightfield channels via 
spinning-disk confocal microscopy. Nonetheless, VE200 and NAP signals were 
successfully multiplexed and imaged via FCE.  
When neutrophil activation detection was attempted in the ex vivo lung ventilation 
model (EVLV), neutrophil and HNE-probe incubation times were decreased, to 1 
minute, to improve the throughput of this rarely accessible model. 2 µM VE200 
produced constant saturation in the 650 nm channel despite any concentration 
reductions due to regent volumes dispersing through the alveolar space. Neutrophil 
staining in the alveolar space via catheterised reagent instillation is significantly 
different from the same experiments in a 96-well plate format and well plate dose 
combinations were inappropriate in EVLV. Titration in EVLV showed optimal 
resolution and NAP multiplexing at 400 nM VE200.  
Despite providing a relatively course level of image analysis, framewise histograms 
described imaging thresholds for the deletion of untreated frame signals such that 
neutrophil activation can be objectively measured using these images. Separating 
untreated and activated neutrophils by image analysis satisfies the first step 
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towards more sophisticated classification with EVLV data. Neutrophil activation can 
be detected in real-time in a ventilated lung using NAP and/or VE200. With calcium 
ionophore stimulation producing maximal HNE release, neutrophil activation 
detection occurs more readily than under gentler stimulation. It would be 
unsurprising if necrotic neutrophils were detectable using Versicolour and HNE 
probes as necrosis leads to maximal HNE release. Although neutrophils are 
effectively detected following priming and sub-maximal activating stimuli via 
confocal microscopy it is unclear whether FCE will facilitate equally robust HNE 
detection. Significant advances in the resolution of fibre-based microscopy have 
been made since the inception of Versicolour, improving image resolution and 
benefiting the application of machine learning techniques to clinical imaging data. 
Cell segmentation will be an important part of translating the classification 
techniques described (Fig.s 5.14-16) into an FCE technique. Stained neutrophils 
display a blinking phenomenon in the 650 and 370 nm channels. Being of 
comparable size to the imaging cores of the optical fibre, light from stained 
neutrophils is transiently obscured by cladding between imaging cores as the lung 
and fibre move. The cellular blinking phenomenon supports the detection of 
neutrophils as it is not present prior to stained neutrophil installation. With the 
application of appropriate image analysis tools, and in less densely populated fields 
of view, cellular blinking may be sufficient to extract individual cells from video 
frames for image cytometric analyses. Finally, the EVLV model recapitulates fluid 
dynamic properties of probe multiplexing that are important for FCE and sequential 
waves of inflammatory infiltrates can be modelled. Instilling two waves of activated 
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neutrophils into the same field of view, with NAP and then with VE200, made it 
possible to identify neutrophils from the primary and secondary installations 
respectively, by understanding changes in extracellular probe concentration and the 
antagonistic signal generation mechanisms of these HNE probes.  
 
These findings are limited by the direct instillation of allogenic neutrophils into the 
alveolar space. The pulmonary remnant of the aorta can be connected to an 
artificial circulation of whole blood to add perfusion dynamics to the EVLV model 
and image neutrophil activation detection following extravasation. It was surprising 
to find that neutrophils were not sufficiently activated by instillation into an 
allogenic lung to become stained. A low level of neutrophil activation may have 
occurred and achieved insufficient HNE probe staining to be visible using 
Versicolour. The narrow and tortuous tracts of the pulmonary vasculature may 
considerably challenge, if not prevent, activated allogenic neutrophil extravasation. 
Whether or not this challenge can be overcome, the detection of neutrophils will 
provide previously inaccessible clarity into disease prognosis as work from Ionita et 
al. has already demonstrated in their study of hundreds of atherosclerotic 
plaques.107 As image cytometric and neural network techniques become integrated 
with FCE, the clinician may be able to read a functionally categorized inflammatory 
sites, using information compressed from a multidimensional wealth of microscopic 











CHAPTER 6:  














In chapter one the biomarker potential of neutrophils was described. Short half-
lives make for safer imaging paradigms as imaging reagents are rapidly cleared 
along with stained cells. At the same time, continuous neutrophil influx, makes 
neutrophil imaging useful over extensive, chronic inflammatory disease time-
frames. Rapid response and accumulation are properties that allow labelled 
neutrophils to describe pathophysiological events quickly, with signal amplification. 
It can therefore be envisaged that cohorts of neutrophils will arrive at inflammatory 
sites, take up optical imaging agents and generate images which may be used to 
rapidly target patients to appropriate treatment groups. In a patient monitoring 
context, successive cohorts of infiltrating neutrophils may behave differently and 
the changes between cohorts maybe interpreted to describe treatment 
responsiveness. In addition to describing heterogeneity between neutrophil cohorts 
over time, indicating a trajectory, heterogeneity within each neutrophil population 
can be described at a given timepoint as a range of neutrophil activation states 
creates a granular picture of the inflammatory response. Optical molecular imaging 
is an inexpensive, specific and sensitive paradigm whereby the complexity of 
neutrophil biology can be organized into a versatile patient stratification tool. The 






6.1.1 CHAPTER THREE SUMMARY 
In Chapter Three an activable optical imaging probe, Neutrophil Activation Probe 
(NAP) was characterised in vitro with purified HNE and primary human neutrophils. 
Chapter Three reported:  
• 500nM NAP could be detected in a spectrometric system and a 3 μM 
concentration was useful in sensitive measurements of purified HNE activity 
without detector saturation.  
• NAP signal proved temperature sensitive with maximal fluorescence at 
26.1oC  
• Physiologically relevant HNE concentrations increase in activity under 
alkalinisation with predictable, linear dynamics. A 100-fold decrease in 
proton concentration yields a 4-fold increase in HNE activity. 
• NAP fluorescence increases under alkalinisation. 
• NAP is highly selective for HNE although at supra-physiological doses other 
serine proteases, cathepsin G and protease 3 can generate relatively small 
fractions of NAP signal. 
• High NAP selectivity can be expected to be further increased in the 
phagolysosome where increasing serine protease and alkalinisation both 
effect greater contributions from HNE to NAP signal than other serine 
proteases. 
• Calcium ionophore stimulation generates a large assay window within which 
to measure changes in neutrophil activation.  
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• NAP signal sensitively reports pharmacological modulation of HNE activity 
following calcium ionophore stimulation. 
• Calcium ionophore stimulated primary human neutrophil’s generate HNE-
specific NAP signals which evolve with rapid kinetics and are stable over a 
ten minute time course. Subcellular NAP signals are readily quantified via 
image-analysis.  
• LPS/fMLF stimulated primary human neutrophil’s generate HNE-specific NAP 
signals which evolve with rapid kinetics and decay over a ten minute time 
course. The more subtle subcellular NAP signals induced by physiologically 
relevant stimuli are still readily quantified via image-analysis.  
• NAP signals can be used to detect neutrophil activation in viable ageing 
neutrophils and in the presence of neutrophil apoptosis and necrosis, 
whether apoptotic or necrosis precede neutrophil activation or follow it. In 
mixed populations of viable apoptotic and necrotic neutrophils image 
analysis and fluorescence thresholding and intracellular distribution patterns 








6.1.2. CHAPTER FOUR SUMMARY 
In chapter four a lead, HNE-targeted, optical imaging probe was selected from a 
panel of candidate probes developed in-house. VE200 was characterised in vitro 
with purified HNE and primary human neutrophils before its interaction with NAP 
was characterised. Finally, multiplexed HNE-imaging was conducted in an image 
cytometric assay investigating HNE dynamics across the neutrophil lifespan. Chapter 
four reported: 
• GW447631 is a potent HNE inhibitor, which can abrogate NAP signal without 
appropriate titration. 
• GW447631 achieves intracellular HNE inhibition and can reduce neutrophil 
shape-change upon stimulation.  
• VE136 can be used to detect stimulus intensity as neutrophils release HNE 
with stimulus proportionality. 
• VE200 detects neutrophil activation more sensitively than VE135 or VE136 
and has improved neutrophil specificity over VE135. VE200 is therefore the 
lead HNE-targeted probe. 
• VE200 displays neutrophil specificity among the leukocytes by virtue of its 
HNE specificity. 
• Displaying biphasic binding kinetics and increased HNE inhibition over time, 
VE200 is an irreversibly binding HNE-targeted probe. 
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• Neutrophil activation is detected most sensitively by VE200 at a 
concentration of 200 nM when intracellular signal is quantified and 500 nM 
when extracellular signal is included in quantification. 
• VE200 stains neutrophils with significantly increased efficiency compared to 
free Cy5 dye and at 200 nM, VE200 multiplexes 71.1% NAP signal is 
preserved in a multiplexed imaging assay. 
• 3 µM NAP detects neutrophil activation and distinctions between viable, 
apoptotic and necrotic neutrophil populations more sensitively than 100 nM 
VE200. However, VE200’s altered affinity for activated, viable, apoptotic and 
necrotic neutrophils adds discriminatory power when multiplexed with NAP. 
• Image cytometry reveals that NAP and VE200 signals remain highly 
correlated in the presence of untreated, activated or necrotic neutrophils 











6.1.3 CHAPTER FIVE SUMMARY 
In chapter five the richness of imaging datasets generated via NAP and VE200 
multiplexed imaging, was processed with the aim of classifying neutrophils by HNE-
phenotype. Using image cytometry and the understanding of activation-detection 
by thresholding, established in chapters three and four, a simple classifier is used to 
parse overtly activated neutrophils by chemokinetic stimulus. Next a more complex 
classifier is used to parse all neutrophil imaged by chemokinetic stimulus. Finally, 
image cytometry is applied to human lung adenocarcinomatous tissue to detect 
neutrophil activation. And multiplexed HNE-imaging is applied via fibred-confocal 
endomicroscopy in an ex vivo, ventilated lung model. Chapter five reported: 
• 63% of HNE activity is available for detection following gentle fixation, 
although fixation introduces artefactual NAP fluorescence. This enables 
membranous HNE detection in fixed samples of primary human neutrophils.  
• HNE release follows a predictable trend of increase from untreated, primed, 
activated to primed-activated neutrophils. Imaging these treatment groups 
affords fluorescence intensity and textural data for the identification of 
activated neutrophils. By optimising combinations of imaging features 
neutrophils may be described in different classes, or chemokinetic 
phenotypes, occupying unique feature-spaces.  
• Neural network modelling of multiplexed imaging data can produce specific 
and sensitive phenotypic classification of neutrophils responding to 
physiologically relevant stimuli, over time. Neural networks can organise 
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neutrophil phenotypes into functionally meaningful categories, a priori, 
facilitating the detection of abnormal activation responses.  
• Image cytometry can be applied to HNE imaging in fixed human tissues to 
enable neutrophil multiparametric activation detection. 
• HNE and the prognostic indicator GLUT-1 are positively correlated in lung 
adenocarcinoma. 
• Via fibred-confocal microscopy multiplexed NAP and VE200 signals and 
hence neutrophil activation are detectable in vitro. 
• Via fibred-confocal microscopy, multiplexed NAP and VE200 signals and 
hence neutrophil activation are detectable and quantifiable in an ex vivo 
ventilated lung model. 
• Sequential NAP and VE200 staining can identify temporally distinct 
neutrophil populations in an ex vivo ventilated lung model.  
6.2.1 LIMITATIONS AND FUTURE DIRECTIONS  
There are several directions for future research that may prove useful to the fields 
of molecular imaging agent development, cellular phenotyping for optical molecular 
imaging and interventional clinical imaging. Although discussed in detail in chapters 







6.2.2 IN VIVO RELEVANCE  
The main limitation of the current work is the lack of in vivo studies supporting in 
vitro and ex vivo findings. Focusing on in vitro characterisation was necessary to 
understand how novel HNE imaging probes would relay information particularly in 
the destructive environment of the neutrophil’s phagolysosome. The constraints of 
chemical synthesis also played a non-negligible role in the characterisation and 
development cycles of imaging agents. However, the ex vivo ventilated lung model 
contributes significantly to the argument for the clinical relevance of findings 
presented in chapter five. There are multiple avenues along which to develop this 
investigation: 1) instilling HNE imaging agents into animal models of disease for 
fibred confocal endomicroscopy at pertinent time points either in vivo or in 
inflamed organs of interest ex vivo. 2) Perfusing the ex vivo ventilated lung with 
human whole blood and delivering stimuli into the alveolar airspace to stimulate 
neutrophil extravasation would create a paradigm in which detection of the earliest 
inflammatory events may be evaluated. 3) Conducting a clinical trial to evaluate 
HNE imaging probes in diseased patients, wherein disease pathophysiology may 
impact on the quality of imaging data accessible. Options 2) and 3) may be 
preferable as the current characterisation has taken place using only human 
enzymes, primary human cells and tissues. Chapter three highlights the complex, 
multifactorial nature of probe signal generation in vitro, a matter which may be 
complicated further in vivo particular with the consideration of intrinsic tissue 
autofluorescence. Although autofluorescence can be removed from measurements 
of neutrophil activation in humans, the autofluorescence of tissues from different 
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species, and methods for its subtraction from signal, may vary significantly, 
potentially confounding inferences about probe sensitivity. Unpublished data from 
the Dhaliwal group shows sheep lungs are far more autofluorescent than human 
lungs by fibred confocal microscopy.  
 
6.2.3 PHYSICAL LIMITATIONS TO THE CURRENT FIBRED CONFOCAL 
MICROSCOPY TECHNIQUE 
Limited field of view and imaging resolution are limitations of the current fibred 
confocal endomicroscopy assays. However, both limitations can be resolved with 
existing technology. Recent technological advances in reflectance fibred microscopy 
enable multiple frames of a video to be automatically mosaiced creating 100 mm2 
or larger, fields of view without reduction in imaging resolution.250 The resolution of 
the current fibred confocal microscopy apparatus can also be readily improved. 
Currently, graded refractive index lensed fibres achieve subcellular imaging 
resolutions to drive fibred microscopy into a similarly information-dense regime as 
benchtop confocal microscopy. With this in mind, the current technique to image 
and individually parse large numbers of neutrophils may be achieved in clinics in the 
near-future. This presents several areas of future research for neutrophil HNE-
phenotyping. Neutrophils exist in numerous primed and activated states depending 
on their environment and activating stimuli and, due to the real-time nature of 
optical molecular imaging, transitory states may also be imaged. With this 
complexity in mind, it may be useful to investigate the minimum number of 
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neutrophil phenotypes which are necessary to make a given diagnosis or patient 
stratification decision and thereby expedite data acquisition and processing.  
 
6.2.4 CONTEXTUALISED NEUTROPHIL QUANTITATION 
The neutrophil to lymphocyte ratio (NLR) has been reported to be useful in making 
patient stratification decisions in across an impressive breadth of disease.5–7,95–100 
NLR seems a versatile means of translating inflammatory information into clinical 
decisions however, there is an important caveat to the implementation of NLR in a 
given patient cohort. The precise NLR thresholds dividing high and low risk cohorts 
are not stationary between patient cohorts and hence reported thresholds may 
prove unreliable in a new study. Although the number of neutrophils is 
contextualized by the number of lymphocytes in NLR calculations each neutrophil 
can exist in numerous states which may combine such two patients with the same 
NLR reach different outcomes. What may be required is a contextualised NLR which 
takes into consideration the activation state of specific immune cells, describing the 
compositions of inflammatory cell populations. The recent neutrophil to platelet 
ratio may be an attempt to address the limitations of NLR. A combined neutrophil-
platelet-lymphocyte ratio may have advantages over NLR but the new ratio also 
lacks defined methodologies for establishing intra-cohort cut-offs.251 
Despite their reliance on human operators, histological indices represent algorithms 
for assessing disease progression. Neutrophilia is quantified in histological indices, 
such as those used to score ulcerative colitis, but these scoring methods capture 
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much more information than the number of two or three cell-types. These 
comprehensive histological indices have been used to robustly compare patient 
strata for decades and seem a fitting model to learn from to address less-
standardized quantitative, prognostic methods. However, histological scores also 
have their limitations, including the considerable time taken to produce readouts 
and intra-observer reproducibility.252 With HNE-phenotyping the number and 
quality of neutrophils may be acquired in real-time, predicting  disease stage and 
revealing the composition of neutrophil populations in a manner that may enable 
standardized thresholds to be applied. Other histological data such as 
autofluorescence or probe multiplexing may afford, may further inform image 
analysis algorithms to create more robust summaries of pathophysiology. These 
metrics may make neutrophil quantitation techniques for patient stratification 
applicable between patient cohorts. 
 
6.2.5 SUMMARY 
Neutrophil activation can be detected in an ex vivo human lung via fibred confocal 
endomicroscopy. Neutrophil imaging combined with image analysis and artificial 
intelligence can describe functionally different categories of neutrophil activation. 
This classification has exquisite precision, subdividing neutrophil priming and 
activation phenotypes by bacterial or lipid mediator stimulus. The diverse responses 





6.3.1 SUBSTRATES OF HNE AND THE EFFECTS OF THEIR CLEAVAGE 
Substrate/Effect Methods Implication Reference 
HNE SDS-PAGE / SDS-






253 / 254 
Protease Inhibitors 
Elafin / SLPI / α1-PI 
HPLC, WB / HPLC, 
WB / SDS-PAGE 
Reduced inhibition 
/ suicide inhibition 
and neutrophil 
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255 / 256 / 
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Protease Zymogens 
TIMP-1, pro-MMP-9 /  
pro-MMP-12 














Elastin / Decorin /Collagens 
I, IV and XVII and Laminin /  
meprin α/ fibronectin 
SDS-PAGE / SDS-
PAGE,WB / Mass 
spec., WB, Kinetic 
analysis / WB, 
Mass spec. 
/Fluoregenic 
substrate, CF BALF 
zymography / SDS-
PAGE 
ECM remodelling / 
neutrophil 
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/ 23 
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upregulation 











































CD43 (neutrophil and T cell 
isoforms) and CD62P /  
ICAM-1 
Flow cytometry 
and SDS-PAGE /  
Flow cytometry 
and SDS-PAGE 
Partial cleavage – 
unknown effect on 
Leukocyte 




TACE  WB, NB TGF-α and Mucus 
Production 
22,268 







TNFα, Interleukins: 1β, 2, 3, 
4,6, 8, 10, 12p40, 12p70 
G-CSF, GM-CSF, 
IFNα2, IFNγ, MCP-1, MIP-
1α, MIP-1β 
ELISA with HNE 
inhibitor control 
269 
TNF, IL6 and IL8 mRNA 
transcription KD 
Q-PCR of THP-1 
macrophages 
269 
NF-κB nuclear translocation 
KD 
IF of THP-1 
macrophages 
269 
Surfactant Protein D Fragment analysis 





IL-2R and IL-6R Flow cytometry 
and Dot blot/ Flow 
cytometry and  
Reverse-Phase 
HPLC 










Epithelial Cadherin, JAM-C 
Fragment analysis 












Flagellin WB and SDS-PAGE Reduced 
immunogenicity 
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Vitamin D-binding protein SDS-PAGE, 
autoradiography 





















Table 7.0 Pleiotropic effects of HNE activity demonstrated in vitro  
HNE – Human Neutrophil Elastase 
SLPI – secretory leukocyte protease inhibitor  
TACE – Tumour necrosis factor alpha converting enzyme 
TNF-α -Tumour necrosis factor alpha 
GCSF – Granulocyte colony stimulating factor 
GM-CSF- Granulocyte-macrophage colony stimulating factor 
VEGF – Vascular endothelial growth factor 
TLR- Toll-like Receptor  
MMP – Matrix metalloprotease   
TIMP – Tissue inhibitor of metalloprotease 
IL – Interleukin  
IG – immunoglobulin 
ICAM-1 intercellular adhesion molecule 1 
WB – Western blot 
NB – Northern Blot 
SDS-PAGE – sodium dodecyl sulphate polyacrylamide gel electrophoresis 
KO – Knock-out 




6.3.2 STATISTICAL RANKING FOR OBJECTIVE FEATURE SELECTION 
HNE Immunofluorescence  




HNE Immunofluorescence  






Multiplexed VE200 and NAP Time-lapsed imaging  
NAP Intensities       
 











Multiplexed VE200 and NAP Time-lapsed imaging 
DAPI Intensities       
 




Multiplexed VE200 and NAP Time-lapsed imaging  
CellMaskTM Orange Intensities  
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